10-Q

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

0001193125-16-677968.txt : 20160810 0001193125-16-677968.hdr.sgml : 20160810 20160810150458 ACCESSION NUMBER: 0001193125-16-677968 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 67 CONFORMED PERIOD OF REPORT: 20160630 FILED AS OF DATE: 20160810 DATE AS OF CHANGE: 20160810 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Stereotaxis, Inc. CENTRAL INDEX KEY: 0001289340 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 943120386 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-36159 FILM NUMBER: 161821244 BUSINESS ADDRESS: STREET 1: 4320 FOREST PARK AVENUE STREET 2: SUITE 100 CITY: ST.LOUIS STATE: MO ZIP: 63108 BUSINESS PHONE: 314-678-6100 MAIL ADDRESS: STREET 1: 4320 FOREST PARK AVENUE STREET 2: SUITE 100 CITY: ST.LOUIS STATE: MO ZIP: 63108 10-Q 1 d200712d10q.htm 10-Q 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

x	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2016

¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number: 001-36159

STEREOTAXIS, INC.

(Exact name of registrant as specified in its charter)


Delaware		94-3120386
(State of Incorporation)		(I.R.S. employer identification no.)

4320 Forest Park Avenue Suite 100 St. Louis, Missouri		63108
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (314) 678-6100

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. x Yes ¨ No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Registration S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). x Yes ¨ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b -2 of the Exchange Act). ¨ Yes x No

The number of outstanding shares of the registrant’s common stock on July 29, 2016 was 21,853,376.

STEREOTAXIS, INC.

INDEX TO FORM 10-Q


		Page
Part I Financial Information
Item 1.	Financial Statements (unaudited)
	Balance Sheets		3
	Statements of Operations		4
	Statements of Cash Flows		5
	Notes to Financial Statements		6-16
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations		17-22
Item 3.	[Reserved]		22
Item 4.	Controls and Procedures		22
Part II Other Information
Item 1.	Legal Proceedings		23
Item 1A.	Risk Factors		23
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds		23
Item 3.	Defaults upon Senior Securities		23
Item 4.	[Reserved]		23
Item 5.	Other Information		23
Item 6.	Exhibits		23
Signatures			24
Exhibit Index			25

ITEM 1.

FINANCIAL STATEMENTS

STEREOTAXIS, INC.

BALANCE SHEETS


	June 30,			December 31,
	2016			2015
	(Unaudited)
Assets
Current assets:
Cash and cash equivalents	$	3,858,089		$	5,593,582
Accounts receivable, net of allowance of $251,933 and $93,478 in 2016 and 2015, respectively		5,057,503			6,376,470
Inventories		5,334,687			4,504,282
Prepaid expenses and other current assets		569,825			668,659

Total current assets		14,820,104			17,142,993
Property and equipment, net		857,869			1,067,321
Intangible assets, net		536,229			635,889
Other assets		44,774			31,693

Total assets	$	16,258,976		$	18,877,896

Liabilities and stockholders’ deficit
Current liabilities:
Short-term debt	$	3,000,000		$	—
Accounts payable		2,427,697			1,840,135
Accrued liabilities		5,431,055			6,058,390
Deferred revenue		7,435,975			7,445,935
Warrants and debt conversion features		627,466			794,130

Total current liabilities		18,922,193			16,138,590
Long-term debt		18,114,408			18,080,159
Long-term deferred revenue		620,945			2,009,198
Other liabilities		270,296			275,603

Total liabilities		37,927,842			36,503,550
Stockholders’ deficit:
Preferred stock, par value $0.001; 10,000,000 shares authorized, none outstanding at 2016 and 2015		—			—
Common stock, par value $0.001; 300,000,000 shares authorized, 21,846,095 and 21,551,173, shares issued at 2016 and 2015, respectively		21,846			21,551
Additional paid in capital		449,081,382			448,517,472
Treasury stock, 4,015 shares at 2016 and 2015		(205,999	)		(205,999	)
Accumulated deficit		(470,566,095	)		(465,958,678	)

Total stockholders’ deficit		(21,668,866	)		(17,625,654	)

Total liabilities and stockholders’ deficit	$	16,258,976		$	18,877,896

See accompanying notes.

STEREOTAXIS, INC.

STATEMENTS OF OPERATIONS

(Unaudited)


	Three Months Ended June 30,						Six Months Ended June 30,
	2016			2015			2016			2015
Revenue:
Systems	$	935,978		$	3,092,935		$	3,010,997			5,924,113
Disposables, service and accessories		6,938,645			6,571,315			13,511,632			13,271,163

Total revenue		7,874,623			9,664,250			16,522,629			19,195,276
Cost of revenue:
Systems		395,898			1,849,275			1,478,996			3,249,542
Disposables, service and accessories		699,173			1,093,988			1,796,888			2,324,359

Total cost of revenue		1,095,071			2,943,263			3,275,884			5,573,901
Gross margin		6,779,552			6,720,987			13,246,745			13,621,375
Operating expenses:
Research and development		1,421,380			1,419,826			2,894,465			2,905,533
Sales and marketing		4,211,706			4,250,779			8,105,819			8,285,150
General and administrative		2,786,046			2,772,708			5,372,838			5,567,297

Total operating expenses		8,419,132			8,443,313			16,373,122			16,757,980

Operating loss		(1,639,580	)		(1,722,326	)		(3,126,377	)		(3,136,605	)
Other income		135,370			999,169			166,664			106,792
Interest income		140			493			362			1,355
Interest expense		(829,046	)		(816,023	)		(1,648,066	)		(1,645,810	)

Net loss	$	(2,333,116	)	$	(1,538,687	)	$	(4,607,417	)	$	(4,674,268	)

Net loss per common share:
Basic	$	(0.11	)	$	(0.07	)	$	(0.21	)	$	(0.22	)
Diluted	$	(0.11	)	$	(0.07	)	$	(0.21	)	$	(0.22	)

Weighted average shares used in computing net loss per common share:
Basic		21,793,583			21,007,103			21,702,597			20,871,244
Diluted		21,793,583			21,007,103			21,702,597			20,871,244

See accompanying notes.

STEREOTAXIS, INC.

STATEMENTS OF CASH FLOWS

(Unaudited)


	Six Months Ended June 30,
	2016			2015
Cash flows from operating activities
Net loss	$	(4,607,417	)	$	(4,674,268	)
Adjustments to reconcile net loss to cash used in operating activities:
Depreciation		185,802			134,025
Amortization of intangibles		99,660			149,917
Amortization of deferred finance costs		108,850			111,018
Share-based compensation		566,975			637,246
Adjustment of warrants		(166,664	)		(106,792	)
Changes in operating assets and liabilities:
Accounts receivable		1,318,967			(969,414	)
Inventories		(806,755	)		609,088
Prepaid expenses and other current assets		147,942			244,527
Other assets		(13,081	)		67,541
Accounts payable		587,562			(60,014	)
Accrued liabilities		(627,335	)		497,625
Deferred revenue		(1,398,213	)		(435,029	)
Other liabilities		(5,307	)		(409,358	)

Net cash used in operating activities		(4,609,014	)		(4,203,888	)
Cash flows from investing activities
Purchase of equipment		—			(52,410	)

Net cash used in investing activities		—			(52,410	)
Cash flows from financing activities
Payments of deferred financing costs		(100,000	)		—
Proceeds from (payments of) revolving line of credit		3,000,000			—
Payments of Healthcare Royalty Partners debt		(23,709	)		(80,328	)
Proceeds from issuance of stock, net of issuance costs		(2,770	)		695,598

Net cash provided by (used in) financing activities		2,873,521			615,270

Net increase (decrease) in cash and cash equivalents		(1,735,493	)		(3,641,028	)

Cash and cash equivalents at beginning of period		5,593,582			7,270,301

Cash and cash equivalents at end of period	$	3,858,089		$	3,629,273

See accompanying notes.

STEREOTAXIS, INC.

NOTES TO FINANCIAL STATEMENTS

(Unaudited)

Notes to Financial Statements

In this report, “Stereotaxis”, the “Company”, “Registrant”, “we”, “us”, and “our” refer to Stereotaxis, Inc. and its wholly owned subsidiaries. Epoch^®, Niobe^®, Odyssey^®, Odyssey Cinema™, Vdrive^®, Vdrive Duo™, V-CAS™, V-Loop™, V-Sono™, V-CAS Deflect™, QuikCAS™, Cardiodrive^®, and Pegasus™ are trademarks of Stereotaxis, Inc. All other trademarks that appear in this report are the property of their respective owners.

1. Description of Business

Stereotaxis designs, manufactures, and markets the Epoch^® Solution, an advanced remote robotic navigation system for use in a hospital’s interventional surgical suite or “interventional lab”, that we believe revolutionizes the treatment of arrhythmias and coronary artery disease by enabling enhanced safety, efficiency, and efficacy for catheter-based or interventional procedures. The Epoch Solution is comprised of the Niobe^® ES Magnetic Navigation System (“Niobe ES system”), Odyssey^® Information Management Solution (“Odyssey Solution”), and the Vdrive^® Robotic Navigation System (“Vdrive system”) and related devices.

The Niobe ES system is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. This is achieved using externally applied magnetic fields that govern the motion of the working tip of the catheter or guidewire, resulting in improved navigation, efficient procedures, and reduced X-ray exposure.

In addition to the Niobe ES system and its components, Stereotaxis has also developed the Odyssey Solution, which consolidates all lab information, enabling doctors to focus on the patient for optimal procedure efficiency. The platform also features a remote viewing and recording capability called the Odyssey Cinema™ system, an innovative system delivering synchronized content for optimized workflow, advanced care, and improved productivity. This tool includes an archiving capability that allows clinicians to store and replay entire procedures or segments of procedures. This information can be accessed from locations throughout the hospital’s local area network and over the global Odyssey Network, providing physicians with a tool for clinical collaboration, remote consultation, and training.

Our Vdrive system provides navigation and stability for diagnostic and therapeutic devices designed to improve interventional procedures. The Vdrive system complements the Niobe ES system’s control of therapeutic catheters for fully remote procedures and enables single-operator workflow. It is sold as two options, the Vdrive system and the Vdrive Duo™ system. In addition to the Vdrive system and the Vdrive Duo system, we also manufacture and market various disposable components which can be manipulated by these systems.

We promote the full Epoch Solution in a typical hospital implementation, subject to regulatory approvals or clearances. The full Epoch Solution implementation requires a hospital to agree to an upfront capital payment and recurring payments. The upfront capital payment typically includes equipment and installation charges. The recurring payments typically include disposable costs for each procedure, equipment service costs beyond the warranty period, and software licenses. In hospitals where the full Epoch Solution has not been implemented, equipment upgrade or expansion may be implemented upon purchase of the necessary components. As of June 30, 2016, the Company has an installed base of 129 Niobe ES systems.

The core components of Stereotaxis’ systems have received regulatory clearance in the United States, European Union, Canada, China, Japan and various other countries. We have received regulatory clearance, licensing and/or CE Mark approvals necessary for us to market the Vdrive and Vdrive Duo systems with the V-CAS, V-Loop and V-Sono devices in the U.S., Canada and European Union. The V-CAS Deflect catheter advancement system has been CE Marked for sale in the European Union. We have received Food and Drug Administration (“FDA”) clearance and the CE Mark necessary for us to market our suite of Pegasus™ coronary peripheral guidewires in the United States and Europe.

Since our inception, we have generated significant losses. As of June 30, 2016, we have incurred cumulative net losses of approximately $470.6 million. In 2016, the Company plans to continue developing the Niobe ES system with the goal of furthering clinical adoption and new system placements. We expect to incur additional losses in 2016 as we continue the development and commercialization of our products, conduct our research and development activities, advance new products into clinical development from our existing research programs and fund additional sales and marketing initiatives. During 2016, we will continue to monitor operating expenses and make additional investments in certain targeted areas.

Our existing cash, cash equivalents, and borrowing facilities may not be sufficient to fund our operating expenses and capital equipment requirements through the next 12 months, which would require us to obtain additional financing. We may be required to raise capital or pursue other financing strategies to continue our operations. Until we can generate significant cash flow from our operations, we expect to continue to fund our operations with cash resources primarily generated from the proceeds of our past and future public offerings, private sales of our equity securities, and loans collateralized by working capital and equipment. We continue to explore financing alternatives, which may include the sale of equity securities or non-core assets, strategic collaboration agreements, debt financings, or distribution rights. We cannot accurately predict the timing and amount of our utilization of capital, which will depend on a number of factors outside of our control.

We cannot assure that additional financing will be available on acceptable terms or that such financing will not be dilutive to our stockholders. If adequate funds are not available to us, we could be required to delay development or commercialization of new products, to license to third parties the rights to commercialize products or technologies that we would otherwise seek to commercialize ourselves, or to reduce the sales, marketing, customer support or other resources devoted to our products, any of which could have a material adverse effect on our business, financial condition, and operational results. In addition, we could be required to cease operations.

2. Summary of Significant Accounting Policies

Basis of Presentation

The accompanying unaudited financial statements of Stereotaxis, Inc. have been prepared in accordance with generally accepted accounting principles for interim financial information and the instructions to Form 10-Q. Accordingly, they do not include all the disclosures required by U.S. generally accepted accounting principles for complete financial statements. In the opinion of management, they include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods presented. Operating results for the six month period ended June 30, 2016 are not necessarily indicative of the results that may be expected for the year ended December 31, 2016 or for future operating periods.

These interim financial statements and the related notes should be read in conjunction with the annual financial statements and notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2015 as filed with the Securities and Exchange Commission (SEC) on March 11, 2016.

Financial Instruments

Financial instruments consist of cash and cash equivalents, accounts receivable, accounts payable and debt. The carrying value of such amounts reported at the applicable balance sheet dates approximates fair value. See Note 9 for disclosure of the fair value of debt.

The Company measures certain financial assets and liabilities, including warrants, at fair value on a recurring basis. General accounting principles for fair value measurement established a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets and liabilities (“Level 1”) and the lowest priority to unobservable inputs (“Level 3”). See Note 11 for additional details.

Revenue and Costs of Revenue

The Company accounts for revenue using Accounting Standards Codification Topic 605-25, Multiple-Element Arrangements (“ASC 605-25”).

ASC 605-25 permits management to estimate the selling price of undelivered components of a bundled sale for which it is unable to establish vendor-specific objective evidence (“VSOE”) or third-party evidence (“TPE”). This requires management to record revenue for certain elements of a transaction even though it might not have delivered other elements of the transaction, for which it was unable to meet the requirements for establishing VSOE or TPE. The Company believes that the guidance significantly improves the reporting of these types of transactions to more closely reflect the underlying economic circumstances. This guidance also prohibits the use of the residual method for allocating revenue to the various elements of a transaction and requires that the revenue be allocated proportionally based on the relative estimated selling prices.

Under our revenue recognition policy, a portion of revenue for Niobe systems, Vdrive systems and certain Odyssey systems is recognized upon delivery, provided that title has passed, there are no uncertainties regarding acceptance, persuasive evidence of an arrangement exists, the sales price is fixed and determinable, and collection of the related receivable is reasonably assured. Revenue is recognized for other types of Odyssey systems upon completion of installation, since there are no qualified third party installers. When installation is the responsibility of the customer, revenue from system sales is recognized upon shipment since these arrangements do not include an installation element or right of return privileges. The Company does not recognize revenue in situations in which inventory remains at a Stereotaxis warehouse or in situations in which title and risk of loss have not transferred to the customer. Amounts collected prior to satisfying the above revenue recognition criteria are reflected as deferred revenue. Revenue from services and license fees, whether sold individually or as a separate unit of accounting in a multiple-deliverable arrangement, is deferred and amortized over the service or license fee period, which is typically one year. Revenue from services is derived primarily from the sale of annual product maintenance plans. We recognize revenue from disposable device sales or accessories upon shipment and establish an appropriate reserve for returns. The return reserve, which is applicable only to disposable devices, is estimated based on historical experience which is periodically reviewed and updated as necessary. In the past, changes in estimate have had only a de minimis effect on revenue recognized in the period. We believe that the estimate is not likely to change significantly in the future.

Costs of systems revenue include direct product costs, installation labor and other costs, estimated warranty costs, and initial training and product maintenance costs. These costs are recorded at the time of sale. Costs of disposable revenue include direct product costs and estimated warranty costs and are recorded at the time of sale. Cost of revenue from services and license fees are recorded when incurred.

Share-Based Compensation

The Company accounts for its grants of stock options, stock appreciation rights, restricted shares, and restricted stock units and for its employee stock purchase plan in accordance with the provisions of general accounting principles for share-based payments. These accounting principles require the determination of the fair value of the share-based compensation at the grant date and the recognition of the related expense over the period in which the share-based compensation vests.

The Company utilizes the Black-Scholes valuation model to determine the fair value of stock options and stock appreciation rights at the date of grant. The resulting compensation expense is recognized over the requisite service period, which is generally four years. Compensation expense is recognized only for those awards expected to vest, with forfeitures estimated based on the Company’s historical experience and future expectations. Restricted shares granted to employees are valued at the fair market value at the date of grant. The Company amortizes the fair market value to expense over the service period. If the shares are subject to performance objectives, the resulting compensation expense is amortized over the anticipated vesting period and is subject to adjustment based on the actual achievement of objectives.

Net Earnings (Loss) per Common Share (“EPS”)

Basic and diluted net earnings (loss) per common share are computed by dividing the net income (loss) for the period by the weighted average number of common shares outstanding during the period.

The following table sets forth the computation of basic and diluted EPS:


	Three months ended June 30,						Six months ended June 30,
	2016			2015			2016			2015
Numerator:
Numerator for basic EPS	$	(2,333,116	)	$	(1,538,687	)	$	(4,607,417	)	$	(4,674,268	)

Numerator for diluted EPS	$	(2,333,116	)	$	(1,538,687	)	$	(4,607,417	)	$	(4,674,268	)

Denominator:
Denominator for basic EPS—weighted average shares		21,793,583			21,007,103			21,702,597			20,871,244

Denominator for diluted EPS—weighted average shares		21,793,583			21,007,103			21,702,597			20,871,244

Basic EPS	$	(0.11	)	$	(0.07	)	$	(0.21	)	$	(0.22	)
Diluted EPS	$	(0.11	)	$	(0.07	)	$	(0.21	)	$	(0.22	)

In addition, the Company did not include any portion of unearned restricted shares, outstanding options, stock appreciation rights or warrants in the calculation of diluted loss per common share because all such securities are anti-dilutive for all periods presented. The application of the two-class method of computing earnings per share under general accounting principles for participating securities is not applicable during these periods because the Company’s unearned restricted shares do not contractually participate in its losses.

As of June 30, 2016, the Company had 686,383 shares of common stock issuable upon the exercise of outstanding options and stock appreciation rights at a weighted average exercise price of $8.66 per share, 2,040,365 shares of common stock issuable upon the exercise of outstanding warrants at a weighted average exercise price of $3.44 per share, and 1,212,496 shares of unvested restricted share units.

Recently Issued Accounting Pronouncements

In March 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU” or “Update”) No. 2016-09, “Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting”. This amendment is intended to simplify several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, forfeitures, and classification on the statement of cash flows. This update is effective for fiscal years beginning after December 15, 2016 (January 1, 2017 for the Company) and interim periods within those fiscal years, with earlier application permitted. The Company is evaluating the impact of this guidance on its financial statements and related disclosures.

In February 2016, the FASB issued ASU 2016-02, “Leases (ASC 842)”, which sets out the principles for the recognition, measurement, presentation and disclosure of leases for both parties to a contract (i.e. lessees and lessors). The new standard requires lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. This classification will determine whether lease expense is recognized based on an effective interest method or on a straight line basis over the term of the lease, respectively. A lessee is also required to record a right-of-use asset and a lease liability for all leases with a term of greater than 12 months regardless of their classification. Leases with a term of 12 months or less will be accounted for similar to existing guidance for operating leases today. The new standard requires lessors to account for leases using an approach that is substantially equivalent to existing guidance for sales-type leases, direct financing leases and operating leases. ASC 842 supersedes the previous leases standard, ASC 840 Leases. The standard is effective for interim and annual periods beginning after December 31, 2018 (January 1, 2019 for the Company), with early adoption permitted. The Company is in the process of evaluating the impact of this accounting standard update.

In November 2015, the FASB issued ASU No. 2015-17, “Income Taxes (Topic 740): To simplify the presentation of deferred income taxes”. The amendments in this Update require that deferred tax liabilities and assets be classified as noncurrent in a classified statement of financial position. The amendments in this Update apply to all entities that present a classified statement of financial position. The current requirement that deferred tax liabilities and assets of a tax-paying component of an entity be offset and presented as a single amount is not affected by the amendments in this Update. This standard is effective for public companies for financial statements issued for annual periods beginning after December 15, 2016 (January 1, 2017 for the Company), and interim periods within those annual periods. We adopted this accounting standard update in 2015 and there was no impact to the results of operations or cash flows.

In July 2015, the FASB issued ASU No. 2015-11, “Inventory (Topic 330): Simplifying the Measurement of Inventory” regarding the subsequent measurement of inventory as part of its Simplification Initiative. This standard is effective for public companies for fiscal years beginning after December 15, 2016 (January 1, 2017 for the Company), including interim periods within those fiscal years. This Update should be applied prospectively, and early application is permitted as of the beginning of an interim or annual reporting period. We are currently evaluating the impact of adopting this accounting standard update but do not expect this to significantly impact the results of operations, financial conditions, cash flows, or financial statement presentation.

In April 2015, the FASB issued ASU No. 2015-03, “Interest—Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs”. To simplify the presentation of debt issuance costs, the amendments in this Update require that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from that debt liability, consistent with the presentation of a debt discount. In August 2015, the FASB issued ASU 2015-15, Presentation and Subsequent Measurement of Debt Issuance Costs Associated with Line-of-Credit Arrangements—Amendments to SEC Paragraphs Pursuant to Staff Announcement at June 18, 2015 EITF Meeting (SEC Update), which adds the SEC staff’s guidance on the presentation of debt issuance costs associated with lines of credit to the Codification. The SEC staff stated it will not object to an entity presenting the costs of securing line-of-credit arrangements as an asset, regardless of whether there are any outstanding borrowings. The Standard is effective for financial statements issued for fiscal years beginning after December 15, 2015 (January 1, 2016 for the Company), and interim periods within those fiscal years. Early adoption of the amendments in this Update is permitted for financial statements that have not been previously issued. We have adopted this accounting standard update. The Company’s balance sheets as of June 30, 2016 and December 31, 2015 included $291,060 and $349,018, respectively, of deferred financing costs (excluding $75,068 and $25,960, respectively, related to line-of-credit arrangements) that were, under the new guidance, presented as a direct reduction to debt liabilities.

In August 2014, the FASB issued ASU No. 2014-15, to communicate amendments to FASB Account Standards Codification Subtopic 205-40, “Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern”. The ASU requires management to evaluate relevant conditions, events and certain management plans that are known or reasonably knowable as of the evaluation date when determining whether substantial doubt about an entity’s ability to continue as a going concern exists. Management will be required to make this evaluation for both annual and interim reporting periods. Management will have to make certain disclosures if it concludes that substantial doubt exists and when it plans to alleviate substantial doubt about the entity’s ability to continue as a going concern. The standard is effective for annual periods ending after December 15, 2016 and for interim reporting periods starting in the first quarter of 2017 (December 31, 2016 for the Company). Early adoption is permitted. We are currently evaluating the impact of adopting this accounting standard update on our financial statement disclosures.

In May 2014, the FASB issued ASU No. 2014-09, “Revenue from Contracts with Customers” which converges the FASB’s and the International Accounting Standards Board’s current standards on revenue recognition. The standard provides companies with a single model to use in accounting for revenue arising from contracts with customers and supersedes current revenue guidance. The standard is effective for annual and interim periods beginning after December 15, 2016. Early adoption is not permitted. The standard permits companies to either apply the adoption to all periods presented, or apply the requirements in the year of adoption through a cumulative adjustment. In April 2015, the FASB issued an exposure draft related to the deferral of the effective date, which would delay our effective date one year. Therefore, the standard would be effective for annual and interim periods beginning after December 15, 2017 (January 1, 2018 for the Company). We are currently evaluating the impact of adopting this accounting standard update on our financial statements and disclosures and have not concluded on an adoption method.

3. Inventories

Inventories consist of the following:


	June 30, 2016			December 31, 2015
Raw materials	$	2,476,263		$	2,065,676
Work in process		876,105			24,758
Finished goods		2,014,872			2,433,819
Reserve for obsolescence		(32,553	)		(19,971	)

Total inventory	$	5,334,687		$	4,504,282

4. Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consist of the following:


	June 30, 2016			December 31, 2015
Prepaid expenses	$	293,484		$	454,822
Deferred financing costs		75,068			25,960
Deposits		245,650			136,583
Deferred cost of revenue		397			82,987

Total prepaid expenses and other assets		614,599			700,352
Less: Noncurrent prepaid expenses and other assets		(44,774	)		(31,693	)

Total current prepaid expenses and other assets	$	569,825		$	668,659

Certain prior year amounts have been reclassified to conform to the 2016 presentation.

5. Property and Equipment

Property and equipment consist of the following:


	June 30, 2016			December 31, 2015
Equipment	$	8,386,835		$	8,496,636
Equipment held for lease		303,412			303,412
Leasehold improvements		2,320,368			2,320,368

		11,010,615			11,120,416
Less: Accumulated depreciation		(10,152,746	)		(10,053,095	)

Net property and equipment	$	857,869		$	1,067,321

6. Intangible Assets

As of June 30, 2016, the Company had total intangible assets of $3,221,069. Accumulated amortization at June 30, 2016, was $2,684,840.

7. Accrued Liabilities

Accrued liabilities consist of the following:


	June 30,			December 31,
	2016			2015
Accrued salaries, bonus, and benefits	$	2,652,318		$	3,053,012
Accrued rent		1,159,038			1,361,379
Accrued licenses and maintenance fees		575,583			666,373
Accrued interest		494,067			494,703
Accrued warranties		258,450			316,835
Accrued taxes		313,379			324,226
Other		248,516			117,465

Total accrued liabilities		5,701,351			6,333,993
Less: Long term accrued liabilities		(270,296	)		(275,603	)

Total current accrued liabilities	$	5,431,055		$	6,058,390

Our primary company facilities are located in St. Louis, Missouri where we currently lease approximately 52,000 square feet of office and 12,000 square feet of demonstration and assembly space. In the third quarter of 2013, the Company modified the existing lease agreement to terminate approximately 13,000 square feet of unimproved space. The costs associated with the termination were $515,138 and were accrued as a rent liability as of September 30, 2013. As of June 30, 2016, the remaining accrued costs associated with the termination were $233,197.

In the fourth quarter of 2015, the Company entered a sublease agreement to sublease 3,152 square feet of the first floor office space through December 31, 2018. In July 2016, the Company and the subtenant mutually agreed to an early termination of the sublease, effective July 31, 2016.

8. Deferred Revenue

Deferred revenue consists of the following:


	June 30,			December 31,
	2016			2015
Product shipped, revenue deferred	$	338,831		$	366,388
Customer deposits		1,050,000			2,505,000
Deferred service and license fees		6,668,089			6,583,745

Total deferred revenue		8,056,920			9,455,133
Less: Long-term deferred revenue		(620,945	)		(2,009,198	)

Total current deferred revenue	$	7,435,975		$	7,445,935

9. Long-Term Debt and Credit Facilities

Debt outstanding consists of the following:


	June 30, 2016						December 31, 2015
	Carrying			Estimated			Carrying		Estimated
	Amount			Fair Value			Amount		Fair Value
Revolving line of credit, due March 31, 2018	$	3,000,000		$	3,000,000		$	—	$	—
Healthcare Royalty Partners debt		18,114,408			18,405,468			18,080,159		18,429,177

Total debt		21,114,408			21,405,468			18,080,159		18,429,177
Less current maturities		(3,000,000	)		(3,000,000	)		—		—

Total long term debt	$	18,114,408		$	18,405,468		$	18,080,159	$	18,429,177

In accordance with general accounting principles for fair value measurement, the Company’s debt and credit facilities were measured at fair value as of June 30, 2016 and December 31, 2015. Long-term debt fair value estimates are based on estimated borrowing rates to discount the cash flows to their present value (Level 3).

Certain prior year amounts have been reclassified to conform to the 2016 presentation.

Revolving Line of Credit

The Company has had a working capital line of credit with its primary lender, Silicon Valley Bank, since 2004. The revolving line of credit is secured by substantially all of the Company’s assets. The maximum available under the line is $10.0 million subject to the value of collateralized assets. The Company is required under the revolving line of credit to maintain its primary operating account and the majority of its cash and investment balances in accounts with its primary lender. The facility was amended on March 27, 2015, extending the maturity date to March 31, 2018 and on May 10, 2016, the Company and the primary lender agreed to modify certain financial covenants. The amended agreement requires the Company to maintain a liquidity ratio greater than 1.50:1.00, excluding certain short term advances from the calculation, and a minimum tangible net worth of not less than (no worse than) negative $24.0 million for the quarters ended June 30, 2016, September 30, 2016, December 31, 2016, March 31, 2017, June 30, 2017, and September 30, 2017; and not less than (no worse than) negative $24.5 million for the quarters ended December 31, 2017 and March 31, 2018.

As of June 30, 2016, the Company had $3.0 million outstanding under the revolving line of credit. Draws on the line of credit are made based on the borrowing capacity one week in arrears. As of June 30, 2016, the Company had a borrowing capacity of $4.0 million based on the Company’s collateralized assets, including amounts already drawn. As such, the Company has the ability to borrow an additional $1.0 million under the revolving line of credit at June 30, 2016. The Company’s total liquidity as of June 30, 2016, was $4.9 million which included cash and cash equivalents of $3.9 million. The $3.0 million outstanding under the revolving line of credit was repaid shortly after June 30, 2016.

Healthcare Royalty Partners Debt

In November 2011, the Company entered into a loan agreement with Healthcare Royalty Partners. Under the agreement the Company borrowed from Healthcare Royalty Partners $15 million. The Company was permitted to borrow up to an additional $5 million in the aggregate based on the achievement by the Company of certain milestones related to Niobe ES system sales in 2012. On August 8, 2012, the Company borrowed an additional $2.5 million based upon achievement of a milestone related to Niobe ES system sales for the three months ended June 30, 2012. On January 31, 2013, the Company borrowed an additional $2.5 million based upon achievement of a milestone related to Niobe ES system sales for the twelve months ended December 31, 2012. The loan will be repaid through, and secured by, royalties payable to the Company under its Development, Alliance and Supply Agreement with Biosense Webster, Inc. (the “Biosense Agreement”). The Biosense Agreement relates to the development and distribution of magnetically enabled catheters used with Stereotaxis’ Niobe ES system in cardiac ablation procedures. Under the terms of the agreement, Healthcare Royalty Partners will be entitled to receive 100% of all royalties due to the Company under the Biosense Agreement until the loan is repaid. The loan is a full recourse loan, matures on December 31, 2018, and bears interest at an annual rate of 16% payable quarterly with royalties received under the Biosense Agreement. If the payments received by the Company under the Biosense Agreement are insufficient to pay all amounts of interest due on the loan, then such deficiency will increase the outstanding principal amount on the loan. After the loan obligation is repaid, the royalties under the Biosense Agreement will again be paid to the Company. The loan is also secured by certain assets and intellectual property of the Company. The agreement also contains customary affirmative and negative covenants. The use of payments due to the Company under the Biosense Agreement was approved by our primary lender.

10. Stockholders’ Equity

The holders of common stock are entitled to one vote for each share held and to receive dividends whenever funds are legally available and when declared by the Board of Directors subject to the prior rights of holders of all classes of stock having priority rights as dividends and the conditions of the revolving line of credit agreement. Since the Company’s inception, no dividends have been declared or paid.

Controlled Equity Offering

The Company entered into a Controlled Equity Offering^SM sales agreement (the “Sales Agreement”) in May 2014, as amended on March 26, 2015, with Cantor Fitzgerald & Co. (“Cantor”), as agent and/or principal, pursuant to which the Company could issue and sell, from time to time, shares of its common stock having an aggregate gross sales price of up to $18.0 million. The Company will pay Cantor a commission of 3.0% of the gross proceeds from any common stock sold through the Sales Agreement.

There were no proceeds from the Controlled Equity Offering during the three months ended June 30, 2016. As of June 30, 2016, $13.8 million of common stock remained available to be sold under this facility, subject to certain conditions as specified in the Sales Agreement. Due to the Company’s transfer to the OTCQX^® Best Market on August 4, 2016, the Company’s ability to generate proceeds from the sale of stock under the Controlled Equity Offering in the future may be limited or prohibited.

Offerings of Common Stock

On October 8, 2015 the Company announced the results of its previously announced offering of transferable subscription warrants (the “Warrants Offering) to holders of record of the Company’s common stock. Pursuant to the Warrants Offering, subscription warrants to purchase 267,256 shares of common stock were exercised, resulting in gross proceeds to the Company of $293,982.

Stock Award Plans

The Company has various stock plans that permit the Company to provide incentives to employees and directors of the Company in the form of equity compensation. In August 2012, the Board of Directors adopted the 2012 Stock Incentive Plan (the “Plan”) which was subsequently approved by the Company’s shareholders. This plan replaced the 2002 Stock Incentive Plan which expired on March 25, 2012.

On June 5, 2013, June 10, 2014, and on May 24, 2016 the shareholders approved amendments to the Plan, which were previously approved and adopted by the Compensation Committee of the Board of Directors of the Company. Under each of the amendments on June 5, 2013 and June 10, 2014, the number of shares authorized for issuance under the Plan was increased by one million shares. The amendment on May 24, 2016 increased the number of shares authorized for issuance under the Plan by 1.5 million shares. At June 30, 2016, the Company had 1,508,565 remaining shares of the Company’s common stock to provide for current and future grants under its various equity plans.

At June 30, 2016, the total compensation cost related to options, stock appreciation rights and non-vested stock granted to employees under the Company’s stock award plans but not yet recognized was approximately $1.9 million, net of estimated forfeitures of approximately $0.9 million. This cost will be amortized over a period of up to four years over the underlying estimated service periods and will be adjusted for subsequent changes in estimated forfeitures and anticipated vesting periods.

A summary of the option and stock appreciation rights activity for the six month period ended June 30, 2016 is as follows:


	Number of Options/SARs			Range of Exercise Price	Weighted Average Exercise Price per Share
Outstanding, December 31, 2015		706,494		$1.45 - $116.40	$	9.34
Granted		1,000		$1.55	$	1.55
Exercised		—		—		—
Forfeited		(21,111	)	$1.74 - $99.00	$	30.82

Outstanding, June 30, 2016		686,383		$1.45 - $116.40	$	8.66

A summary of the restricted stock unit activity for the six month period ended June 30, 2016 is as follows:


	Number of Restricted Stock Units			Weighted Average Grant Date Fair Value per Unit
Outstanding, December 31, 2015		752,008		$	2.63
Granted		791,600		$	0.84
Vested		(274,850	)	$	2.56
Forfeited		(56,262	)	$	1.49

Outstanding, June 30, 2016		1,212,496		$	1.53

11. Fair Value Measurements

The Company measures certain financial assets and liabilities at fair value on a recurring basis, including cash equivalents and warrants. General accounting principles for fair value measurement established a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets and liabilities (“Level 1”) and the lowest priority to unobservable inputs (“Level 3”). The three levels of the fair value hierarchy are described below:

Level 1:

Values are based on unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.

Level 2:

Values are based on quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, or other model-based valuation techniques for which all significant assumptions are observable in the market.

Level 3:

Values are generated from model-based techniques that use significant assumptions not observable in the market.

The following table sets forth the Company’s assets and liabilities measured at fair value on a recurring basis by level within the fair value hierarchy. As required by the Fair Value Measurements and Disclosures topic of the Accounting Standards Codification, assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.


	Fair Value Measurement Using
	Total		Quoted Prices in Active Markets for Identical Instruments (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Assets at June 30, 2016:
Cash equivalents	$	74,346		74,346		—		—

Total assets at fair value	$	74,346		74,346		—		—

Liabilities at June 30, 2016:
Warrants issued May 2012	$	209,156		—		—		209,156
Warrants issued August 2013	$	418,310		—		—		418,310

Total liabilities at fair value:	$	627,466		—		—		627,466

Assets at December 31, 2015:
Cash equivalents	$	524,083		524,083		—		—

Total assets at fair value	$	524,083		524,083		—		—

Liabilities at December 31, 2015:
Warrants issued May 2012	$	143,681		—		—		143,681
Warrants issued August 2013	$	650,449		—		—		650,449

Total liabilities at fair value:	$	794,130		—		—		794,130

Level 1

The Company’s financial assets consist of cash equivalents invested in money market funds in the amount of $74,346 and $524,083 at June 30, 2016 and December 31, 2015, respectively. These assets are classified as Level 1 as described above and total interest income recorded for these investments was insignificant during both the six month periods ended June 30, 2016, and June 30, 2015. There were no transfers in or out of Level 1 during the period ended June 30, 2016.

Level 2

The Company does not have any financial assets or liabilities classified as Level 2.

Level 3

In conjunction with the Company’s May 2012 and August 2013 financing transactions, the Company issued warrants to purchase shares of the Company’s common stock. Due to the provisions included in the warrant agreements, the warrants did not meet the exemptions for equity classification and as such, the Company accounts for these warrants as derivative instruments. The calculated fair value of the warrants is classified as a liability and is periodically re-measured with any changes in value recognized in “Other expense” in the Statements of Operations.

The remaining warrants from the May 2012 transaction expire in May 2018 and were revalued as of June 30, 2016 using the following assumptions: 1) volatility of 124.33%; 2) risk-free interest rate of 0.58%; and 3) a closing stock price of $0.98.

The remaining warrants from the August 2013 expire in November 2018 and were revalued as of June 30, 2016 using the following assumptions: 1) volatility of 113.17%; 2) risk-free interest rate of 0.58%; and 3) a closing stock price of $0.98.

The significant unobservable input used in the fair value measurement of the Company’s warrants is volatility. Significant increases (decreases) in the volatility in isolation would result in significantly higher (lower) liability fair value measurements.

The following table sets forth a summary of changes in the fair value of the Company’s Level 3 financial liabilities for the six month period ended June 30, 2016:


	Warrants issued May 2012		Warrants issued August 2013			Total Liabilities
Balance at beginning of period	$	143,681	$	650,449		$	794,130
Issues		—		—			—
Settlements		—		—			—
Revaluation		65,475		(232,139	)		(166,664	)

Balance at end of period	$	209,156	$	418,310		$	627,466

The Company currently does not have derivative instruments to manage its exposure to currency fluctuations or other business risks. The Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. All derivative financial instruments are recognized in the balance sheet at fair value.

12. Product Warranty Provisions

The Company’s standard policy is to warrant all Niobe, Odyssey, and Vdrive systems against defects in material or workmanship for one year following installation. The Company’s estimate of costs to service the warranty obligations is based on historical experience and current product performance trends. A regular review of warranty obligations is performed to determine the adequacy of the reserve and adjustments are made to the estimated warranty liability as appropriate.

Accrued warranty, which is included in other accrued liabilities, consists of the following:


	June 30, 2016			December 31, 2015
Warranty accrual, beginning of the fiscal period	$	316,835		$	364,548
Accrual adjustment for product warranty		48,064			171,384
Payments made		(106,449	)		(219,097	)

Warranty accrual, end of the fiscal period	$	258,450		$	316,835

13. Commitments and Contingencies

The Company at times becomes a party to claims in the ordinary course of business. Management believes that the ultimate resolution of pending or threatened proceedings will not have a material effect on the financial position, results of operations or liquidity of the Company.

14. Subsequent Events

On August 2, 2016, Stereotaxis, Inc. (the “Company”) received a determination letter from the Nasdaq Hearings Panel (the “Panel”) notifying the Company that its common stock would be delisted from The Nasdaq Capital Market (“Nasdaq”) and that suspension of trading in the shares would be effective at the open of business on August 4, 2016. The determination letter also indicated that Nasdaq would complete the delisting by filing a Form 25 Notification of Delisting with the Securities Exchange Commission, after applicable appeal periods have lapsed. The Panel made the determination to delist the Company’s common stock because the Company did not demonstrate compliance with the minimum $35 million market value of listed securities requirement for a period of ten consecutive trading days by August 1, 2016, as required by a decision previously issued by the Panel on May 2, 2016. The Company’s shares of common stock commenced trading on the OTCQX^® Best Market on August 4, 2016 under the Company’s current ticker symbol of “STXS.”

ITEM 2.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis should be read in conjunction with our financial statements and notes thereto included in this report on Form 10-Q and in our Annual Report on Form 10-K for the year ended December 31, 2015. Operating results are not necessarily indicative of results that may occur in future periods.

This report includes various forward-looking statements that are subject to risks and uncertainties, many of which are beyond our control. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors, including those set forth in “Item 1A. Risk Factors”. Forward-looking statements discuss matters that are not historical facts. Forward-looking statements include, but are not limited to, discussions regarding our operating strategy, sales and marketing strategy, regulatory strategy, industry, economic conditions, financial condition, liquidity, capital resources, and results of operations. Such statements include, but are not limited to, statements preceded by, followed by, or that otherwise include the words “believe”, “expects”, “anticipates”, “intends”, “estimates”, “projects”, “can”, “could”, “may”, “would”, or similar expressions. For those statements, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. You should not unduly rely on these forward-looking statements, which speak only as of the date on which they are made. They give our expectations regarding the future, but are not guarantees. We undertake no obligation to update publicly or revise any forward-looking statements, whether as a result of new information, future events or otherwise, unless required by law.

Overview

Stereotaxis designs, manufactures, and markets the Epoch^® Solution, an advanced cardiology instrument-control system for use in a hospital’s interventional surgical suite, to enhance the treatment of arrhythmias and coronary artery disease. The Epoch Solution is comprised of the Niobe^® ES system, Odyssey^® solution, and the Vdrive^® system. We believe that the Epoch Solution represents a revolutionary technology in the interventional surgical suite, or “interventional lab” and has the potential to become the standard of care for a broad range of complex cardiology procedures. We also believe that our technology represents an important advance in the ongoing trend toward digital instrumentation in the interventional lab and provides substantial, clinically-important improvements and cost efficiencies over manual interventional methods, which require years of physician training and often result in long and unpredictable procedure times and sub-optimal therapeutic outcomes.

Stereotaxis also has developed the Odyssey Solution, which consolidates all lab information enabling doctors to focus on the patient for optimal procedure efficiency. The system also features a remote viewing and recording capability called Odyssey Cinema, an innovative solution delivering synchronized content for optimized workflow, advanced care, and improved productivity. This tool includes an archiving capability that allows clinicians to store and replay entire procedures or segments of procedures. This information can be accessed from locations throughout the hospital’s local area network and over the global Odyssey Network, providing physicians with a tool for clinical collaboration, remote consultation, and training. The Odyssey Solution may be acquired, in conjunction with a Niobe ES system or on a stand-alone basis, for installation in interventional labs and other locations where clinicians often desire the benefits of the Odyssey Solution that we believe can improve clinical workflows and related efficiencies.

Our Vdrive system provides navigation and stability for diagnostic and therapeutic devices designed to improve interventional procedures. The Vdrive system complements the Niobe ES system’s control of therapeutic catheters for fully remote procedures and enables single-operator workflow. It is sold as two options, the Vdrive system and the Vdrive Duo system. In addition to the Vdrive system and the Vdrive Duo system, we also manufacture and market various disposable components (V-Loop, V-Sono, V-CAS, and V-CAS Deflect) which can be manipulated by these systems.

We generate revenue from both the initial capital sale of the Niobe, Odyssey, and Vdrive systems as well as recurring revenue from the sale of our proprietary disposable devices, from ongoing license and service contracts, and from royalties paid to the Company by Biosense Webster for the sale of co-developed catheters. We market our products to a broad base of hospitals in the United States and internationally. As of June 30, 2016, the Company has an installed base of 129 Niobe ES systems.

The core components of Stereotaxis’ systems have received regulatory clearance in the United States, European Union, Canada, China, Japan, and elsewhere. We have received regulatory clearance, licensing and/or CE Mark approvals necessary for us to market the Vdrive and Vdrive Duo systems with the V-CAS, V-Loop and V-Sono devices in the U.S., Canada and European Union. The V-CAS Deflect catheter advancement system has been CE Marked for sale in the European Union. We have received Food and Drug Administration (“FDA”) clearance and the CE Mark necessary for us to market our suite of Pegasus™ coronary peripheral guidewires in the United States and Europe.

Critical Accounting Policies and Estimates

Our discussion and analysis of our financial condition and results of operations are based on our financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses and related disclosures. We review our estimates and judgments on an on-going basis. We base our estimates and judgments on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. Actual results may differ from these estimates. We believe the following accounting policies are critical to the judgments and estimates we use in preparing our financial statements. For a complete listing of our critical accounting policies, please refer to our Annual Report on Form 10-K for the year ended December 31, 2015.

Revenue Recognition

The Company accounts for revenue using Accounting Standards Codification Topic 605-25, Multiple-Element Arrangements (“ASC 605-25”).

Results of Operations

Comparison of the Three Months Ended June 30, 2016 and 2015

Revenue. Revenue decreased from $9.7 million for the three months ended June 30, 2015 to $7.9 million for the three months ended June 30, 2016, a decrease of 19%. Revenue from the sale of systems decreased from $3.1 million to $0.9 million, a decrease of approximately 70%, primarily due to decreased system sales volumes across the Niobe, Odyssey, and Vdrive product lines. We recognized revenue of $0.3 million for Niobe system installations, $0.5 million for Odyssey and Odyssey Cinema systems, and $0.1 million for Vdrive system installations during the 2016 period. System revenue for the prior period included two Niobe systems, a total $1.0 million for Odyssey and Odyssey Cinema systems, and $0.2 million for Vdrive systems. Revenue from sales of disposable interventional devices, service and accessories increased to $6.9 million for the three months ended June 30, 2016 from $6.6 million for the three months ended June 30, 2015, an increase of approximately 6% primarily driven by increased disposable sales volumes.

Cost of Revenue. Cost of revenue decreased to $1.1 million for the three months ended June 30, 2016 from $2.9 million for the three months ended June 30, 2015. As a percentage of our total revenue, overall gross margin increased to 86% for the three months ended June 30, 2016 from 70% for the three months ended June 30, 2015 due to a shift in mix from systems revenue to disposables, service and accessories revenue. Cost of revenue for systems sold decreased from $1.8 million for the three months ended June 30, 2015 to $0.4 million for the three months ended June 30, 2016, driven by decreased system sales volumes across the Niobe, Odyssey, and Vdrive product lines. Gross margin for systems increased to 58% for the three months ended June 30, 2016 from 40% for the three months ended June 30, 2015 due to a change in product mix. Cost of revenue for disposables, service and accessories decreased to $0.7 million for the three months ended June 30, 2016 from $1.1 million for the three months ended June 30, 2015, due to lower expenses incurred under service contracts in the current year period. Gross margin for disposables, service and accessories was 90% for the current quarter compared to 83% for the three months ended June 30, 2015.

Research and Development Expenses. Research and development expenses have remained relatively consistent with the three months ended June 30, 2015 at $1.4 million.

Sales and Marketing Expenses. Sales and marketing expenses decreased slightly from $4.3 million for the three months ended June 30, 2015 to $4.2 million for the three months ended June 30, 2016.

General and Administrative Expenses. General and administrative expenses include regulatory, clinical, finance, information systems, legal, general management and routine training expenses. General and administrative expenses have remained relatively consistent with the three months ended June 30, 2015 at $2.8 million.

Other Income. Other income represents the non-cash change in market value of certain warrants classified as a derivative and recorded as a current liability under general accounting principles for determining whether an instrument (or embedded feature) is indexed to an entity’s own stock.

Interest Expense. Interest expense has remained relatively consistent with the three months ended June 30, 2015 at $0.8 million.

Comparison of the Six Months Ended June 30, 2016 and 2015

Revenue. Revenue decreased from $19.2 million for the six months ended June 30, 2015 to $16.5 million for the six months ended June 30, 2016, a decrease of approximately 14%. Revenue from the sale of systems decreased from $5.9 million to $3.0 million, a decrease of approximately 49%, primarily due to decreased sales volumes across the Niobe, Odyssey, and Vdrive product lines. We recognized revenue on one Niobe system, a total of $1.4 million on Odyssey and Odyssey Cinema systems, and a total of $0.1 million on Vdrive system installations during the 2016 period. System revenue for the prior year period included four Niobe systems, a total of $1.5 million on Odyssey and Odyssey systems, and $0.5 million for Vdrive systems during the 2015 period. Revenue from sales of disposable interventional devices, service and accessories increased to $13.5 million for the six months ended June 30, 2016 from $13.3 million for the six months ended June 30, 2015, an increase of approximately 2% due to higher service revenue in the current year.

Cost of Revenue. Cost of revenue decreased from $5.6 million for the six months ended June 30, 2015 to $3.3 million for the six months ended June 30, 2016, a decrease of approximately 41%. As a percentage of our total revenue, overall gross margin increased to 80% for the six months ended June 30, 2016 compared to 71% during the same six month period of the prior year due to a shift in mix from system revenue to disposable, service and accessory revenue. Cost of revenue for systems sold decreased from $3.2 million for the six months ended June 30, 2015 to $1.5 million for the six months ended June 30, 2016, an decrease of approximately 54%, primarily due to decreased system sales volumes across Niobe, Odyssey, and Vdrive product lines. Gross margin for systems increased from 45% for the six months ended June 30, 2015 to 51% for the six months ended June 30, 2016. Cost of revenue for disposables, service and accessories decreased to $1.8 million during the 2016 period from $2.3 million during the 2015 period, resulting in an increase in gross margin to 87% from 82% between these periods driven by lower expenses incurred under service contracts in the current year period.

Research and Development Expenses. Research and development expenses have remained relatively consistent with the six months ended June 30, 2015 at $2.9 million.

Sales and Marketing Expenses. Sales and marketing expenses decreased from $8.3 million for the six months ended June 30, 2015 to $8.1 million for the six months ended June 30, 2016, a decrease of approximately 2%. This decrease was due to decreased headcount expenses and third party commissions in the current year period.

General and Administrative Expenses. General and administrative expenses include regulatory, clinical, finance, information systems, legal, general management and training expenses. General and administrative expenses decreased to $5.4 million for the six months ended June 30, 2016 from $5.6 million for the six months ended June 30, 2015, a decrease of 3%. This decrease was primarily driven by lower headcount costs and changes in foreign currency.

Other Income. Other income represents the change in market value of certain warrants classified as a derivative and recorded as a current liability under general accounting principles for determining whether an instrument (or embedded feature) is indexed to an entity’s own stock. The primary drivers of fluctuations in this balance are changes in the Company’s stock price from one period to the next.

Interest Expense. Interest expense remained relatively consistent with the six months ended June 30, 2015 at $1.6 million.

Liquidity and Capital Resources

Liquidity refers to the liquid financial assets available to fund our business operations and pay for near-term obligations. These liquid financial assets consist of cash and cash equivalents. At June 30, 2016 we had $3.9 million of cash and equivalents. We had a working capital deficit of $4.1 million and working capital of $1.0 million as of June 30, 2016 and December 31, 2015, respectively. The decrease in the working capital is due principally to the net losses incurred for the first six months of 2016.

The following table summarizes our cash flow by operating, investing and financing activities for the six months ended June 30, 2016 and 2015 (in thousands):


	Six Months Ended June 30,
	2016			2015
Cash flow used in operating activities	$	(4,609	)	$	(4,204	)
Cash flow used in investing activities		—			(52	)
Cash flow provided by financing activities		2,874			615

Net cash used in operating activities. We used approximately $4.6 million and $4.2 million of cash for operating activities during the six months ended June 30, 2016 and 2015, respectively. The increase in cash used in operating activities was primarily driven by changes in working capital.

Net cash used in investing activities. There were no purchases of equipment for the six month period ended June 30, 2016 and we used less than $0.1 million during the six month period ended June 30, 2015 for the purchase of equipment.

Net cash provided by financing activities. We generated approximately $2.9 million of cash for the six month period ended June 30, 2016 compared to $0.6 million generated for the six month period ended June 30, 2015. The increase in cash generated for the period ended June 30, 2016 was driven by borrowings against our revolving line of credit. The cash generated for the period ended June 30, 2015 was driven by proceeds from stock issued through the Controlled Equity Offering.

We may be required to raise capital or pursue other financing strategies to continue our operations. Until we can generate significant cash flow from our operations, we expect to continue to fund our operations with cash resources primarily generated from the proceeds of our past and future public offerings, private sales of our equity securities, and loans collateralized by working capital and equipment. We continue to explore financing alternatives, which may include the sale of equity securities or non-core assets, strategic collaboration agreements, debt financings or distribution rights. We cannot accurately predict the timing and amount of our utilization of capital, which will depend on a number of factors outside of our control.

Our existing cash, cash equivalents and borrowing facilities may not be sufficient to fund our operating expenses and capital equipment requirements through the next 12 months, which would require us to obtain additional financing before that time. We cannot assure that additional financing will be available on a timely basis on terms acceptable to us or at all, or that such financing will not be dilutive to our stockholders. If adequate funds are not available to us, we could be required to delay development or commercialization of new products, to license to third parties the rights to commercialize products or technologies that we would otherwise seek to commercialize ourselves or to reduce the sales, marketing, customer support or other resources devoted to our products, any of which could have a material adverse effect on our business, financial condition and results of operations. In addition, we could be required to cease operations.

Capital Resources

As of June 30, 2016, our borrowing facilities were comprised of a revolving line of credit maintained with our primary lender, Silicon Valley Bank, as well as the Healthcare Royalty Partners debt discussed in the following sections.

Revolving Line of Credit

Healthcare Royalty Partners Debt

In November 2011, we entered into a loan agreement with Healthcare Royalty Partners. Under the agreement the Company borrowed from Healthcare Royalty Partners $15 million. The Company was permitted to borrow up to an additional $5 million in the aggregate based on the achievement by the Company of certain milestones related to Niobe ES system sales in 2012. On August 8, 2012, the Company borrowed an additional $2.5 million based upon achievement of a milestone related to Niobe ES system sales for the three months ended June 30, 2012. On January 31, 2013, the Company borrowed an additional $2.5 million based upon achievement of a milestone related to Niobe ES system sales for the twelve months ended December 31, 2012. The loan will be repaid through, and secured by, royalties payable to the Company under its Development, Alliance and Supply Agreement with Biosense Webster, Inc. (the “Biosense Agreement”). The Biosense Agreement relates to the development and distribution of magnetically enabled catheters used with Stereotaxis’ Niobe ES system in cardiac ablation procedures. Under the terms of the agreement, Healthcare Royalty Partners will be entitled to receive 100% of all royalties due to the Company under the Biosense Agreement until the loan is repaid. The loan is a full recourse loan, matures on December 31, 2018, and bears interest at an annual rate of 16% payable quarterly with royalties received under the Biosense Agreement. If the payments received by the Company under the Biosense Agreement are insufficient to pay all amounts of interest due on the loan, then such deficiency will increase the outstanding principal amount on the loan. After the loan obligation is repaid, royalties under the Biosense Agreement will again be paid to the Company. The loan is also secured by certain assets and intellectual property of the Company. The agreement also contains customary affirmative and negative covenants. The use of payments due to the Company under the Biosense Agreement was approved by our primary lender.

Common Stock

The holders of common stock are entitled to one vote for each share held and to receive dividends whenever funds are legally available and when declared by the Board of Directors subject to the prior rights of holders of all classes of stock having priority rights as dividends and the conditions of the revolving line of credit agreement. No dividends have been declared or paid as of June 30, 2016.

Controlled Equity Offering

Offerings of Common Stock

Off-Balance Sheet Arrangements

We do not currently have, nor have we ever had, any relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities, which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. In addition, we do not engage in trading activities involving non-exchange traded contracts. As a result, we are not materially exposed to any financing, liquidity, market or credit risk that could have arisen if we had engaged in these relationships.

ITEM 3.

[RESERVED]

None.

ITEM 4.

CONTROLS AND PROCEDURES

Disclosure Controls and Procedures: The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the Company’s disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), as of the end of the period covered by this report. Any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on such evaluation, the Company’s Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of such period, the Company’s disclosure controls and procedures were effective.

Changes In Internal Control Over Financial Reporting: The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, also conducted an evaluation of the Company’s internal control over financial reporting to determine whether any changes occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting. Based on that evaluation, there has been no such change during the period covered by this report.

PART II – OTHER INFORMATION

ITEM 1.

LEGAL PROCEEDINGS

We are involved from time to time in various lawsuits and claims arising in the normal course of business. Although the outcomes of these lawsuits and claims are uncertain, we do not believe any of them will have a material adverse effect on our business, financial condition or results of operations.

ITEM 1A.

RISK FACTORS

On August 4, 2016, trading in our common stock on The Nasdaq Capital Market was suspended as a result of a determination from Nasdaq to delist our common stock. On August 4, 2016, shares of our common stock commenced trading on the OTCQX^® Best Market. Trading of our shares on the over-the-counter markets could negatively impact the liquidity of our common stock and our ability to access the capital markets, which could impair the value of your investment.

On August 2, 2016, we received a determination letter from the Nasdaq Hearings Panel (the “Panel”) notifying us that our common stock would be delisted from The Nasdaq Capital Market (“Nasdaq”) and that suspension of trading in the shares would be effective at the open of business on August 4, 2016. The determination letter also indicated that Nasdaq would complete the delisting by filing a Form 25 Notification of Delisting with the Securities Exchange Commission, after applicable appeal periods have lapsed. The Panel made the determination to delist our common stock because we did not demonstrate compliance with the minimum $35 million market value of listed securities requirement for a period of ten consecutive trading days by August 1, 2016, as required by a decision previously issued by the Panel on May 2, 2016. Our shares of common stock commenced trading on the OTCQX^® Best Market on August 4, 2016 under the Company’s existing ticker symbol of “STXS.”

The delisting of our common stock from The Nasdaq Capital Market could have negative consequences, including the potential loss of confidence by suppliers, customers and employees, the loss of investor interest and fewer business development opportunities. The trading of our common stock on the over-the-counter market, including the OTCQX, may adversely affect the market liquidity of our common stock, limit or prohibit the use of our Controlled Equity Offering program, limit our ability to issue additional securities (including pursuant to registration statements on Form S-3) and adversely affect our ability to obtain financing for the continuation of our operations, which could harm our business or cause us to cease operations.

Furthermore, we can provide no assurance that our common stock will continue to trade on the OTCQX^® Best Market in the future, whether broker-dealers will continue to agree to provide public quotes of our common stock on this market, or whether the trading volume of our common stock will be sufficient to provide for an efficient trading market. Any such developments could impair the value of your investment.

Additional Risk Factors are discussed in our Annual Report on Form 10-K for the year ended December 31, 2015.

ITEM 2.

UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None.

ITEM 3.

DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4.

[RESERVED]

None.

ITEM 5.

OTHER INFORMATION

None.

ITEM 6.

EXHIBITS

Exhibits: See Exhibit Index herein

STEREOTAXIS, INC.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

EXHIBIT INDEX


Number		Description

3.1		Restated Certificate of Incorporation of the Registrant, incorporated by reference to Exhibit 3.1 of the Registrant’s Form 10-Q (file No. 000-50884) for the fiscal quarter ended September 30, 2004.

3.2		Certificate of Amendment to Amended and Restated Certificate of Incorporation, incorporated by reference to Exhibit 3.1 of the Registrant’s Current Report on Form 8-K (File No. 000-50884) filed on July 10, 2012.

3.3		Restated Bylaws of the Registrant, incorporated by reference to Exhibit 3.2 of the Registrant’s Form 10-Q (File No. 000-50884) for the fiscal quarter ended September 30, 2004.

10.1		Eleventh Loan Modification Agreement (Domestic), dated May 10, 2016, between the Company, Stereotaxis International, Inc., and Silicon Valley Bank, incorporated by reference to Exhibit 10.1 of the Registrant’s Form 10-Q (file No. 001-36159) for the fiscal quarter ended March 31, 2016.

10.2		Amended and restated Stereotaxis, Inc. Stock Incentive Plan, as adopted February 9, 2016, filed herewith.

31.1		Rule 13a-14(a)/15d-14(a) Certification (pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, executed by Chief Executive Officer).

31.2		Rule 13a-14(a)/15d-14(a) Certification (pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, executed by Chief Financial Officer).

32.1		Section 1350 Certification (pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, executed by Chief Executive Officer).

32.2		Section 1350 Certification (pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, executed by Chief Financial Officer).

101.INS		XBRL Instance Document.

101.SCH		XBRL Taxonomy Extension Schema Document.

101.CAL		XBRL Taxonomy Extension Calculation Linkbase Document.

101.DEF		XBRL Taxonomy Extension Definition Linkbase Document.

101.LAB		XBRL Taxonomy Extension Label Linkbase Document.

101.PRE		XBRL Taxonomy Extension Presentation Linkbase Document.

EX-10.2 2 d200712dex102.htm EX-10.2 EX-10.2

Exhibit 10.2

STEREOTAXIS, INC.

2012 STOCK INCENTIVE PLAN

As amended and restated effective February 9, 2016

1. Purpose of the Plan.

The purpose of the Plan is to provide the Company with a means to assist in recruiting, retaining, and rewarding certain employees, directors, consultants, and other individuals providing services to the Company and to motivate such individuals to exert their best efforts on behalf of the Company by providing incentives through the granting of Awards. By granting Awards to such individuals, the Company expects that the interests of the recipients will be better aligned with those of the Company by providing recipients with a proprietary interest in the growth and performance of the Company.

2. Definitions. Unless the context clearly indicates otherwise, the following capitalized terms shall have the meanings set forth below:

A. “Act” means the Securities Exchange Act of 1934, as amended, or any successor thereto.

B. “Award” means a grant under the Plan of an Option, Stock Appreciation Right, Cash-Based Award or Other Stock-Based Award.

C. “Award Agreement” means the document (in written or electronic form) communicating the terms, conditions and limitations applicable to an Award. The Committee may, in its discretion, require that the Participant execute such Award Agreement, or may provide for procedures through which Award Agreements are made available but not executed. Any Participant who is granted an Award and who does not affirmatively reject the applicable Award Agreement shall be deemed to have accepted the terms of Award as embodied in the Award Agreement.

D. “Board” means the Board of Directors of the Company.

E. “Cash-Based Award” means an Award described in Section 7 as a Cash-Based Award.

F. “Change of Control” means the occurrence of one or more of the following:

(1) The purchase or other acquisition (other than from the Company) by any person, entity or group of persons, within the meaning of Section 13(d) or 14(d) of the Act (excluding, for this purpose, the Company or its subsidiaries or any employee benefit plan of the Company or its subsidiaries), of beneficial ownership (within the meaning of Rule 13d-3 promulgated under the Act) of 35% or more of either the then-outstanding shares of common stock of the Company or the combined voting power of the Company’s then-outstanding voting securities entitled to vote generally in the election of directors;

(2) Individuals who, as of the date hereof, constitute the Board (as of the date hereof, the “Incumbent Board”) cease for any reason to constitute at least a majority of the Board, provided

that any person who becomes a director subsequent to the date hereof whose election, or nomination for election by the Company’s shareholders, was approved by a vote of at least a majority of the directors then comprising the Incumbent Board (other than an individual whose initial assumption of office is in connection with an actual or threatened election contest relating to the election of directors of the Company, as such terms are used in Rule 14a-11 of Regulation 14A promulgated under the Act) shall be, for purposes of this section, considered as though such person were a member of the Incumbent Board; or

(3) The consummation of a reorganization, merger or consolidation, in each case with respect to which persons who were the stockholders of the Company immediately prior to such reorganization, merger or consolidation do not, immediately thereafter, own more than 50% of, respectively, the common stock and the combined voting power entitled to vote generally in the election of directors of the reorganized, merged or consolidated corporation’s then-outstanding voting securities, or of a liquidation or dissolution of the Company or of the sale of all or substantially all of the assets of the Company.

Notwithstanding the foregoing, a Change of Control shall not be deemed to have occurred with respect to any Award that (i) provides “non-qualified deferred compensation” within the meaning of Code Section 409A and (ii) settles upon a Change of Control, unless such foregoing event constitutes a “change in ownership” of the Company, a “change in effective control” of the Company, or a “change in the ownership of a substantial portion of the assets” of the Company in each case, as defined under Code Section 409A.

G. “Code” means the Internal Revenue Code of 1986, as amended, or any successor thereto, and the regulations and other guidance promulgated thereunder.

H. “Committee” means the Compensation Committee of the Board, and any successor committee thereto or such other committee of the Board as may be designated by the Board to administer this Plan in whole or in part including any subcommittee of the Board as designated by the Board.

I. “Company” means Stereotaxis, Inc., a Delaware corporation, and any successor thereto.

J. “Employer” means the Company and any other entity directly or indirectly controlling, controlled by, or under common control with, the Company or any other entity designated by the Board or the Committee in which the Company has an interest. The term “control” (including the terms “controlling”, “controlled by” and “under common control with”) has the meaning ascribed to it under Rule 405 of the Securities Act of 1933, as amended, or any successor thereto, and the regulations and other guidance promulgated thereunder.

K. “Fair Market Value” means the closing sale price, regular way, or, in case no such sale takes place on such date, the average of the closing bid and asked prices, regular way, on the date such Fair Market Value is measured of one share of Stock as reported in the principal consolidated transaction reporting system with respect to securities listed or admitted to trading on the Nasdaq Global Market or, if the shares of Stock are not listed or admitted to trading on the Nasdaq Global Market, as reported in the principal consolidated transaction reporting system with respect to securities listed on the principal national securities exchange on which the shares of Stock are listed or admitted to trading or, if the shares of Stock are not listed or admitted to trading on any national

securities exchange, the last quoted sale price on such date or, if not so quoted, the average of the high bid and low asked prices in the over-the-counter market on such date, as reported by the National Association of Securities Dealers, Inc. Automated Quotations System or such other system then in use. If shares of Stock are not publicly held or so listed or publicly traded, the Fair Market Value per share of Stock shall be 100% of the fair market value of a share of Stock on the date such Fair Market Value is measured, as determined in good faith by the Committee.

L. “Incentive Stock Option” means a stock option which is intended to be an incentive stock option within the meaning of Code Section 422.

M. “Non-Qualified Stock Option” means a stock option which is not an Incentive Stock Option.

N. “Option” means both an Incentive Stock Option and a Non-Qualified Stock Option.

O. “Other Stock-Based Award” means an Award granted pursuant to Section 7 and described as an Other Stock-Based Award.

P. “Parent” means any corporation (other than the Company) in an unbroken chain of corporations ending with the Company if, at the time of the granting of the Option, each of the corporations other than the Company owns stock possessing 50% or more of the total combined voting power of all classes of stock in one of the other corporations in such chain, or such other meaning as may be hereafter ascribed to it in Code Section 424.

Q. “Participant” means any director or any employee of the Company, or any of its subsidiaries (including subsidiaries of subsidiaries), or any other entity in which the Company has a significant equity or other interest, as determined by the Committee, as well as any individual providing services to the Company who is selected to receive an Award; provided, that Incentive Stock Options may only be granted to employees of the Company or any of its Subsidiaries.

R. “Plan” means the Stereotaxis, Inc. 2012 Stock Incentive Plan.

S. “Stock” means the common stock, par value of $0.001 per share, of the Company.

T. “Stock Appreciation Right” means a stock appreciation right described in Section 6.

U. “Subsidiary” means any corporation (other than the Company) in an unbroken chain of corporations beginning with the Company if, at the time of granting an Award, each of the corporations other than the last corporation in the unbroken chain owns stock possessing 50% or more of the total combined voting power of all classes of stock in one of the other corporations in such chain, or such other meaning as may be hereafter ascribed to it in Code Section 424.

3. Stock Subject to the Plan.

As of the date of adoption of this Plan by the Board or the Committee, as applicable, the number of shares of Stock available for Awards under the Plan shall be four million two hundred ninety thousand (4,290,000). The maximum number of shares of Stock subject to Awards which may be granted during a calendar year to a Participant shall be 1,000,000. The Company may, in its

discretion, use shares of Stock held in the treasury in lieu of authorized but unissued shares of Stock. If any Award shall expire or terminate or be cancelled or forfeited for any reason, the shares subject to the Award shall again be available for the purposes of the Plan. Any shares of Stock which are tendered by a Participant as full or partial payment to the Company to satisfy a purchase price related to an Award shall not be available for the purposes of the Plan. To the extent any shares subject to an Award are not delivered to a Participant because such shares are used to satisfy an applicable tax-withholding obligation or used to satisfy a purchase price related to an Option, such withheld shares shall not be available for the purposes of the Plan. Shares of Stock subject to the grant of a Stock Appreciation Right shall not become available again for issuance under this Plan upon exercise or settlement of such Stock Appreciation Right for a lesser number of shares. Awards that by their terms may only be settled in cash shall not reduce the number of shares available for purposes of the Plan, and if cash is issued in lieu of Stock pursuant to an Award, such shares will not become available again for issuance under this Plan.

All the shares of Stock available under the Plan may be used for the grant of Incentive Stock Options.

4. Administration.

The Plan shall be administered by the Committee. Subject to the express provisions of the Plan, the Committee shall have plenary authority, in its discretion, to determine the individuals to whom, and the time or times at which, Awards shall be granted and the number of shares, if applicable, to be subject to each Award. In making such determinations, the Committee may take into account the nature of services rendered by the respective individuals, their present and potential contributions to the Employer’s success and such other factors as the Committee, in its discretion, shall deem relevant. Subject to the express provisions of the Plan, the Committee shall also have plenary discretionary authority to interpret the Plan, to prescribe, amend and rescind rules and regulations relating to it, to determine the terms and provisions of the respective Award Agreements (which need not be identical) and to make all other determinations necessary or advisable for the administration of the Plan. The Committee’s determinations on the matters referred to in this Section 4 shall be conclusive.

Notwithstanding the foregoing, the Committee may not amend the terms of outstanding Award Agreements without the approval of the Company’s shareholders in accordance with applicable law or regulation to either reduce the exercise price of any outstanding Option or Stock Appreciation Right, or cancel any outstanding Option or Stock Appreciation Right in exchange for cash, another Award, or another Option or Stock Appreciation Right with an exercise price that is less than the exercise price of the original Option or Stock Appreciation Right.

The Committee shall have the power and authority to determine which individuals, including individuals outside the United States, shall be eligible to receive Awards under the Plan. The Committee may adopt, amend or rescind rules, procedures or sub-plans relating to the operation and administration of the Plan to accommodate the specific requirements of local laws, procedures, and practices. Without limiting the generality of the foregoing, the Committee is specifically authorized to adopt rules, procedures and sub-plans with provisions that limit or modify rights on death, disability, retirement, separation from service or termination of employment, available methods of exercise or settlement of an Award, payment of income, social insurance contributions and payroll taxes, withholding procedures and handling of any stock certificates or other indicia of ownership which vary with local requirements. The Committee may also adopt rules, procedures or sub-plans applicable to Participants employed by particular Employers or at particular locations.

5. Options.

The Committee, in its discretion, may grant Options which are Incentive Stock Options or Non-Qualified Stock Options, as evidenced by the Award Agreement, and shall be subject to the foregoing and the following terms and conditions and to such other terms and conditions, not inconsistent therewith, as the Committee shall determine:

A. Type of Option. Incentive Stock Options may be granted to any individual classified by the Committee as an employee of the Company, a Parent or a Subsidiary. A Non-Qualified Stock Option may be granted to any individual selected by the Committee, provided that in no event shall a Non-Qualified Stock Option be granted in exchange for services performed by an individual unless the Company is an “eligible issuer of service recipient stock” within the meaning of Code Section 409A with respect to such individual. No individual may be granted Options to purchase more than 1,000,000 shares of Stock during any single fiscal year of the Company.

B. Option Prices. The purchase price of the Stock under each Option shall not be less than 100% of the Fair Market Value of the Stock at the time of the granting of the Option, as determined under Section 16; provided that, in the case of a Participant who owns more than 10% of the total combined voting power of all classes of stock of the Company, a Parent or a Subsidiary (as determined in accordance with Code Section 422), the purchase price of the Stock under each Incentive Stock Option shall not be less than 110% of the Fair Market Value of the Stock on the date such Option is granted.

C. Exercise – Elections and Restrictions. The purchase price for an Option is to be paid in full upon the exercise of the Option, either (i) in cash, (ii) in the discretion of the Committee, by the tender to the Company (either actual or by attestation) of shares of Stock already owned by the Participant and registered in his or her name, having a Fair Market Value equal to the cash exercise price of the Option being exercised, (iii) through a net or cashless (including broker-assisted cashless exercise, to the extent permissible) form of exercise as permitted by the Committee, or (iv) in the discretion of the Committee, by any combination of the payment methods specified in clauses (i), (ii), or (iii) hereof; provided that, no shares of Stock may be tendered in exercise of an Incentive Stock Option if such shares were acquired by the Participant through the exercise of an Incentive Stock Option unless (a) such shares have been held by the Participant for at least one year and (b) at least two years have elapsed since such prior Incentive Stock Option was granted.

D. Option Terms. The term of each Option shall not be more than ten (10) years from the date of granting thereof, as determined under Section 16, or such shorter period as is prescribed in the Award Agreement; provided that, in the case of a Participant who owns more than ten percent (10%) of the total combined voting power of all classes of stock of the Company, a Parent or a Subsidiary, the term of any Incentive Stock Option shall not be more than five (5) years from the date of granting thereof or such shorter period as prescribed in the Award Agreement. Within such limit, Options will be exercisable at such time or times, and subject to such restrictions and conditions, as the Committee shall, in each instance, approve, which need not be uniform for all Participants. The holder of an Option shall have none of the rights of a shareholder with respect to the shares subject to Option until such shares shall be issued to him or her upon the exercise of his or her Option. In no event shall Option holders be entitled to dividends or dividend equivalents with respect to such Options.

E. Successive Option Grants. As determined by the Committee, successive option grants may be made to any Participant under the Plan.

F. Additional Incentive Stock Option Requirements. The maximum aggregate Fair Market Value (determined at the time an Option is granted) of the Stock with respect to which Incentive Stock Options are exercisable for the first time by a Participant during any calendar year (under all plans of the Company, a Parent and a Subsidiary) shall not exceed $100,000. A Participant who disposes of Stock acquired upon the exercise of an Incentive Stock Option either (i) within two years after the date of grant of such Incentive Stock Option or (ii) within one year after the transfer of such shares to the Participant, shall notify the Company of such disposition and of the amount realized upon such disposition.

6. Stock Appreciation Rights.

A. Grant Terms. The Committee may grant a Stock Appreciation Right independent of an Option or in connection with an Option or a portion thereof. A Stock Appreciation Right granted in connection with an Option or a portion thereof shall cover the same shares of Stock covered by the Option, or a lesser number as the Committee may determine. The maximum number of shares of Stock subject to Awards for Stock Appreciation Rights for grants intended to qualify as Performance-Based Awards during a calendar year shall be 1,000,000. The term of each Stock Appreciation Right shall not be more than ten (10) years from the date of granting thereof, as determined under Section 16, or such shorter period as is prescribed in the Award Agreement.

B. Exercise Terms. The exercise price per share of Stock of a Stock Appreciation Right shall not be less than 100% of the Fair Market Value of the Stock at the time of granting, as determined under Section 16, the Stock Appreciation Right. A Stock Appreciation Right granted independent of an Option shall entitle the Participant upon exercise to a payment from the Company in an amount equal to the excess of the Fair Market Value on the exercise date of a share of Stock over the exercise price per share, times the number of Stock Appreciation Rights exercised. A Stock Appreciation Right granted in connection with an Option shall entitle the Participant to surrender an unexercised Option (or portion thereof) and to receive in exchange an amount equal to the excess of the Fair Market Value on the exercise date of a share of Stock over the exercise price per share for the Option, times the number of shares covered by the Option (or portion thereof) which is surrendered. Payment may be made, in the discretion of the Committee, in (i) Stock, (ii) cash or (iii) any combination of Stock and cash. Cash shall be paid for fractional shares of Stock upon the exercise of a Stock Appreciation Right.

C. Limitations. The Committee may include in the Award Agreement such conditions upon the exercisability or transferability of Stock Appreciation Rights as it determines in its sole discretion. In no event shall Stock Appreciation Right holders be entitled to dividends or dividend equivalents with respect to such Stock Appreciation Rights.

7. Other Stock-Based Awards and Cash-Based Awards.

The Committee may, in its sole discretion, grant Awards of Stock, restricted Stock, restricted Stock units and other Awards that are valued in whole or in part by reference to the Fair Market Value of Stock. These Awards shall collectively be referred to herein as Other Stock-Based Awards. The Committee may also, in its sole discretion, grant Cash-Based Awards, which shall have a value as may be determined by the Committee. Other Stock-Based Awards shall be in such form, and dependent on such conditions, if any, as the Committee shall determine, including, but not limited to, the right to receive fully-vested shares or the right to receive one or more shares of Stock (or the cash-equivalent thereof) upon the completion of a specified period of service, the occurrence of an event or the attainment of performance objectives. Other Stock-Based Awards and Cash-Based Awards may be granted with or in addition to other Awards. Subject to the other terms of the Plan, Other Stock-Based Awards and Cash-Based Awards may be granted to such Participants in such amounts and upon such terms, and at any time and from time to time, as shall be determined by the Committee and set forth in an Award Agreement; provided that, the maximum Cash-Based Award that may be granted to a Participant in a calendar year is $1,000,000 to the extent it is also a Performance-Based Award. Notwithstanding the foregoing, no dividends or dividend equivalents shall be paid with respect to unvested Other Stock-Based Awards, including Other Stock-Based Awards that are intended to be Performance-Based Awards.

8. Performance-Based Awards.

The Committee may, in its sole and absolute discretion, determine that certain Awards should be subject to such requirements so that they are deductible by the Employer under Code Section 162(m). If the Committee so determines, such Awards shall be considered Performance-Based Awards subject to the terms of this Section 8, as provided in the Award Agreement. A Performance-Based Award shall be granted by the Committee in a manner to satisfy the requirements of Code Section 162(m) and the regulations thereunder. The performance measures to be used for purposes of a Performance-Based Award shall be determined by the Committee, in its sole and absolute discretion, from among the following: the Company’s earnings per share growth; earnings; earnings per share; cash flow; working capital; expense management; customer satisfaction; revenues; financial return ratios; market performance; shareholder return and/or value; operating income (loss) (including earnings (loss) before income taxes, depreciation and amortization); net income (loss); profit returns; margins; stock price; working capital; business trends; production cost; product cost; return on assets; project milestones; and plant and equipment performance. The performance measures may relate to the Company, a Parent, a Subsidiary, an Employer or one or more units of such an entity.

The Committee shall determine whether, with respect to a performance period, the applicable performance goals have been met with respect to an Award and, if they have, to so certify and ascertain the amount of the applicable Performance-Based Award. Each performance measure that constitutes a criteria measured by reference to the Company’s financial statements shall be determined in accordance with generally accepted accounting principles as consistently applied by the Company and, if so determined by the Committee prior to the date the performance measures are established in writing, adjusted, to the extent permitted under Code Section 162(m), to omit the effects of extraordinary items, gain or loss on the disposal of a business segment, unusual or infrequently occurring events and transactions and cumulative effects of changes in accounting principles. The Committee shall have the discretion to adjust the amount payable on a Company-wide

or divisional basis or to reflect individual performance and/or unanticipated factors; provided, however, that Awards which are designed to qualify as Performance-Based Awards may not be adjusted upward (the Committee shall retain the discretion to adjust such Awards downward).

9. Vesting Limitations.

Except as otherwise provided in this Plan, each Stock Option and Stock Appreciation Right shall have a minimum vesting period of three years from the date of grant of such award, provided that such vesting may occur incrementally over such three-year period. Except as otherwise provided in this Plan, the vesting schedule of any such Award may not accelerate except in the case of death, disability, retirement, a Change of Control, involuntary termination of employment without cause or voluntary termination for good reason. Except as otherwise provided in this Plan, whether an Award will be subject to accelerated vesting upon the occurrence of one or more of these events shall be specified in Award Agreement relating to such Award or another agreement with the Participant, such as an employment agreement.

10. Withholding. Upon exercise of an Option, the Company shall withhold a sufficient number of shares to satisfy the Company’s minimum required statutory withholding obligations for any taxes incurred as a result of such exercise (based on the minimum statutory withholding rates for federal and state tax purposes, including payroll taxes); provided that, in lieu of all or part of such withholding, the Participant may pay an equivalent amount of cash to the Company. Prior to the payment, settlement, or vesting of any Award other than an Option, the Participant shall pay to the Company, or make arrangements acceptable to the Company for the payment of, amounts sufficient for the Company to satisfy its required statutory withholding obligations. The Company shall have the right to satisfy its required statutory withholding obligations by withholding an amount of cash otherwise due to a Participant (or shares of Stock for Awards settled in shares of Stock) upon the settlement of any Award.

11. Nontransferability of Awards.

Unless otherwise determined by the Committee and expressly set forth in an Award Agreement, an Award granted under the Plan shall, by its terms, be non-transferable otherwise than by will or the laws of descent and distribution and an Award may be exercised, if applicable, during the lifetime of the Participant thereof, only by the Participant or his or her guardian or legal representative. Notwithstanding the above, the Committee may not provide in an Award Agreement that an Incentive Stock Option is transferable.

12. Investment Purpose.

Each Award under the Plan shall be awarded only on the condition that all purchases of Stock thereunder shall be for investment purposes, and not with a view to resale or distribution, except that the Committee may make such provision with respect to Awards granted under this Plan as it deems necessary or advisable for the release of such condition upon the registration with the Securities and Exchange Commission of Stock subject to the Award, or upon the happening of any other contingency warranting the release of such condition.

13. Adjustments Upon Changes in Capitalization or Corporation Acquisitions.

In the event of any change in the outstanding Stock of the Company by reason of a stock split, stock dividend, combination or reclassification of shares, recapitalization, consolidation, split-up, merger, or similar event, the Committee shall adjust appropriately: (a) the number of shares or kind of Stock (i) available for issuance under the Plan, (ii) for which Awards may be granted to an individual Participant, and (iii) covered by outstanding Awards denominated in stock or units of stock; (b) the exercise and grant prices related to outstanding Awards; and (c) the appropriate Fair Market Value and other price determinations for such Awards. In the event of any other change affecting the Stock or any distribution (other than normal cash dividends) to holders of Stock, such adjustments in the number and kind of shares and the exercise, grant and conversion prices of the affected Awards as may be deemed equitable by the Committee, including adjustments to avoid fractional shares, shall be made to give proper effect to such event. In the event of a corporate merger, consolidation, acquisition of property or stock, separation, reorganization or liquidation, the Committee shall be authorized to cause to issue or assume stock options, whether or not in a transaction to which section 424(a) of the Code applies, by means of substitution of new stock options for previously issued stock options or an assumption of previously issued stock options. In such event, the aggregate number of shares of Stock available for issuance under Awards under Section 3, including the individual Participant maximums, will be increased to reflect such substitution or assumption.

In the event of a Change of Control, notwithstanding any other provisions of the Plan or an Award Agreement to the contrary, the Committee may, in its sole discretion, provide for:

(1) Termination of an Award upon the consummation of the Change of Control in exchange for the payment of a cash amount (but only in a manner which does not result in a violation of Code Section 409A and only to the extent the terminated Award has, in the discretion of the Committee, a positive value as of the termination date); and/or

(2) Issuance of substitute Awards to substantially preserve the terms of any Awards previously granted under the Plan (but only in a manner which does not result in a violation of Code Section 409A) which are outstanding upon the consummation of the Change of Control.

Prior to the consummation of a Change of Control, the Committee may also provide for accelerated vesting of any outstanding Awards that are otherwise unexercisable or unvested as of a date selected by the Committee.

14. Amendment and Termination.

The Board or the Committee may at any time terminate the Plan, or make such modifications to the Plan as either shall deem advisable; provided, however, that the Board or the Committee may not, without further approval by the shareholders of the Company, increase the maximum number of shares as to which Awards may be granted under the Plan (except under the anti-dilution provisions of Section 13), or change the class of employees to whom Incentive Stock Options may be granted. No termination or amendment of the Plan may, without the consent of the Participant to whom any Award shall theretofore have been granted, adversely affect the rights of such Participant under such Award.

15. Effectiveness of the Plan.

The Plan shall become effective upon adoption by the Board or the Committee subject, however, to its further approval by the shareholders of the Company given within twelve (12) months of the date the Plan is adopted by the Board or the Committee at a regular meeting of the shareholders or at a special meeting duly called and held for such purpose. Grants of Awards may be made prior to such shareholder approval but all Award grants made prior to shareholder approval shall be subject to the obtaining of such approval and if such approval is not obtained, such Awards shall not be effective for any purpose.

16. Time of Granting of an Award.

An Award grant under the Plan shall be deemed to be made on the date on which the Committee, by formal action of its members duly recorded in the records thereof, makes an Award to a Participant (but in no event prior to the adoption of the Plan by the Board or the Committee).

17. Term of Plan.

This Plan shall terminate ten (10) years after the date on which it is approved and adopted by the Board or the Committee and no Award shall be granted hereunder after the expiration of such ten-year period. Awards outstanding at the termination of the Plan shall continue in accordance with their terms and shall not be affected by such termination.

18. No Right To Continued Employment.

Nothing in the Plan or in any Award granted pursuant to the Plan shall confer on any individual any right to continue in the employ of the Employer or interfere in any way with the right of the Employer to terminate his or her employment at any time.

19. Choice of Law.

The Plan shall be governed by and construed in accordance with the laws of the State of Delaware without regard to conflicts of law. Unless otherwise provided in an Award Agreement, recipients of an Award under the Plan are deemed to submit to the exclusive jurisdiction and venue of the federal or state courts of Missouri, County of St. Louis, to resolve any and all issues that may arise out of or relate to the Plan or any Award Agreement.

20. Severability. If any provision of the Plan is, becomes, or is deemed invalid, illegal, or unenforceable in any jurisdiction, or would disqualify the Plan or any Award under any law deemed applicable by the Committee, such provision shall be construed or deemed amended or limited in scope to conform to applicable laws or, in the discretion of the Committee, it shall be stricken and the remainder of the Plan shall remain in full force and effect.

* * *

The foregoing amended and restated Plan was approved and adopted by the Committee on February 9, 2016, and approved by the Stockholders on May 24, 2016.

/s/ Karen W. Duros

Secretary

EX-31.1 3 d200712dex311.htm EX-31.1 EX-31.1

Exhibit 31.1

Certification of Principal Executive Officer

I, William C. Mills III, certify that:

I have reviewed this quarterly report on Form 10-Q of Stereotaxis, Inc.;

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a – 15(f) and 15d – 15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

EX-31.2 4 d200712dex312.htm EX-31.2 EX-31.2

Exhibit 31.2

Certification of Principal Financial Officer

I, Martin C. Stammer, certify that:

I have reviewed this quarterly report on Form 10-Q of Stereotaxis, Inc.;

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

EX-32.1 5 d200712dex321.htm EX-32.1 EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of Stereotaxis, Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2016 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, William C. Mills III, Chief Executive Officer of the Company, certify, pursuant to Rule 13a-14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

EX-32.2 6 d200712dex322.htm EX-32.2 EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of Stereotaxis, Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2016 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Martin C. Stammer, Chief Financial Officer of the Company, certify, pursuant to Rule 13a-14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

EX-101.INS 7 stxs-20160630.xml XBRL INSTANCE DOCUMENT 0001289340 us-gaap:FairValueInputsLevel2Member stxs:WarrantsIssuedMay102012Member us-gaap:FairValueMeasurementsRecurringMember 2016-06-30 0001289340 us-gaap:FairValueInputsLevel2Member stxs:WarrantsIssuedAugustTenthTwoThousandThirteenMember us-gaap:FairValueMeasurementsRecurringMember 2016-06-30 0001289340 us-gaap:FairValueInputsLevel3Member stxs:WarrantsIssuedMay102012Member us-gaap:FairValueMeasurementsRecurringMember 2015-12-31 0001289340 us-gaap:FairValueInputsLevel3Member stxs:WarrantsIssuedAugustTenthTwoThousandThirteenMember us-gaap:FairValueMeasurementsRecurringMember 2015-12-31 0001289340 us-gaap:FairValueInputsLevel2Member stxs:WarrantsIssuedMay102012Member us-gaap:FairValueMeasurementsRecurringMember 2015-12-31 0001289340 us-gaap:FairValueInputsLevel2Member stxs:WarrantsIssuedAugustTenthTwoThousandThirteenMember us-gaap:FairValueMeasurementsRecurringMember 2015-12-31 0001289340 us-gaap:FairValueInputsLevel3Member stxs:WarrantsIssuedMay102012Member us-gaap:FairValueMeasurementsRecurringMember 2016-06-30 0001289340 us-gaap:FairValueInputsLevel3Member stxs:WarrantsIssuedAugustTenthTwoThousandThirteenMember us-gaap:FairValueMeasurementsRecurringMember 2016-06-30 0001289340 us-gaap:EmployeeStockOptionMember stxs:RangeTwoMember 2016-01-01 2016-06-30 0001289340 us-gaap:EmployeeStockOptionMember stxs:RangeThreeMember 2016-01-01 2016-06-30 0001289340 us-gaap:EmployeeStockOptionMember stxs:RangeFourMember 2016-01-01 2016-06-30 0001289340 us-gaap:EmployeeStockOptionMember stxs:RangeOneMember 2015-01-01 2015-12-31 0001289340 us-gaap:EmployeeStockOptionMember 2016-06-30 0001289340 us-gaap:EmployeeStockOptionMember 2015-12-31 0001289340 2016-05-23 2016-05-24 0001289340 2014-06-09 2014-06-10 0001289340 2013-06-04 2013-06-05 0001289340 us-gaap:RestrictedStockUnitsRSUMember 2016-06-30 0001289340 us-gaap:RestrictedStockUnitsRSUMember 2015-12-31 0001289340 us-gaap:RestrictedStockUnitsRSUMember 2016-01-01 2016-06-30 0001289340 us-gaap:EmployeeStockOptionMember 2016-01-01 2016-06-30 0001289340 us-gaap:RevolvingCreditFacilityMember us-gaap:MinimumMember 2016-05-10 0001289340 us-gaap:LeaseholdImprovementsMember 2016-06-30 0001289340 us-gaap:EquipmentMember 2016-06-30 0001289340 us-gaap:AssetsHeldUnderCapitalLeasesMember 2016-06-30 0001289340 us-gaap:LeaseholdImprovementsMember 2015-12-31 0001289340 us-gaap:EquipmentMember 2015-12-31 0001289340 us-gaap:AssetsHeldUnderCapitalLeasesMember 2015-12-31 0001289340 2015-01-01 2015-12-31 0001289340 us-gaap:WarrantMember 2016-01-01 2016-06-30 0001289340 stxs:CowenDebtMember us-gaap:LoansPayableMember 2013-01-30 2013-01-31 0001289340 stxs:CowenDebtMember us-gaap:LoansPayableMember 2012-08-07 2012-08-08 0001289340 us-gaap:PrivatePlacementMember 2016-04-01 2016-06-30 0001289340 stxs:CowenDebtMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:LoansPayableMember 2016-06-30 0001289340 stxs:CowenDebtMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:LoansPayableMember 2016-06-30 0001289340 us-gaap:RevolvingCreditFacilityMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2016-06-30 0001289340 us-gaap:RevolvingCreditFacilityMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2016-06-30 0001289340 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2016-06-30 0001289340 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2016-06-30 0001289340 stxs:CowenDebtMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:LoansPayableMember 2015-12-31 0001289340 stxs:CowenDebtMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:LoansPayableMember 2015-12-31 0001289340 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2015-12-31 0001289340 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2015-12-31 0001289340 us-gaap:RevolvingCreditFacilityMember 2016-01-01 2016-06-30 0001289340 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2016-06-30 0001289340 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2015-12-31 0001289340 us-gaap:OfficeBuildingMember 2016-01-01 2016-06-30 0001289340 stxs:WarrantsIssuedMay102012Member 2016-06-30 0001289340 stxs:WarrantsIssuedAugustTenthTwoThousandThirteenMember 2016-06-30 0001289340 stxs:WarrantsIssuedMay102012Member 2015-12-31 0001289340 stxs:WarrantsIssuedAugustTenthTwoThousandThirteenMember 2015-12-31 0001289340 stxs:ProductShippedRevenueDeferredMember 2016-06-30 0001289340 stxs:DeferredServiceAndLicenseFeesMember 2016-06-30 0001289340 stxs:CustomerDepositsMember 2016-06-30 0001289340 stxs:ProductShippedRevenueDeferredMember 2015-12-31 0001289340 stxs:DeferredServiceAndLicenseFeesMember 2015-12-31 0001289340 stxs:CustomerDepositsMember 2015-12-31 0001289340 stxs:CowenDebtMember us-gaap:LoansPayableMember 2016-01-01 2016-06-30 0001289340 stxs:CowenDebtMember us-gaap:LoansPayableMember 2011-11-30 0001289340 us-gaap:WarrantMember 2016-06-30 0001289340 2015-06-30 0001289340 2014-12-31 0001289340 us-gaap:OtherPropertyMember 2013-07-01 2013-09-30 0001289340 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2016-06-30 0001289340 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2016-06-30 0001289340 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2015-12-31 0001289340 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2015-12-31 0001289340 us-gaap:OfficeBuildingMember us-gaap:SubsequentEventMember 2016-08-31 0001289340 us-gaap:OfficeBuildingMember 2016-06-30 0001289340 stxs:DemonstrationAndAssemblyMember 2016-06-30 0001289340 us-gaap:OfficeBuildingMember 2015-12-31 0001289340 us-gaap:OtherPropertyMember 2013-09-30 0001289340 us-gaap:RevolvingCreditFacilityMember 2016-06-30 0001289340 us-gaap:PrivatePlacementMember 2016-06-30 0001289340 us-gaap:RevolvingCreditFacilityMember 2016-05-10 0001289340 stxs:WarrantsIssuedMay102012Member 2016-01-01 2016-06-30 0001289340 stxs:WarrantsIssuedAugustTenthTwoThousandThirteenMember 2016-01-01 2016-06-30 0001289340 2016-04-01 2016-06-30 0001289340 2015-04-01 2015-06-30 0001289340 2015-01-01 2015-06-30 0001289340 us-gaap:PrivatePlacementMember 2014-05-01 2014-05-31 0001289340 stxs:CowenDebtMember us-gaap:LoansPayableMember 2011-11-01 2011-11-30 0001289340 2016-06-30 0001289340 2015-12-31 0001289340 us-gaap:OtherPropertyMember 2016-06-30 0001289340 us-gaap:FairValueInputsLevel3Member stxs:WarrantsIssuedMay102012Member us-gaap:FairValueMeasurementsRecurringMember 2016-01-01 2016-06-30 0001289340 us-gaap:FairValueInputsLevel3Member stxs:WarrantsIssuedAugustTenthTwoThousandThirteenMember us-gaap:FairValueMeasurementsRecurringMember 2016-01-01 2016-06-30 0001289340 2016-07-29 0001289340 2016-01-01 2016-06-30 iso4217:USD xbrli:shares utr:sqft stxs:item xbrli:pure iso4217:USD xbrli:shares false --12-31 Q2 2016 2016-06-30 10-Q 0001289340 21853376 Smaller Reporting Company Stereotaxis, Inc. stxs 2018-11-01 2018-05-01 233197 666373 575583 5000000 18000000 2324359 1093988 1796888 699173 13271163 6571315 13511632 6938645 -166664 -232139 65475 -24000000 -24500000 1.00 0.030 13800000 <div> <div style="margin-left:0pt;margin-right:0pt;"> Revenue and Costs of Revenue  The Company accounts for revenue using Accounting Standards Codification Topic 605-25, Multiple-Element Arrangements (“ASC 605-25”). ASC 605-25 permits management to estimate the selling price of undelivered components of a bundled sale for which it is unable to establish vendor-specific objective evidence (“VSOE”) or third-party evidence (“TPE”). This requires management to record revenue for certain elements of a transaction even though it might not have delivered other elements of the transaction, for which it was unable to meet the requirements for establishing VSOE or TPE. The Company believes that the guidance significantly improves the reporting of these types of transactions to more closely reflect the underlying economic circumstances. This guidance also prohibits the use of the residual method for allocating revenue to the various elements of a transaction and requires that the revenue be allocated proportionally based on the relative estimated selling prices. Under our revenue recognition policy, a portion of revenue for Niobe systems, Vdrive systems and certain Odyssey systems is recognized upon delivery, provided that title has passed, there are no uncertainties regarding acceptance, persuasive evidence of an arrangement exists, the sales price is fixed and determinable, and collection of the related receivable is reasonably assured. Revenue is recognized for other types of Odyssey systems upon completion of installation, since there are no qualified third party installers. When installation is the responsibility of the customer, revenue from system sales is recognized upon shipment since these arrangements do not include an installation element or right of return privileges. The Company does not recognize revenue in situations in which inventory remains at a Stereotaxis warehouse or in situations in which title and risk of loss have not transferred to the customer. Amounts collected prior to satisfying the above revenue recognition criteria are reflected as deferred revenue. Revenue from services and license fees, whether sold individually or as a separate unit of accounting in a multiple-deliverable arrangement, is deferred and amortized over the service or license fee period, which is typically one year. Revenue from services is derived primarily from the sale of annual product maintenance plans. We recognize revenue from disposable device sales or accessories upon shipment and establish an appropriate reserve for returns. The return reserve, which is applicable only to disposable devices, is estimated based on historical experience which is periodically reviewed and updated as necessary. In the past, changes in estimate have had only a de minimis effect on revenue recognized in the period. We believe that the estimate is not likely to change significantly in the future. Costs of systems revenue include direct product costs, installation labor and other costs, estimated warranty costs, and initial training and product maintenance costs. These costs are recorded at the time of sale. Costs of disposable revenue include direct product costs and estimated warranty costs and are recorded at the time of sale. Cost of revenue from services and license fees are recorded when incurred. </div> </div> P1Y 3249542 1849275 1478996 395898 5924113 3092935 3010997 935978 129 4900000 1

1840135

2427697

6376470

5057503

324226

313379

6058390

5431055

6333993

5701351

1361379

1159038

10053095

10152746

448517472

449081382

93478

251933

111018

108850

149917

99660

13000

3152

12000

52000

27000

18877896

16258976

17142993

14820104

524083

74346

<div> <div style="margin-left:0pt;margin-right:0pt;"> Basis of Presentation The accompanying unaudited financial statements of Stereotaxis, Inc. have been prepared in accordance with generally accepted accounting principles for interim financial information and the instructions to Form 10-Q. Accordingly, they do not include all the disclosures required by U.S. generally accepted accounting principles for complete financial statements. In the opinion of management, they include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods presented. Operating results for the six month period ended June 30, 2016 are not necessarily indicative of the results that may be expected for the year ended December 31, 2016 or for future operating periods. These interim financial statements and the related notes should be read in conjunction with the annual financial statements and notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2015 as filed with the Securities and Exchange Commission (SEC) on March 11, 2016. </div> </div>

515138

7270301

3629273

5593582

3858089

524083

74346

-3641028

-1735493

3.44

2040365

0.001

300000000

21551173

21846095

21551

21846

5573901

2943263

3275884

1095071

<div> <div style="margin-left:0pt;margin-right:0pt;"> 9. Long-Term Debt and Credit Facilities  Debt outstanding consists of the following: <a name="FIS_UNIDENTIFIED_TABLE_7"></a> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="top" style="width:35.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="top" style="width:13.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="top" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="top" style="width:12.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="top" style="width:04.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="top" style="width:14.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="top" style="width:03.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="top" style="width:14.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="top" style="width:35.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> </td> <td colspan="3" valign="top" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> June 30, 2016 </td> <td valign="top" style="width:04.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td colspan="3" valign="top" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> December 31, 2015 </td> </tr> <tr> <td valign="top" style="width:35.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> </td> <td valign="top" style="width:13.46%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Carrying </td> <td valign="top" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="top" style="width:12.14%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Estimated </td> <td valign="top" style="width:04.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="top" style="width:14.04%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Carrying </td> <td valign="top" style="width:03.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="top" style="width:14.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Estimated </td> </tr> <tr> <td valign="top" style="width:35.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> </td> <td valign="top" style="width:13.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Amount </td> <td valign="top" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="top" style="width:12.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Fair Value </td> <td valign="top" style="width:04.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="top" style="width:14.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Amount </td> <td valign="top" style="width:03.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="top" style="width:14.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Fair Value </td> </tr> <tr> <td valign="top" style="width:35.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> </td> <td valign="top" style="width:13.46%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="top" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="top" style="width:12.14%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="top" style="width:04.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="top" style="width:14.04%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="top" style="width:03.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="top" style="width:14.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="top" style="width:35.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Revolving line of credit, due March 31, 2018 </td> <td valign="bottom" style="width:13.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $        3,000,000 </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:12.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $      3,000,000 </td> <td valign="bottom" style="width:04.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $                      - </td> <td valign="bottom" style="width:03.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $                      - </td> </tr> <tr> <td valign="top" style="width:35.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Healthcare Royalty Partners debt </td> <td valign="bottom" style="width:13.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">18,114,408  </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:12.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">18,405,468  </td> <td valign="bottom" style="width:04.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">18,080,159  </td> <td valign="bottom" style="width:03.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">18,429,177  </td> </tr> <tr> <td valign="top" style="width:35.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Total debt </td> <td valign="bottom" style="width:13.46%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">21,114,408  </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:12.14%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">21,405,468  </td> <td valign="bottom" style="width:04.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.04%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">18,080,159  </td> <td valign="bottom" style="width:03.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">18,429,177  </td> </tr> <tr> <td valign="top" style="width:35.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Less current maturities </td> <td valign="bottom" style="width:13.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(3,000,000) </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:12.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(3,000,000) </td> <td valign="bottom" style="width:04.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">  — </td> <td valign="bottom" style="width:03.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:35.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Total long term debt </td> <td valign="bottom" style="width:13.46%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $      18,114,408 </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:12.14%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $    18,405,468 </td> <td valign="bottom" style="width:04.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.04%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $     18,080,159 </td> <td valign="bottom" style="width:03.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $     18,429,177 </td> </tr> </table></div>     In accordance with general accounting principles for fair value measurement, the Company’s debt and credit facilities were measured at fair value as of June  30, 2016 and December 31, 2015.  Long-term debt fair value estimates are based on estimated borrowing rates to discount the cash flows to their present value (Level 3).      Certain prior year amounts have been reclassified to conform to the 2016 presentation. Revolving Line of Credit The Company has had a working capital line of credit with its primary lender, Silicon Valley Bank, since 2004. The revolving line of credit is secured by substantially all of the Company’s assets. The maximum available under the line is $10.0 million subject to the value of collateralized assets. The Company is required under the revolving line of credit to maintain its primary operating account and the majority of its cash and investment balances in accounts with its primary lender. The facility was amended on March 27, 2015, extending the maturity date to March 31, 2018 and on May 10, 2016, the Company and the primary lender agreed to modify certain financial covenants.  The amended agreement requires the Company to maintain a liquidity ratio greater than 1.50:1.00, excluding certain short term advances from the calculation, and a minimum tangible net worth of not less than (no worse than) negative $24.0 million for the quarters ended June 30, 2016, September 30, 2016, December 31, 2016, March 31, 2017, June 30, 2017, and September 30, 2017; and not less than (no worse than) negative $24.5 million for the quarters ended December 31, 2017 and March 31, 2018. As of June 30, 2016, the Company had $3.0 million outstanding under the revolving line of credit. Draws on the line of credit are made based on the borrowing capacity one week in arrears. As of June 30, 2016, the Company had a borrowing capacity of $4.0 million based on the Company’s collateralized assets, including amounts already drawn. As such, the Company has the ability to borrow an additional $1.0 million under the revolving line of credit at June 30, 2016. The Company’s total liquidity as of June 30, 2016, was $4.9 million which included cash and cash equivalents of $3.9 million. The $3.0 million outstanding under the revolving line of credit was repaid shortly after June 30, 2016. Healthcare Royalty Partners Debt In November 2011, the Company entered into a loan agreement with Healthcare Royalty Partners. Under the agreement the Company borrowed from Healthcare Royalty Partners $15 million. The Company was permitted to borrow up to an additional $5 million in the aggregate based on the achievement by the Company of certain milestones related to Niobe ES system sales in 2012. On August 8, 2012, the Company borrowed an additional $2.5 million based upon achievement of a milestone related to Niobe ES system sales for the three months ended June 30, 2012. On January 31, 2013, the Company borrowed an additional $2.5 million based upon achievement of a milestone related to Niobe ES system sales for the twelve months ended December 31, 2012.  The loan will be repaid through, and secured by, royalties payable to the Company under its Development, Alliance and Supply Agreement with Biosense Webster, Inc. (the “Biosense Agreement”). The Biosense Agreement relates to the development and distribution of magnetically enabled catheters used with Stereotaxis' Niobe ES system in cardiac ablation procedures. Under the terms of the agreement, Healthcare Royalty Partners will be entitled to receive 100% of all royalties due to the Company under the Biosense Agreement until the loan is repaid.  The loan is a full recourse loan, matures on December 31, 2018, and bears interest at an annual rate of 16% payable quarterly with royalties received under the Biosense Agreement. If the payments received by the Company under the Biosense Agreement are insufficient to pay all amounts of interest due on the loan, then such deficiency will increase the outstanding principal amount on the loan. After the loan obligation is repaid, the royalties under the Biosense Agreement will again be paid to the Company. The loan is also secured by certain assets and intellectual property of the Company. The agreement also contains customary affirmative and negative covenants. The use of payments due to the Company under the Biosense Agreement was approved by our primary lender.   </div> </div>

0.16

2018-12-31

25960

75068

82987

397

349018

291060

9455133

2505000

6583745

366388

8056920

1050000

6668089

338831

7445935

7435975

2009198

620945

136583

245650

134025

185802

106792

166664

-0.22

-0.07

-0.21

-0.11

-0.22

-0.07

-0.21

-0.11

<div> <div style="margin-left:0pt;margin-right:0pt;"> Net Earnings (Loss) per Common Share (“EPS”) Basic and diluted net earnings (loss) per common share are computed by dividing the net income (loss) for the period by the weighted average number of common shares outstanding during the period. The following table sets forth the computation of basic and diluted EPS: <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:40.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:40.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Three months ended June 30, </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Six months ended June 30, </td> <td valign="bottom" style="width:01.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:40.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> Numerator: </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> 2016 </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> 2015 </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> 2016 </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> 2015 </td> <td valign="bottom" style="width:01.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:40.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> Numerator for basic EPS </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.06%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(2,333,116) </td> <td valign="bottom" style="width:02.08%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(1,538,687) </td> <td valign="bottom" style="width:02.08%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.06%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(4,607,417) </td> <td valign="bottom" style="width:02.08%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(4,674,268) </td> <td valign="bottom" style="width:02.08%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:40.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> Numerator for diluted EPS </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.06%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(2,333,116) </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(1,538,687) </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.06%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(4,607,417) </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(4,674,268) </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:40.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> Denominator: </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.06%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.54%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.06%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.54%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:40.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> Denominator for basic EPS—weighted average shares </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">21,793,583  </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">21,007,103  </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">21,702,597  </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">20,871,244  </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:40.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> Denominator for diluted EPS—weighted average shares </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.06%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">21,793,583  </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">21,007,103  </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.06%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">21,702,597  </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">20,871,244  </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:40.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> Basic EPS </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.06%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(0.11) </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.54%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(0.07) </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.06%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(0.21) </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.54%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(0.22) </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:40.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> Diluted EPS </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(0.11) </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(0.07) </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(0.21) </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(0.22) </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> </tr> </table></div> In addition, the Company did not include any portion of unearned restricted shares, outstanding options, stock appreciation rights or warrants in the calculation of diluted loss per common share because all such securities are anti-dilutive for all periods presented. The application of the two-class method of computing earnings per share under general accounting principles for participating securities is not applicable during these periods because the Company’s unearned restricted shares do not contractually participate in its losses. As of June 30, 2016, the Company had 686,383 shares of common stock issuable upon the exercise of outstanding options and stock appreciation rights at a weighted average exercise price of $8.66 per share, 2,040,365 shares of common stock issuable upon the exercise of outstanding warrants at a weighted average exercise price of $3.44 per share, and 1,212,496 shares of unvested restricted share units. <a name="eolPage9"></a> </div> </div>

3053012

2652318

1900000

P4Y

1.1317

1.2433

0.0058

<div> <div style="margin-left:0pt;margin-right:0pt;"> 11. Fair Value Measurements  The Company measures certain financial assets and liabilities at fair value on a recurring basis, including cash equivalents and warrants. General accounting principles for fair value measurement established a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets and liabilities (“Level 1”) and the lowest priority to unobservable inputs (“Level 3”). The three levels of the fair value hierarchy are described below: Level 1: Values are based on unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities. Level 2: Values are based on quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, or other model-based valuation techniques for which all significant assumptions are observable in the market. Level 3: Values are generated from model-based techniques that use significant assumptions not observable in the market. The following table sets forth the Company’s assets and liabilities measured at fair value on a recurring basis by level within the fair value hierarchy.  As required by the Fair Value Measurements and Disclosures topic of the Accounting Standards Codification, assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="top" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:31.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> </table></div> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> </td> <td colspan="8" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Fair Value Measurement Using </td> </tr> <tr> <td valign="bottom" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:74.25pt;padding:0pt;"> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:74.25pt;padding:0pt;"> Total </td> <td valign="bottom" style="width:04.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:74.25pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:74.25pt;padding:0pt;"> Quoted Prices in Active Markets for Identical Instruments (Level 1) </td> <td valign="bottom" style="width:04.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:74.25pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:74.25pt;padding:0pt;"> Significant Other Observable Inputs (Level 2) </td> <td valign="bottom" style="width:04.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:74.25pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:74.25pt;padding:0pt;"> Significant Unobservable Inputs (Level 3) </td> </tr> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Assets at June 30, 2016: </td> <td valign="bottom" style="width:02.14%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">          Cash equivalents </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">74,346  </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">74,346  </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> </tr> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Total assets at fair value </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">74,346  </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">74,346  </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> </tr> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Liabilities at June 30, 2016: </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.74%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">          Warrants issued May 2012 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">209,156  </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">209,156  </td> </tr> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">          Warrants issued August 2013 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">418,310  </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">418,310  </td> </tr> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Total liabilities at fair value: </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">627,466  </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">627,466  </td> </tr> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Assets at December 31, 2015: </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.74%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">          Cash equivalents </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">524,083  </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">524,083  </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> </tr> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Total assets at fair value </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">524,083  </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">524,083  </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> </tr> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Liabilities at December 31, 2015: </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.74%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">          Warrants issued May 2012 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">143,681  </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">143,681  </td> </tr> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">          Warrants issued August 2013 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">650,449  </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">650,449  </td> </tr> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Total liabilities at fair value: </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">794,130  </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">794,130  </td> </tr> </table></div> Level 1 The Company’s financial assets consist of cash equivalents invested in money market funds in the amount of $74,346 and $524,083 at June 30, 2016 and December 31, 2015, respectively. These assets are classified as Level 1 as described above and total interest income recorded for these investments was insignificant during both the six month periods ended June  30, 2016, and June 30, 2015. There were no transfers in or out of Level 1 during the period ended June  30, 2016. Level 2 The Company does not have any financial assets or liabilities classified as Level 2. Level 3  In conjunction with the Company’s May 2012 and August 2013 financing transactions, the Company issued warrants to purchase shares of the Company’s common stock. Due to the provisions included in the warrant agreements, the warrants did not meet the exemptions for equity classification and as such, the Company accounts for these warrants as derivative instruments. The calculated fair value of the warrants is classified as a liability and is periodically re-measured with any changes in value recognized in “Other expense” in the Statements of Operations. The remaining warrants from the May 2012 transaction expire in May 2018 and were revalued as of June  30, 2016 using the following assumptions: 1) volatility of 124.33%; 2) risk-free interest rate of 0.58%; and 3) a closing stock price of $0.98. The remaining warrants from the August 2013 expire in November 2018  and were revalued as of June  30, 2016 using the following assumptions: 1) volatility of 113.17%; 2) risk-free interest rate of 0.58%; and 3) a closing stock price of $0.98. The significant unobservable input used in the fair value measurement of the Company’s warrants is volatility.  Significant increases (decreases) in the volatility in isolation would result in significantly higher (lower) liability fair value measurements. The following table sets forth a summary of changes in the fair value of the Company’s Level 3 financial liabilities for the six month period ended June  30, 2016: <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:38.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:03.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:19.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:16.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:38.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:49.50pt;padding:0pt;"> </td> <td valign="bottom" style="width:03.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:49.50pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:49.50pt;padding:0pt;">   </td> <td valign="bottom" style="width:19.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:49.50pt;padding:0pt;"> Warrants issued May 2012 </td> <td valign="bottom" style="width:03.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:49.50pt;padding:0pt;">   </td> <td valign="bottom" style="width:16.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:49.50pt;padding:0pt;"> Warrants issued August 2013 </td> <td valign="bottom" style="width:03.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:49.50pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:49.50pt;padding:0pt;"> Total Liabilities </td> </tr> <tr> <td valign="bottom" style="width:38.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Balance at beginning of period </td> <td valign="bottom" style="width:03.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:19.14%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $              143,681 </td> <td valign="bottom" style="width:03.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:16.24%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $          650,449 </td> <td valign="bottom" style="width:03.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.26%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $        794,130 </td> </tr> <tr> <td valign="bottom" style="width:38.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">     Issues </td> <td valign="bottom" style="width:03.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:19.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> - </td> <td valign="bottom" style="width:03.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:16.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> - </td> <td valign="bottom" style="width:03.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> - </td> </tr> <tr> <td valign="bottom" style="width:38.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">     Settlements </td> <td valign="bottom" style="width:03.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:19.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> - </td> <td valign="bottom" style="width:03.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:16.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> - </td> <td valign="bottom" style="width:03.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> - </td> </tr> <tr> <td valign="bottom" style="width:38.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">     Revaluation </td> <td valign="bottom" style="width:03.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:19.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">65,475  </td> <td valign="bottom" style="width:03.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:16.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(232,139) </td> <td valign="bottom" style="width:03.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(166,664) </td> </tr> <tr> <td valign="bottom" style="width:38.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Balance at end of period </td> <td valign="bottom" style="width:03.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:19.14%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $              209,156 </td> <td valign="bottom" style="width:03.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:16.24%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $          418,310 </td> <td valign="bottom" style="width:03.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.26%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $        627,466 </td> </tr> </table></div> The Company currently does not have derivative instruments to manage its exposure to currency fluctuations or other business risks. The Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. All derivative financial instruments are recognized in the balance sheet at fair value.   </div> </div>

794130

650449

143681

627466

418310

209156

<div> <div style="margin-left:0pt;margin-right:0pt;"> Financial Instruments Financial instruments consist of cash and cash equivalents, accounts receivable, accounts payable and debt. The carrying value of such amounts reported at the applicable balance sheet dates approximates fair value. See Note 9 for disclosure of the fair value of debt. The Company measures certain financial assets and liabilities, including warrants, at fair value on a recurring basis. General accounting principles for fair value measurement established a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets and liabilities (“Level 1”) and the lowest priority to unobservable inputs (“Level 3”). See Note 11 for additional details. </div> </div>

2684840

3221069

635889

536229

5567297

2772708

5372838

2786046

13621375

6720987

13246745

6779552

-60014

587562

969414

-1318967

497625

-627335

-435029

-1398213

-609088

806755

-67541

13081

-409358

-5307

-244527

-147942

1645810

816023

1648066

829046

494703

494067

<div> <div style="margin-left:0pt;margin-right:0pt;">   3. Inventories  Inventories consist of the following: <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="top" style="width:45.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:24.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:06.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:24.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="top" style="width:45.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:27.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:24.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:27.00pt;padding:0pt;"> June 30, 2016 </td> <td valign="bottom" style="width:06.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:27.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:24.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:27.00pt;padding:0pt;"> December 31, 2015 </td> </tr> <tr> <td valign="top" style="width:45.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> </td> <td valign="top" style="width:24.32%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="top" style="width:06.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="top" style="width:24.06%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="top" style="width:45.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Raw materials </td> <td valign="bottom" style="width:24.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $          2,476,263 </td> <td valign="bottom" style="width:06.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:24.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $         2,065,676 </td> </tr> <tr> <td valign="top" style="width:45.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Work in process </td> <td valign="bottom" style="width:24.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">876,105  </td> <td valign="bottom" style="width:06.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:24.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">24,758  </td> </tr> <tr> <td valign="top" style="width:45.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Finished goods </td> <td valign="bottom" style="width:24.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2,014,872  </td> <td valign="bottom" style="width:06.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:24.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2,433,819  </td> </tr> <tr> <td valign="top" style="width:45.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Reserve for obsolescence </td> <td valign="bottom" style="width:24.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(32,553) </td> <td valign="bottom" style="width:06.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:24.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(19,971) </td> </tr> <tr> <td valign="top" style="width:45.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Total inventory </td> <td valign="bottom" style="width:24.32%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $          5,334,687 </td> <td valign="bottom" style="width:06.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:24.06%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $         4,504,282 </td> </tr> </table></div> </div> </div>

2433819

2014872

4504282

5334687

2065676

2476263

19971

32553

24758

876105

1355

493

362

140

2018-12-31

36503550

37927842

18877896

16258976

16138590

18922193

794130

627466

3000000

4000000

2018-03-31

10000000

1000000

18080159

18429177

18080159

18429177

21114408

21405468

3000000

18114408

18405468

3000000

18080159

18429177

18114408

18405468

<div> <div style="margin-left:0pt;margin-right:0pt;"> 1. Description of Business Stereotaxis designs, manufactures, and markets the Epoch® Solution, an advanced remote robotic navigation system for use in a hospital’s interventional surgical suite or “interventional lab”, that we believe revolutionizes the treatment of arrhythmias and coronary artery disease by enabling enhanced safety, efficiency, and efficacy for catheter-based or interventional procedures. The Epoch Solution is comprised of the Niobe® ES Magnetic Navigation System (“Niobe ES system”), Odyssey® Information Management Solution (“Odyssey Solution”), and the Vdrive® Robotic Navigation System (“Vdrive system”) and related devices. The Niobe ES system is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. This is achieved using externally applied magnetic fields that govern the motion of the working tip of the catheter or guidewire, resulting in improved navigation, efficient procedures, and reduced X-ray exposure. In addition to the Niobe ES system and its components, Stereotaxis has also developed the Odyssey Solution, which consolidates all lab information, enabling doctors to focus on the patient for optimal procedure efficiency. The platform also features a remote viewing and recording capability called the Odyssey Cinema™ system, an innovative system delivering synchronized content for optimized workflow, advanced care, and improved productivity. This tool includes an archiving capability that allows clinicians to store and replay entire procedures or segments of procedures. This information can be accessed from locations throughout the hospital’s local area network and over the global Odyssey Network, providing physicians with a tool for clinical collaboration, remote consultation, and training. Our Vdrive system provides navigation and stability for diagnostic and therapeutic devices designed to improve interventional procedures. The Vdrive system complements the Niobe ES system’s control of therapeutic catheters for fully remote procedures and enables single-operator workflow. It is sold as two options, the Vdrive system and the Vdrive Duo™ system. In addition to the Vdrive system and the Vdrive Duo system, we also manufacture and market various disposable components which can be manipulated by these systems. We promote the full Epoch Solution in a typical hospital implementation, subject to regulatory approvals or clearances. The full Epoch Solution implementation requires a hospital to agree to an upfront capital payment and recurring payments. The upfront capital payment typically includes equipment and installation charges. The recurring payments typically include disposable costs for each procedure, equipment service costs beyond the warranty period, and software licenses. In hospitals where the full Epoch Solution has not been implemented, equipment upgrade or expansion may be implemented upon purchase of the necessary components. As of June 30, 2016, the Company has an installed base of 129 Niobe ES systems. The core components of Stereotaxis’ systems have received regulatory clearance in the United States, European Union, Canada, China, Japan and various other countries.  We have received regulatory clearance, licensing and/or CE Mark approvals necessary for us to market the Vdrive and Vdrive Duo systems with the V-CAS, V-Loop and V-Sono devices in the U.S., Canada and European Union. The V-CAS Deflect catheter advancement system has been CE Marked for sale in the European Union. We have received Food and Drug Administration (“FDA”) clearance and the CE Mark necessary for us to market our suite of Pegasus™ coronary peripheral guidewires in the United States and Europe. Since our inception, we have generated significant losses. As of June 30, 2016, we have incurred cumulative net losses of approximately $470.6 million. In 2016, the Company plans to continue developing the Niobe ES system with the goal of furthering clinical adoption and new system placements.  We expect to incur additional losses in 2016 as we continue the development and commercialization of our products, conduct our research and development activities, advance new products into clinical development from our existing research programs and fund additional sales and marketing initiatives. During 2016, we will continue to monitor operating expenses and make additional investments in certain targeted areas.   Our existing cash, cash equivalents, and borrowing facilities may not be sufficient to fund our operating expenses and capital equipment requirements through the next 12 months, which would require us to obtain additional financing. We may be required to raise capital or pursue other financing strategies to continue our operations. Until we can generate significant cash flow from our operations, we expect to continue to fund our operations with cash resources primarily generated from the proceeds of our past and future public offerings, private sales of our equity securities, and loans collateralized by working capital and equipment. We continue to explore financing alternatives, which may include the sale of equity securities or non-core assets, strategic collaboration agreements, debt financings, or distribution rights. We cannot accurately predict the timing and amount of our utilization of capital, which will depend on a number of factors outside of our control.  We cannot assure that additional financing will be available on acceptable terms or that such financing will not be dilutive to our stockholders. If adequate funds are not available to us, we could be required to delay development or commercialization of new products, to license to third parties the rights to commercialize products or technologies that we would otherwise seek to commercialize ourselves, or to reduce the sales, marketing, customer support or other resources devoted to our products, any of which could have a material adverse effect on our business, financial condition, and operational results. In addition, we could be required to cease operations. </div> </div>

615270

2873521

-52410

-4203888

-4609014

-4674268

-1538687

-4607417

-2333116

<div> <div style="margin-left:0pt;margin-right:0pt;"> Recently Issued Accounting Pronouncements In March 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU” or “Update”) No. 2016-09, “Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting”. This amendment is intended to simplify several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, forfeitures, and classification on the statement of cash flows. This update is effective for fiscal years beginning after December 15, 2016 (January 1, 2017 for the Company) and interim periods within those fiscal years, with earlier application permitted. The Company is evaluating the impact of this guidance on its financial statements and related disclosures. In February 2016, the FASB issued ASU 2016-02, “Leases (ASC 842)”, which sets out the principles for the recognition, measurement, presentation and disclosure of leases for both parties to a contract (i.e. lessees and lessors). The new standard requires lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. This classification will determine whether lease expense is recognized based on an effective interest method or on a straight line basis over the term of the lease, respectively. A lessee is also required to record a right-of-use asset and a lease liability for all leases with a term of greater than 12 months regardless of their classification. Leases with a term of 12 months or less will be accounted for similar to existing guidance for operating leases today. The new standard requires lessors to account for leases using an approach that is substantially equivalent to existing guidance for sales-type leases, direct financing leases and operating leases. ASC 842 supersedes the previous leases standard, ASC 840 Leases. The standard is effective for interim and annual periods beginning after December 31, 2018 (January 1, 2019 for the Company), with early adoption permitted. The Company is in the process of evaluating the impact of this accounting standard update. In November 2015, the FASB issued ASU No. 2015-17, “Income Taxes (Topic 740): To simplify the presentation of deferred income taxes”. The amendments in this Update require that deferred tax liabilities and assets be classified as noncurrent in a classified statement of financial position. The amendments in this Update apply to all entities that present a classified statement of financial position. The current requirement that deferred tax liabilities and assets of a tax-paying component of an entity be offset and presented as a single amount is not affected by the amendments in this Update. This standard is effective for public companies for financial statements issued for annual periods beginning after December 15, 2016 (January 1, 2017 for the Company), and interim periods within those annual periods. We adopted this accounting standard update in 2015 and there was no impact to the results of operations or cash flows. In July 2015, the FASB issued ASU No. 2015-11, “Inventory (Topic 330): Simplifying the Measurement of Inventory” regarding the subsequent measurement of inventory as part of its Simplification Initiative. This standard is effective for public companies for fiscal years beginning after December 15, 2016 (January 1, 2017 for the Company), including interim periods within those fiscal years. This Update should be applied prospectively, and early application is permitted as of the beginning of an interim or annual reporting period. We are currently evaluating the impact of adopting this accounting standard update but do not expect this to significantly impact the results of operations, financial conditions, cash flows, or financial statement presentation. In April 2015, the FASB issued ASU No. 2015-03, “Interest—Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs”. To simplify the presentation of debt issuance costs, the amendments in this Update require that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from that debt liability, consistent with the presentation of a debt discount. In August 2015, the FASB issued ASU 2015-15, Presentation and Subsequent Measurement of Debt Issuance Costs Associated with Line-of-Credit Arrangements—Amendments to SEC Paragraphs Pursuant to Staff Announcement at June 18, 2015 EITF Meeting (SEC Update), which adds the SEC staff’s guidance on the presentation of debt issuance costs associated with lines of credit to the Codification. The SEC staff stated it will not object to an entity presenting the costs of securing line-of-credit arrangements as an asset, regardless of whether there are any outstanding borrowings. The Standard is effective for financial statements issued for fiscal years beginning after December 15, 2015 (January 1, 2016 for the Company), and interim periods within those fiscal years. Early adoption of the amendments in this Update is permitted for financial statements that have not been previously issued. We have adopted this accounting standard update. The Company’s balance sheets as of June 30, 2016 and December 31, 2015 included $291,060 and $349,018, respectively, of deferred financing costs (excluding $75,068 and $25,960, respectively, related to line-of-credit arrangements) that were, under the new guidance, presented as a direct reduction to debt liabilities. In August 2014, the FASB issued ASU No. 2014-15, to communicate amendments to FASB Account Standards Codification Subtopic 205-40, “Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern”. The ASU requires management to evaluate relevant conditions, events and certain management plans that are known or reasonably knowable as of the evaluation date when determining whether substantial doubt about an entity’s ability to continue as a going concern exists. Management will be required to make this evaluation for both annual and interim reporting periods. Management will have to make certain disclosures if it concludes that substantial doubt exists and when it plans to alleviate substantial doubt about the entity’s ability to continue as a going concern. The standard is effective for annual periods ending after December 15, 2016 and for interim reporting periods starting in the first quarter of 2017 (December 31, 2016 for the Company). Early adoption is permitted. We are currently evaluating the impact of adopting this accounting standard update on our financial statement disclosures. In May 2014, the FASB issued ASU No. 2014-09, "Revenue from Contracts with Customers" which converges the FASB's and the International Accounting Standards Board's current standards on revenue recognition. The standard provides companies with a single model to use in accounting for revenue arising from contracts with customers and supersedes current revenue guidance. The standard is effective for annual and interim periods beginning after December 15, 2016. Early adoption is not permitted. The standard permits companies to either apply the adoption to all periods presented, or apply the requirements in the year of adoption through a cumulative adjustment. In April 2015, the FASB issued an exposure draft related to the deferral of the effective date, which would delay our effective date one year. Therefore, the standard would be effective for annual and interim periods beginning after December 15, 2017 (January 1, 2018 for the Company). We are currently evaluating the impact of adopting this accounting standard update on our financial statements and disclosures and have not concluded on an adoption method. </div> </div>

16757980

8443313

16373122

8419132

-3136605

-1722326

-3126377

-1639580

117465

248516

275603

270296

31693

44774

106792

999169

166664

135370

100000

52410

0.001

10000000

700352

614599

668659

569825

31693

44774

454822

293484

15000000

2500000

3000000

695598

-2770

293982

364548

316835

258450

219097

106449

171384

48064

<div> <div style="margin-left:0pt;margin-right:0pt;"> 12. Product Warranty Provisions  The Company’s standard policy is to warrant all Niobe,  Odyssey, and Vdrive systems against defects in material or workmanship for one year following installation. The Company’s estimate of costs to service the warranty obligations is based on historical experience and current product performance trends. A regular review of warranty obligations is performed to determine the adequacy of the reserve and adjustments are made to the estimated warranty liability as appropriate. Accrued warranty, which is included in other accrued liabilities, consists of the following: <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:46.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="top" style="width:09.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:17.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:05.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:17.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:46.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> </td> <td valign="bottom" style="width:09.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> June 30, 2016 </td> <td valign="bottom" style="width:05.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> December 31, 2015 </td> </tr> <tr> <td valign="bottom" style="width:46.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Warranty accrual, beginning of the fiscal period </td> <td valign="top" style="width:09.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:17.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">316,835  </td> <td valign="bottom" style="width:05.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:17.32%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">364,548  </td> </tr> <tr> <td valign="bottom" style="width:46.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Accrual adjustment for product warranty </td> <td valign="top" style="width:09.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:17.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">48,064  </td> <td valign="bottom" style="width:05.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:17.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">171,384  </td> </tr> <tr> <td valign="bottom" style="width:46.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Payments made </td> <td valign="top" style="width:09.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:17.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(106,449) </td> <td valign="bottom" style="width:05.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:17.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(219,097) </td> </tr> <tr> <td valign="bottom" style="width:46.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Warranty accrual, end of the fiscal period </td> <td valign="top" style="width:09.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:17.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">258,450  </td> <td valign="bottom" style="width:05.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:17.32%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">316,835  </td> </tr> </table></div> </div> </div>

11120416

303412

8496636

2320368

11010615

303412

8386835

2320368

1067321

857869

1.50

3000000

80328

23709

2905533

1419826

2894465

1421380

-465958678

-470566095

19195276

9664250

16522629

7874623

<div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:40.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:40.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Three months ended June 30, </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Six months ended June 30, </td> <td valign="bottom" style="width:01.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:40.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> Numerator: </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> 2016 </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> 2015 </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> 2016 </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> 2015 </td> <td valign="bottom" style="width:01.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:40.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> Numerator for basic EPS </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.06%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(2,333,116) </td> <td valign="bottom" style="width:02.08%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(1,538,687) </td> <td valign="bottom" style="width:02.08%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.06%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(4,607,417) </td> <td valign="bottom" style="width:02.08%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(4,674,268) </td> <td valign="bottom" style="width:02.08%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:40.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> Numerator for diluted EPS </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.06%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(2,333,116) </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(1,538,687) </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.06%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(4,607,417) </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(4,674,268) </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:40.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> Denominator: </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.06%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.54%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.06%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.54%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:40.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> Denominator for basic EPS—weighted average shares </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">21,793,583  </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">21,007,103  </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">21,702,597  </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">20,871,244  </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:40.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> Denominator for diluted EPS—weighted average shares </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.06%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">21,793,583  </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">21,007,103  </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.06%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">21,702,597  </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">20,871,244  </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:40.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> Basic EPS </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.06%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(0.11) </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.54%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(0.07) </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.06%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(0.21) </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.54%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(0.22) </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:40.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> Diluted EPS </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(0.11) </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(0.07) </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(0.21) </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(0.22) </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> </tr> </table></div> </div> </div>

<div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> </td> <td colspan="8" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Fair Value Measurement Using </td> </tr> <tr> <td valign="bottom" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:74.25pt;padding:0pt;"> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:74.25pt;padding:0pt;"> Total </td> <td valign="bottom" style="width:04.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:74.25pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:74.25pt;padding:0pt;"> Quoted Prices in Active Markets for Identical Instruments (Level 1) </td> <td valign="bottom" style="width:04.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:74.25pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:74.25pt;padding:0pt;"> Significant Other Observable Inputs (Level 2) </td> <td valign="bottom" style="width:04.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:74.25pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:74.25pt;padding:0pt;"> Significant Unobservable Inputs (Level 3) </td> </tr> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Assets at June 30, 2016: </td> <td valign="bottom" style="width:02.14%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">          Cash equivalents </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">74,346  </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">74,346  </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> </tr> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Total assets at fair value </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">74,346  </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">74,346  </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> </tr> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Liabilities at June 30, 2016: </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.74%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">          Warrants issued May 2012 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">209,156  </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">209,156  </td> </tr> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">          Warrants issued August 2013 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">418,310  </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">418,310  </td> </tr> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Total liabilities at fair value: </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">627,466  </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">627,466  </td> </tr> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Assets at December 31, 2015: </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.74%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">          Cash equivalents </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">524,083  </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">524,083  </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> </tr> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Total assets at fair value </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">524,083  </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">524,083  </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> </tr> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Liabilities at December 31, 2015: </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.74%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">          Warrants issued May 2012 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">143,681  </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">143,681  </td> </tr> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">          Warrants issued August 2013 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">650,449  </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">650,449  </td> </tr> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Total liabilities at fair value: </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">794,130  </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">794,130  </td> </tr> </table></div> </div> </div>

8285150

4250779

8105819

4211706

637246

566975

P4Y

56262

1.49

791600

0.84

752008

1212496

2.63

1.53

274850

2.56

1000000

1500000

1508565

21111

1000

706494

686383

9.34

8.66

30.82

1.55

1.45

1.74

116.40

99.00

1.55

0.98

<div> <div style="margin-left:0pt;margin-right:0pt;"> 2. Summary of Significant Accounting Policies  Basis of Presentation The accompanying unaudited financial statements of Stereotaxis, Inc. have been prepared in accordance with generally accepted accounting principles for interim financial information and the instructions to Form 10-Q. Accordingly, they do not include all the disclosures required by U.S. generally accepted accounting principles for complete financial statements. In the opinion of management, they include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods presented. Operating results for the six month period ended June 30, 2016 are not necessarily indicative of the results that may be expected for the year ended December 31, 2016 or for future operating periods. These interim financial statements and the related notes should be read in conjunction with the annual financial statements and notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2015 as filed with the Securities and Exchange Commission (SEC) on March 11, 2016. Financial Instruments Financial instruments consist of cash and cash equivalents, accounts receivable, accounts payable and debt. The carrying value of such amounts reported at the applicable balance sheet dates approximates fair value. See Note 9 for disclosure of the fair value of debt. The Company measures certain financial assets and liabilities, including warrants, at fair value on a recurring basis. General accounting principles for fair value measurement established a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets and liabilities (“Level 1”) and the lowest priority to unobservable inputs (“Level 3”). See Note 11 for additional details. Revenue and Costs of Revenue  The Company accounts for revenue using Accounting Standards Codification Topic 605-25, Multiple-Element Arrangements (“ASC 605-25”). ASC 605-25 permits management to estimate the selling price of undelivered components of a bundled sale for which it is unable to establish vendor-specific objective evidence (“VSOE”) or third-party evidence (“TPE”). This requires management to record revenue for certain elements of a transaction even though it might not have delivered other elements of the transaction, for which it was unable to meet the requirements for establishing VSOE or TPE. The Company believes that the guidance significantly improves the reporting of these types of transactions to more closely reflect the underlying economic circumstances. This guidance also prohibits the use of the residual method for allocating revenue to the various elements of a transaction and requires that the revenue be allocated proportionally based on the relative estimated selling prices. Under our revenue recognition policy, a portion of revenue for Niobe systems, Vdrive systems and certain Odyssey systems is recognized upon delivery, provided that title has passed, there are no uncertainties regarding acceptance, persuasive evidence of an arrangement exists, the sales price is fixed and determinable, and collection of the related receivable is reasonably assured. Revenue is recognized for other types of Odyssey systems upon completion of installation, since there are no qualified third party installers. When installation is the responsibility of the customer, revenue from system sales is recognized upon shipment since these arrangements do not include an installation element or right of return privileges. The Company does not recognize revenue in situations in which inventory remains at a Stereotaxis warehouse or in situations in which title and risk of loss have not transferred to the customer. Amounts collected prior to satisfying the above revenue recognition criteria are reflected as deferred revenue. Revenue from services and license fees, whether sold individually or as a separate unit of accounting in a multiple-deliverable arrangement, is deferred and amortized over the service or license fee period, which is typically one year. Revenue from services is derived primarily from the sale of annual product maintenance plans. We recognize revenue from disposable device sales or accessories upon shipment and establish an appropriate reserve for returns. The return reserve, which is applicable only to disposable devices, is estimated based on historical experience which is periodically reviewed and updated as necessary. In the past, changes in estimate have had only a de minimis effect on revenue recognized in the period. We believe that the estimate is not likely to change significantly in the future. Costs of systems revenue include direct product costs, installation labor and other costs, estimated warranty costs, and initial training and product maintenance costs. These costs are recorded at the time of sale. Costs of disposable revenue include direct product costs and estimated warranty costs and are recorded at the time of sale. Cost of revenue from services and license fees are recorded when incurred. Share-Based Compensation The Company accounts for its grants of stock options, stock appreciation rights, restricted shares, and restricted stock units and for its employee stock purchase plan in accordance with the provisions of general accounting principles for share-based payments. These accounting principles require the determination of the fair value of the share-based compensation at the grant date and the recognition of the related expense over the period in which the share-based compensation vests. The Company utilizes the Black-Scholes valuation model to determine the fair value of stock options and stock appreciation rights at the date of grant. The resulting compensation expense is recognized over the requisite service period, which is generally four years. Compensation expense is recognized only for those awards expected to vest, with forfeitures estimated based on the Company’s historical experience and future expectations. Restricted shares granted to employees are valued at the fair market value at the date of grant. The Company amortizes the fair market value to expense over the service period. If the shares are subject to performance objectives, the resulting compensation expense is amortized over the anticipated vesting period and is subject to adjustment based on the actual achievement of objectives. Net Earnings (Loss) per Common Share (“EPS”) Basic and diluted net earnings (loss) per common share are computed by dividing the net income (loss) for the period by the weighted average number of common shares outstanding during the period. The following table sets forth the computation of basic and diluted EPS: <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:40.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:40.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Three months ended June 30, </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Six months ended June 30, </td> <td valign="bottom" style="width:01.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:40.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> Numerator: </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> 2016 </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> 2015 </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> 2016 </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> 2015 </td> <td valign="bottom" style="width:01.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:40.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> Numerator for basic EPS </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.06%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(2,333,116) </td> <td valign="bottom" style="width:02.08%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(1,538,687) </td> <td valign="bottom" style="width:02.08%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.06%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(4,607,417) </td> <td valign="bottom" style="width:02.08%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(4,674,268) </td> <td valign="bottom" style="width:02.08%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:40.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> Numerator for diluted EPS </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.06%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(2,333,116) </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(1,538,687) </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.06%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(4,607,417) </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(4,674,268) </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:40.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> Denominator: </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.06%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.54%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.06%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.54%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:40.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> Denominator for basic EPS—weighted average shares </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">21,793,583  </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">21,007,103  </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">21,702,597  </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">20,871,244  </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:40.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> Denominator for diluted EPS—weighted average shares </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.06%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">21,793,583  </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">21,007,103  </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.06%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">21,702,597  </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">20,871,244  </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:40.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> Basic EPS </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.06%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(0.11) </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.54%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(0.07) </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.06%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(0.21) </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.54%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(0.22) </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:40.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> Diluted EPS </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(0.11) </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(0.07) </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(0.21) </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(0.22) </td> <td valign="bottom" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> </tr> </table></div> In addition, the Company did not include any portion of unearned restricted shares, outstanding options, stock appreciation rights or warrants in the calculation of diluted loss per common share because all such securities are anti-dilutive for all periods presented. The application of the two-class method of computing earnings per share under general accounting principles for participating securities is not applicable during these periods because the Company’s unearned restricted shares do not contractually participate in its losses. As of June 30, 2016, the Company had 686,383 shares of common stock issuable upon the exercise of outstanding options and stock appreciation rights at a weighted average exercise price of $8.66 per share, 2,040,365 shares of common stock issuable upon the exercise of outstanding warrants at a weighted average exercise price of $3.44 per share, and 1,212,496 shares of unvested restricted share units. <a name="eolPage9"></a> Recently Issued Accounting Pronouncements In March 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU” or “Update”) No. 2016-09, “Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting”. This amendment is intended to simplify several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, forfeitures, and classification on the statement of cash flows. This update is effective for fiscal years beginning after December 15, 2016 (January 1, 2017 for the Company) and interim periods within those fiscal years, with earlier application permitted. The Company is evaluating the impact of this guidance on its financial statements and related disclosures. In February 2016, the FASB issued ASU 2016-02, “Leases (ASC 842)”, which sets out the principles for the recognition, measurement, presentation and disclosure of leases for both parties to a contract (i.e. lessees and lessors). The new standard requires lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. This classification will determine whether lease expense is recognized based on an effective interest method or on a straight line basis over the term of the lease, respectively. A lessee is also required to record a right-of-use asset and a lease liability for all leases with a term of greater than 12 months regardless of their classification. Leases with a term of 12 months or less will be accounted for similar to existing guidance for operating leases today. The new standard requires lessors to account for leases using an approach that is substantially equivalent to existing guidance for sales-type leases, direct financing leases and operating leases. ASC 842 supersedes the previous leases standard, ASC 840 Leases. The standard is effective for interim and annual periods beginning after December 31, 2018 (January 1, 2019 for the Company), with early adoption permitted. The Company is in the process of evaluating the impact of this accounting standard update. In November 2015, the FASB issued ASU No. 2015-17, “Income Taxes (Topic 740): To simplify the presentation of deferred income taxes”. The amendments in this Update require that deferred tax liabilities and assets be classified as noncurrent in a classified statement of financial position. The amendments in this Update apply to all entities that present a classified statement of financial position. The current requirement that deferred tax liabilities and assets of a tax-paying component of an entity be offset and presented as a single amount is not affected by the amendments in this Update. This standard is effective for public companies for financial statements issued for annual periods beginning after December 15, 2016 (January 1, 2017 for the Company), and interim periods within those annual periods. We adopted this accounting standard update in 2015 and there was no impact to the results of operations or cash flows. In July 2015, the FASB issued ASU No. 2015-11, “Inventory (Topic 330): Simplifying the Measurement of Inventory” regarding the subsequent measurement of inventory as part of its Simplification Initiative. This standard is effective for public companies for fiscal years beginning after December 15, 2016 (January 1, 2017 for the Company), including interim periods within those fiscal years. This Update should be applied prospectively, and early application is permitted as of the beginning of an interim or annual reporting period. We are currently evaluating the impact of adopting this accounting standard update but do not expect this to significantly impact the results of operations, financial conditions, cash flows, or financial statement presentation. In April 2015, the FASB issued ASU No. 2015-03, “Interest—Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs”. To simplify the presentation of debt issuance costs, the amendments in this Update require that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from that debt liability, consistent with the presentation of a debt discount. In August 2015, the FASB issued ASU 2015-15, Presentation and Subsequent Measurement of Debt Issuance Costs Associated with Line-of-Credit Arrangements—Amendments to SEC Paragraphs Pursuant to Staff Announcement at June 18, 2015 EITF Meeting (SEC Update), which adds the SEC staff’s guidance on the presentation of debt issuance costs associated with lines of credit to the Codification. The SEC staff stated it will not object to an entity presenting the costs of securing line-of-credit arrangements as an asset, regardless of whether there are any outstanding borrowings. The Standard is effective for financial statements issued for fiscal years beginning after December 15, 2015 (January 1, 2016 for the Company), and interim periods within those fiscal years. Early adoption of the amendments in this Update is permitted for financial statements that have not been previously issued. We have adopted this accounting standard update. The Company’s balance sheets as of June 30, 2016 and December 31, 2015 included $291,060 and $349,018, respectively, of deferred financing costs (excluding $75,068 and $25,960, respectively, related to line-of-credit arrangements) that were, under the new guidance, presented as a direct reduction to debt liabilities. In August 2014, the FASB issued ASU No. 2014-15, to communicate amendments to FASB Account Standards Codification Subtopic 205-40, “Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern”. The ASU requires management to evaluate relevant conditions, events and certain management plans that are known or reasonably knowable as of the evaluation date when determining whether substantial doubt about an entity’s ability to continue as a going concern exists. Management will be required to make this evaluation for both annual and interim reporting periods. Management will have to make certain disclosures if it concludes that substantial doubt exists and when it plans to alleviate substantial doubt about the entity’s ability to continue as a going concern. The standard is effective for annual periods ending after December 15, 2016 and for interim reporting periods starting in the first quarter of 2017 (December 31, 2016 for the Company). Early adoption is permitted. We are currently evaluating the impact of adopting this accounting standard update on our financial statement disclosures. In May 2014, the FASB issued ASU No. 2014-09, "Revenue from Contracts with Customers" which converges the FASB's and the International Accounting Standards Board's current standards on revenue recognition. The standard provides companies with a single model to use in accounting for revenue arising from contracts with customers and supersedes current revenue guidance. The standard is effective for annual and interim periods beginning after December 15, 2016. Early adoption is not permitted. The standard permits companies to either apply the adoption to all periods presented, or apply the requirements in the year of adoption through a cumulative adjustment. In April 2015, the FASB issued an exposure draft related to the deferral of the effective date, which would delay our effective date one year. Therefore, the standard would be effective for annual and interim periods beginning after December 15, 2017 (January 1, 2018 for the Company). We are currently evaluating the impact of adopting this accounting standard update on our financial statements and disclosures and have not concluded on an adoption method. </div> </div>

900000

-17625654

-21668866

<div> <div style="margin-left:0pt;margin-right:0pt;"> 10. Stockholders’ Equity  The holders of common stock are entitled to one vote for each share held and to receive dividends whenever funds are legally available and when declared by the Board of Directors subject to the prior rights of holders of all classes of stock having priority rights as dividends and the conditions of the revolving line of credit agreement. Since the Company’s inception, no dividends have been declared or paid. Controlled Equity Offering The Company entered into a Controlled Equity OfferingSM sales agreement (the “Sales Agreement”) in May 2014, as amended on March 26, 2015, with Cantor Fitzgerald & Co. (“Cantor”), as agent and/or principal, pursuant to which the Company could issue and sell, from time to time, shares of its common stock having an aggregate gross sales price of up to $18.0 million. The Company will pay Cantor a commission of 3.0% of the gross proceeds from any common stock sold through the Sales Agreement. There were no proceeds from the Controlled Equity Offering during the three months ended June 30, 2016.  As of June  30, 2016,  $13.8 million of common stock remained available to be sold under this facility, subject to certain conditions as specified in the Sales Agreement.  Due to the Company’s transfer to the OTCQX® Best Market on August 4, 2016, the Company’s ability to generate proceeds from the sale of stock under the Controlled Equity Offering in the future may be limited or prohibited. Offerings of Common Stock  On October 8, 2015 the Company announced the results of its previously announced offering of transferable subscription warrants (the “Warrants Offering) to holders of record of the Company’s common stock. Pursuant to the Warrants Offering, subscription warrants to purchase 267,256 shares of common stock were exercised, resulting in gross proceeds to the Company of $293,982. Stock Award Plans The Company has various stock plans that permit the Company to provide incentives to employees and directors of the Company in the form of equity compensation.  In August 2012, the Board of Directors adopted the 2012 Stock Incentive Plan (the “Plan”) which was subsequently approved by the Company’s shareholders. This plan replaced the 2002 Stock Incentive Plan which expired on March 25, 2012.  On June 5, 2013, June 10, 2014, and on May 24, 2016 the shareholders approved amendments to the Plan, which were previously approved and adopted by the Compensation Committee of the Board of Directors of the Company. Under each of the amendments on June 5, 2013 and June 10, 2014, the number of shares authorized for issuance under the Plan was increased by one million shares. The amendment on May 24, 2016 increased the number of shares authorized for issuance under the Plan by 1.5 million shares. At June 30, 2016, the Company had 1,508,565 remaining shares of the Company’s common stock to provide for current and future grants under its various equity plans. At June  30, 2016, the total compensation cost related to options, stock appreciation rights and non-vested stock granted to employees under the Company’s stock award plans but not yet recognized was approximately $1.9 million, net of estimated forfeitures of approximately $0.9 million. This cost will be amortized over a period of up to four years over the underlying estimated service periods and will be adjusted for subsequent changes in estimated forfeitures and anticipated vesting periods.  A summary of the option and stock appreciation rights activity for the six month period ended June 30, 2016 is as follows: <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="top" style="width:34.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:18.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:17.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:24.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="top" style="width:34.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:25.50pt;padding:0pt;"> </td> <td valign="bottom" style="width:18.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:25.50pt;padding:0pt;"> Number of Options/SARs </td> <td valign="bottom" style="width:03.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:25.50pt;padding:0pt;">   </td> <td valign="bottom" style="width:17.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:25.50pt;padding:0pt;"> Range of Exercise Price </td> <td valign="bottom" style="width:02.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:25.50pt;padding:0pt;">   </td> <td valign="bottom" style="width:24.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:25.50pt;padding:0pt;"> Weighted Average Exercise Price per Share </td> </tr> <tr> <td valign="top" style="width:34.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> </td> <td valign="top" style="width:18.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="top" style="width:03.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="top" style="width:17.34%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="top" style="width:02.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="top" style="width:24.26%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="top" style="width:34.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Outstanding, December 31, 2015 </td> <td valign="top" style="width:18.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">706,494  </td> <td valign="top" style="width:03.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="top" style="width:17.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $1.45 - $116.40 </td> <td valign="top" style="width:02.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:24.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">$9.34  </td> </tr> <tr> <td valign="top" style="width:34.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Granted </td> <td valign="bottom" style="width:18.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:9pt;text-align:right;" nowrap="nowrap">1,000  </td> <td valign="top" style="width:03.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:17.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $1.55 </td> <td valign="top" style="width:02.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:24.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">$1.55  </td> </tr> <tr> <td valign="top" style="width:34.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Exercised </td> <td valign="bottom" style="width:18.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">  - </td> <td valign="top" style="width:03.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:17.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">  - </td> <td valign="top" style="width:02.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:24.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">  - </td> </tr> <tr> <td valign="top" style="width:34.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Forfeited </td> <td valign="top" style="width:18.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(21,111) </td> <td valign="top" style="width:03.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="top" style="width:17.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $1.74 - $99.00 </td> <td valign="top" style="width:02.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:24.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">$30.82  </td> </tr> <tr> <td valign="top" style="width:34.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Outstanding, June 30, 2016 </td> <td valign="top" style="width:18.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">686,383  </td> <td valign="top" style="width:03.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="top" style="width:17.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $1.45 - $116.40 </td> <td valign="top" style="width:02.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:24.26%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">$8.66  </td> </tr> </table></div>  <a name="FIS_UNIDENTIFIED_TABLE_9"></a> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="top" style="width:57.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:17.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:06.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:17.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> </table></div> A summary of the restricted stock unit activity for the six month period ended June  30, 2016 is as follows: <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="top" style="width:49.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:20.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:06.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:23.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="top" style="width:49.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:56.25pt;padding:0pt;"> </td> <td valign="bottom" style="width:20.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:56.25pt;padding:0pt;"> Number of Restricted Stock Units </td> <td valign="bottom" style="width:06.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:56.25pt;padding:0pt;">   </td> <td valign="bottom" style="width:23.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:56.25pt;padding:0pt;"> Weighted Average Grant Date Fair Value per Unit </td> </tr> <tr> <td valign="top" style="width:49.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> </td> <td valign="top" style="width:20.10%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="top" style="width:06.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="top" style="width:23.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="top" style="width:49.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Outstanding, December 31, 2015 </td> <td valign="top" style="width:20.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">752,008  </td> <td valign="top" style="width:06.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:23.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">$2.63  </td> </tr> <tr> <td valign="top" style="width:49.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Granted </td> <td valign="top" style="width:20.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">791,600  </td> <td valign="top" style="width:06.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:23.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">$0.84  </td> </tr> <tr> <td valign="top" style="width:49.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Vested </td> <td valign="top" style="width:20.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(274,850) </td> <td valign="top" style="width:06.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:23.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">$2.56  </td> </tr> <tr> <td valign="top" style="width:49.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Forfeited </td> <td valign="top" style="width:20.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(56,262) </td> <td valign="top" style="width:06.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:23.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">$1.49  </td> </tr> <tr> <td valign="top" style="width:49.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Outstanding, June 30, 2016 </td> <td valign="top" style="width:20.10%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1,212,496  </td> <td valign="top" style="width:06.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="top" style="width:23.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">$1.53  </td> </tr> </table></div> </div> </div>

267256

4015

205999

-4674268

-1538687

-4607417

-2333116

794130

650449

143681

650449

143681

627466

418310

209156

418310

209156

20871244

21007103

21702597

21793583

20871244

21007103

21702597

21793583

EX-101.SCH 8 stxs-20160630.xsd XBRL TAXONOMY EXTENSION SCHEMA 00100 - Statement - Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00200 - Statement - Statements Of Operations link:presentationLink link:calculationLink link:definitionLink 00400 - Statement - Statements Of Cash Flows link:presentationLink link:calculationLink link:definitionLink 40301 - Disclosure - Inventories (Details) link:presentationLink link:calculationLink link:definitionLink 40401 - Disclosure - Prepaid Expenses And Other Current Assets (Details) link:presentationLink link:calculationLink link:definitionLink 40401 - Disclosure - Prepaid Expenses And Other Current Assets (Schedule Of Prepaid Expenses And Other Current Assets) (Details) (Alternative) link:presentationLink link:calculationLink link:definitionLink 40501 - Disclosure - Property And Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 40701 - Disclosure - Accrued Liabilities (Schedule Of Accrued Liabilities) (Details) (Alternative) link:presentationLink link:calculationLink link:definitionLink 40702 - Disclosure - Accrued Liabilities (Schedule Of Accrued Liabilities) (Details) link:presentationLink link:calculationLink link:definitionLink 40801 - Disclosure - Deferred Revenue (Details) link:presentationLink link:calculationLink link:definitionLink 40902 - Disclosure - Long-Term Debt And Credit Facilities (Schedule Of Debt Outstanding) (Details) link:presentationLink link:calculationLink link:definitionLink 41102 - Disclosure - Fair Value Measurements (Assets And Liabilities Measured At Fair Value On Recurring Basis By Level) (Details) link:presentationLink link:calculationLink link:definitionLink 00090 - Document - Document And Entity Information link:presentationLink link:calculationLink link:definitionLink 00105 - Statement - Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 10101 - Disclosure - Description Of Business link:presentationLink link:calculationLink link:definitionLink 10201 - Disclosure - Summary Of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 10301 - Disclosure - Inventories link:presentationLink link:calculationLink link:definitionLink 10401 - Disclosure - Prepaid Expenses And Other Current Assets link:presentationLink link:calculationLink link:definitionLink 10501 - Disclosure - Property And Equipment link:presentationLink link:calculationLink link:definitionLink 10601 - Disclosure - Intangible Assets link:presentationLink link:calculationLink link:definitionLink 10701 - Disclosure - Accrued Liabilities link:presentationLink link:calculationLink link:definitionLink 10801 - Disclosure - Deferred Revenue link:presentationLink link:calculationLink link:definitionLink 10901 - Disclosure - Long-Term Debt And Credit Facilities link:presentationLink link:calculationLink link:definitionLink 11001 - Disclosure - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 11101 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 11201 - Disclosure - Product Warranty Provisions link:presentationLink link:calculationLink link:definitionLink 11301 - Disclosure - Commitments And Contingencies link:presentationLink link:calculationLink link:definitionLink 11401 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 20202 - Disclosure - Summary Of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 30203 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 30303 - Disclosure - Inventories (Tables) link:presentationLink link:calculationLink link:definitionLink 30403 - Disclosure - Prepaid Expenses And Other Current Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 30503 - Disclosure - Property And Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 30703 - Disclosure - Accrued Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 30803 - Disclosure - Deferred Revenue (Tables) link:presentationLink link:calculationLink link:definitionLink 30903 - Disclosure - Long-Term Debt And Credit Facilities (Tables) link:presentationLink link:calculationLink link:definitionLink 31003 - Disclosure - Stockholder's Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 31103 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 31203 - Disclosure - Product Warranty Provisions (Tables) link:presentationLink link:calculationLink link:definitionLink 40101 - Disclosure - Description Of Business (Details) link:presentationLink link:calculationLink link:definitionLink 40201 - Disclosure - Summary Of Significant Accounting Policies (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 40202 - Disclosure - Summary Of Significant Accounting Policies (Computation Of Basic And Diluted EPS) (Details) link:presentationLink link:calculationLink link:definitionLink 40601 - Disclosure - Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 40701 - Disclosure - Accrued Liabilities (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 40901 - Disclosure - Long-Term Debt And Credit Facilities (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 41001 - Disclosure - Stockholders' Equity (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 41002 - Disclosure - Stockholders' Equity (Summary Of Option And Stock Appreciation Rights Activity) (Details) link:presentationLink link:calculationLink link:definitionLink 41003 - Disclosure - Stockholders' Equity (Summary Of Restricted Stock Unit Activity) (Details) link:presentationLink link:calculationLink link:definitionLink 41101 - Disclosure - Fair Value Measurements (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 41103 - Disclosure - Fair Value Measurements (Summary Of Changes In Fair Value Of Level 3 Financial Liabilities) (Details) link:presentationLink link:calculationLink link:definitionLink 41201 - Disclosure - Product Warranty Provisions (Details) link:presentationLink link:calculationLink link:definitionLink 41401 - Disclosure - Subsequent Events (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 9 stxs-20160630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 10 stxs-20160630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 11 stxs-20160630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Document and Entity Information [Abstract] Document And Entity Information [Abstract] Statement [Table] Statement [Line Items] Entity Registrant Name Entity Filer Category Entity Central Index Key Trading Symbol Amendment Flag Document Type Document Fiscal Period Focus Document Period End Date Document Fiscal Year Focus Current Fiscal Year End Date Entity Common Stock, Shares Outstanding Balance Sheets [Abstract] Assets Abstract Assets Current assets [Abstract] Current assets: Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents at end of period Cash and cash equivalents at beginning of period Cash and cash equivalents Accounts Receivable, Net, Current Accounts receivable, net of allowance of $251,933 and $93,478 in 2016 and 2015, respectively Inventory, Net Total inventory Inventories Prepaid Expenses And Other Current Assets Prepaid expenses and other current assets Total current prepaid expenses and other assets Assets, Current Total current assets Property, Plant and Equipment, Net Net property and equipment Property and equipment, net Finite-Lived Intangible Assets, Net Intangible assets, net Other Assets, Noncurrent Other assets Assets Total assets Liabilities and Stockholders' Equity [Abstract] Liabilities and stockholders' deficit Current liabilities [Abstract] Current liabilities: Long term debt current Less current maturities Short-term debt Accounts Payable, Current Accounts payable Accrued Liabilities, Current Total current accrued liabilities Accrued liabilities Deferred Revenue, Current Total current deferred revenue Deferred revenue Warrants and Rights Outstanding Warrants and debt conversion features Warrants issued Liabilities, Current Total current liabilities Long-term Debt, Excluding Current Maturities Total long term debt Long-term debt Deferred Revenue, Noncurrent Less: Long-term deferred revenue Long-term deferred revenue Other Accrued Liabilities, Noncurrent Less: Long term accrued liabilities Other liabilities Liabilities Total liabilities Stockholders' Equity Attributable to Parent [Abstract] Stockholders' deficit: Preferred stock, par value $0.001; 10,000,000 shares authorized at 2011 and 2010, none outstanding at 2011 and 2010 Preferred stock, par value $0.001; 10,000,000 shares authorized, none outstanding at 2016 and 2015 Common Stock, Value, Issued Common stock, par value $0.001; 300,000,000 shares authorized, 21,846,095 and 21,551,173, shares issued at 2016 and 2015, respectively Additional Paid in Capital, Common Stock Additional paid in capital Treasury Stock, Common, Value Treasury stock, 4,015 shares at 2016 and 2015 Retained Earnings (Accumulated Deficit) Cumulative net losses Accumulated deficit Stockholders' Equity Attributable to Parent Total stockholders' deficit Liabilities and Stockholders' Equity Total liabilities and stockholders' deficit Allowance for Doubtful Accounts Receivable, Current Accounts receivable, allowance Preferred Stock, Par or Stated Value Per Share Preferred stock, par value Preferred Stock, Shares Authorized Preferred stock, shares authorized Preferred Stock, Shares Outstanding Preferred stock, shares outstanding Common Stock, Par or Stated Value Per Share Common stock, par value Common Stock, Shares Authorized Common stock, shares authorized Common Stock, Shares, Issued Common stock, shares issued Treasury Stock, Common, Shares Treasury stock, shares Statements Of Operations [Abstract] Revenues [Abstract] Revenue: Aggregate revenue during the period from the sale of systems in the normal course of business, after deducting returns, allowances and discounts. Systems Revenue Systems Total revenue related to disposables and accessories sold and services rendered during the reporting period. Disposables Service And Accessories Revenue Disposables, service and accessories Revenues Total revenue Cost of Revenue [Abstract] Cost of revenue: Total costs related to systems produced and sold during the reporting period. Systems Cost Of Revenue Systems Total costs related to disposables and accessories sold and services rendered during the reporting period. Disposables, Service And Accessories Cost Of Revenue Disposables, service and accessories Cost of Revenue Total cost of revenue Gross Profit Gross margin Operating Expenses [Abstract] Operating expenses: Research and Development Expense Research and development Selling and Marketing Expense Sales and marketing General and Administrative Expense General and administrative Operating Expenses Total operating expenses Operating Income (Loss) Operating loss Other Nonoperating Income (Expense) Other income Investment Income, Interest Interest income Interest Expense Interest expense Net Income (Loss) Available to Common Stockholders, Basic Net loss Net loss Numerator for basic EPS Net Loss Per Share [Abstract] Net loss per common share: Basic EPS Basic Basic EPS Diluted EPS Diluted Diluted EPS Weighted Average Number Of Basic And Diluted Shares Outstanding Abstract Weighted average shares used in computing net loss per common share: Denominator for basic EPS - weighted average shares Basic Denominator for basic EPS-weighted average shares Denominator for diluted EPS Diluted Denominator for diluted EPS-weighted average shares Statements Of Cash Flows [Abstract] Net Cash Provided by (Used in) Operating Activities [Abstract] Cash flows from operating activities Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net loss to cash used in operating activities: Depreciation Amortization expense Amortization of intangibles Amortization of Financing Costs Amortization of deferred finance costs Share-based compensation Warrant adjustment Adjustment of warrants Increase (Decrease) in Operating Capital [Abstract] Changes in operating assets and liabilities: Accounts receivable Accounts receivable Inventories Inventories Increase Decrease In Prepaid Deferred Expense And Other Assets Prepaid expenses and other current assets Other assets Other assets Accounts payable Increase Decrease In Accrued Liabilities Accrued liabilities Increase Decrease In Deferred Revenue Deferred revenue Other liabilities Net cash used in operating activities Net cash used in operating activities Net Cash Provided by (Used in) Investing Activities [Abstract] Cash flows from investing activities Purchase of equipment Purchase of equipment Net cash used in investing activities Net cash used in investing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Cash flows from financing activities Payments of Financing Costs Payments of deferred financing costs Proceeds from revolving line of credit Proceeds from (payments of) revolving line of credit Repayments of Secured Debt Payments of Healthcare Royalty Partners debt Proceeds from (Repurchase of) Equity Proceeds from issuance of stock, net of issuance costs Net cash provided by financing activities Net cash provided by (used in) financing activities Net decrease in cash and cash equivalents Net increase (decrease) in cash and cash equivalents Description Of Business [Abstract] Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Description Of Business Summary Of Significant Accounting Policies [Abstract] Significant Accounting Policies [Text Block] Summary Of Significant Accounting Policies Inventories [Abstract] Inventory Disclosure [Text Block] Inventories Prepaid Expenses And Other Current Assets [Abstract] Other Current Assets [Text Block] Prepaid Expenses And Other Current Assets Property And Equipment [Abstract] Property, Plant and Equipment Disclosure [Text Block] Property And Equipment Intangible Assets [Abstract] Intangible Assets Disclosure [Text Block] Intangible Assets Accrued Liabilities [Abstract] Accounts Payable and Accrued Liabilities Disclosure [Text Block] Accrued Liabilities Deferred Revenue [Abstract] Deferred Revenue Disclosure [Text Block] Deferred Revenue Long-Term Debt And Credit Facilities [Abstract] Long-term Debt [Text Block] Long-Term Debt And Credit Facilities Stockholders' Equity [Abstract] Stockholders' Equity Note Disclosure [Text Block] Stockholders' Equity Fair Value Measurements [Abstract] Fair Value Disclosures [Text Block] Fair Value Measurements Product Warranty Provisions [Abstract] Product Warranty Disclosure [Text Block] Product Warranty Provisions Commitments And Contingencies [Abstract] Commitments and Contingencies Disclosure [Text Block] Commitments And Contingencies Subsequent Events [Abstract] Schedule of Subsequent Events [Text Block] Subsequent Events Basis Of Presentation [Policy Text Block] Basis Of Presentation Fair Value of Financial Instruments, Policy [Policy Text Block] Financial Instruments Revenue Recognition And Cost Of Revenue Policy [Text Block] Revenue Recognition And Cost Of Revenue Policy [Text Block] Revenue And Costs Of Revenue Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block] Share-Based Compensation Earnings Per Share, Policy [Policy Text Block] Net Earnings (Loss) Per Common Share ("EPS") New Accounting Pronouncements, Policy [Policy Text Block] Recently Issued Accounting Pronouncements Computation Of Basic And Diluted EPS Schedule of Inventory, Current [Table Text Block] Schedule Of Inventories Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Text Block] Schedule Of Prepaid Expenses And Other Current Assets Property, Plant and Equipment [Table Text Block] Schedule Of Property And Equipment Schedule of Accrued Liabilities [Table Text Block] Schedule Of Accrued Liabilities Deferred Revenue, by Arrangement, Disclosure [Table Text Block] Schedule Of Deferred Revenue Schedule of Debt [Table Text Block] Schedule Of Debt Outstanding Schedule of Share-based Compensation, Stock Options and Stock Appreciation Rights Award Activity [Table Text Block] Summary Of Option And Stock Appreciation Rights Activity Schedule of Share-based Compensation, Restricted Stock Units Award Activity [Table Text Block] Summary Of Restricted Stock Unit Activity Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Assets And Liabilities Measured At Fair Value On Recurring Basis By Level Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Summary Of Changes In Fair Value Of Level 3 Financial Liabilities Schedule of Product Warranty Liability [Table Text Block] Schedule Of Accrued Warranty The total number Niobe ES systems installed system upgrades number Installed base Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period Share-based compensation, requisite service period Options To Purchase Common Stock Number of Options/SARs, Outstanding, June 30, 2016 Number of Options/SARs, Outstanding, December 31, 2015 Options and stock appreciation rights outstanding Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Weighted Average Exercise Price per Share, Outstanding, June 30, 2016 Weighted Average Exercise Price per Share, Outstanding, December 31, 2015 Weighted average exercise price Warrants Common stock issuable upon exercise of outstanding warrants Class of Warrant or Right, Exercise Price of Warrants or Rights Exercise price of warrants Restricted shares outstanding Number of Restricted Stock Units, Outstanding, June 30, 2016 Number of Restricted Stock Units, Outstanding, December 31, 2015 Unvested restricted shares Deferred Finance Costs, Net Deferred financing costs Debt Issuance Costs, Line of Credit Arrangements, Net Deferred financing costs Deferred financing costs related to line-of-credit arrangements Numerator for diluted EPS Numerator for diluted EPS Inventory, Raw Materials Raw materials Inventory, Work in Process Work in process Inventory, Finished Goods Finished goods Inventory Valuation Reserves Reserve for obsolescence Prepaid Expense Prepaid expenses Deposits Assets Deposits Deferred Costs, Current Deferred cost of revenue Prepaid Expense and Other Assets Total prepaid expenses and other assets Prepaid Expense and Other Assets, Noncurrent Less: Noncurrent prepaid expenses and other assets Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Property, Plant and Equipment, Gross Gross property and equipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Less: Accumulated depreciation Finite-Lived Intangible Assets, Gross Total intangible assets Finite-Lived Intangible Assets, Accumulated Amortization Accumulated amortization Real Estate [Table] Real Estate [Line Items] Area of Real Estate Property Square feet of leased space Business Exit Costs Accrued lease termination costs Accrued Lease Termination Costs Remaining Accrued Lease Termination Costs Remaining Accrued lease termination costs remaining Lease Expiration Date Sublease expiration date Employee-related Liabilities, Current Accrued salaries, bonus, and benefits Accrued rent Carrying value as of the balance sheet date of obligations incurred through that date and payable for license and maintenance fees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Accrued Licenses And Maintenance Fees Current Accrued licenses and maintenance fees Interest Payable, Current Accrued interest Product Warranty Accrual, Current Warranty accrual, end of the fiscal period Warranty accrual, beginning of the fiscal period Accrued warranties Accrued Income Taxes, Current Accrued taxes Other Accrued Liabilities, Current Other EX-101.PRE 12 stxs-20160630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 13 R1.htm IDEA: XBRL DOCUMENT

Document And Entity Information - shares	6 Months Ended
Document And Entity Information - shares	Jun. 30, 2016	Jul. 29, 2016
Document And Entity Information [Abstract]
Entity Registrant Name	Stereotaxis, Inc.
Entity Filer Category	Smaller Reporting Company
Entity Central Index Key	0001289340
Trading Symbol	stxs
Amendment Flag	false
Document Type	10-Q
Document Fiscal Period Focus	Q2
Document Period End Date	Jun. 30, 2016
Document Fiscal Year Focus	2016
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding		21,853,376

XML 14 R2.htm IDEA: XBRL DOCUMENT

Balance Sheets - USD ($)	Jun. 30, 2016	Dec. 31, 2015
Current assets:
Cash and cash equivalents	$ 3,858,089	$ 5,593,582
Accounts receivable, net of allowance of $251,933 and $93,478 in 2016 and 2015, respectively	5,057,503	6,376,470
Inventories	5,334,687	4,504,282
Prepaid expenses and other current assets	569,825	668,659
Total current assets	14,820,104	17,142,993
Property and equipment, net	857,869	1,067,321
Intangible assets, net	536,229	635,889
Other assets	44,774	31,693
Total assets	16,258,976	18,877,896
Current liabilities:
Short-term debt	3,000,000
Accounts payable	2,427,697	1,840,135
Accrued liabilities	5,431,055	6,058,390
Deferred revenue	7,435,975	7,445,935
Warrants and debt conversion features	627,466	794,130
Total current liabilities	18,922,193	16,138,590
Long-term debt	18,114,408	18,080,159
Long-term deferred revenue	620,945	2,009,198
Other liabilities	270,296	275,603
Total liabilities	37,927,842	36,503,550
Stockholders' deficit:
Preferred stock, par value $0.001; 10,000,000 shares authorized, none outstanding at 2016 and 2015
Common stock, par value $0.001; 300,000,000 shares authorized, 21,846,095 and 21,551,173, shares issued at 2016 and 2015, respectively	21,846	21,551
Additional paid in capital	449,081,382	448,517,472
Treasury stock, 4,015 shares at 2016 and 2015	(205,999)	(205,999)
Accumulated deficit	(470,566,095)	(465,958,678)
Total stockholders' deficit	(21,668,866)	(17,625,654)
Total liabilities and stockholders' deficit	$ 16,258,976	$ 18,877,896

XML 15 R3.htm IDEA: XBRL DOCUMENT

Balance Sheets (Parenthetical) - USD ($)	Jun. 30, 2016	Dec. 31, 2015
Current assets:
Accounts receivable, allowance	$ 251,933	$ 93,478
Stockholders' deficit:
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	300,000,000	300,000,000
Common stock, shares issued	21,846,095	21,551,173
Treasury stock, shares	4,015	4,015

XML 16 R4.htm IDEA: XBRL DOCUMENT

Statements Of Operations - USD ($)	3 Months Ended		6 Months Ended
Statements Of Operations - USD ($)	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Revenue:
Systems	$ 935,978	$ 3,092,935	$ 3,010,997	$ 5,924,113
Disposables, service and accessories	6,938,645	6,571,315	13,511,632	13,271,163
Total revenue	7,874,623	9,664,250	16,522,629	19,195,276
Cost of revenue:
Systems	395,898	1,849,275	1,478,996	3,249,542
Disposables, service and accessories	699,173	1,093,988	1,796,888	2,324,359
Total cost of revenue	1,095,071	2,943,263	3,275,884	5,573,901
Gross margin	6,779,552	6,720,987	13,246,745	13,621,375
Operating expenses:
Research and development	1,421,380	1,419,826	2,894,465	2,905,533
Sales and marketing	4,211,706	4,250,779	8,105,819	8,285,150
General and administrative	2,786,046	2,772,708	5,372,838	5,567,297
Total operating expenses	8,419,132	8,443,313	16,373,122	16,757,980
Operating loss	(1,639,580)	(1,722,326)	(3,126,377)	(3,136,605)
Other income	135,370	999,169	166,664	106,792
Interest income	140	493	362	1,355
Interest expense	(829,046)	(816,023)	(1,648,066)	(1,645,810)
Net loss	$ (2,333,116)	$ (1,538,687)	$ (4,607,417)	$ (4,674,268)
Net loss per common share:
Basic	$ (0.11)	$ (0.07)	$ (0.21)	$ (0.22)
Diluted	$ (0.11)	$ (0.07)	$ (0.21)	$ (0.22)
Weighted average shares used in computing net loss per common share:
Basic	21,793,583	21,007,103	21,702,597	20,871,244
Diluted	21,793,583	21,007,103	21,702,597	20,871,244

XML 17 R5.htm IDEA: XBRL DOCUMENT

Statements Of Cash Flows - USD ($)	6 Months Ended
Statements Of Cash Flows - USD ($)	Jun. 30, 2016	Jun. 30, 2015
Cash flows from operating activities
Net loss	$ (4,607,417)	$ (4,674,268)
Adjustments to reconcile net loss to cash used in operating activities:
Depreciation	185,802	134,025
Amortization of intangibles	99,660	149,917
Amortization of deferred finance costs	108,850	111,018
Share-based compensation	566,975	637,246
Adjustment of warrants	(166,664)	(106,792)
Changes in operating assets and liabilities:
Accounts receivable	1,318,967	(969,414)
Inventories	(806,755)	609,088
Prepaid expenses and other current assets	147,942	244,527
Other assets	(13,081)	67,541
Accounts payable	587,562	(60,014)
Accrued liabilities	(627,335)	497,625
Deferred revenue	(1,398,213)	(435,029)
Other liabilities	(5,307)	(409,358)
Net cash used in operating activities	(4,609,014)	(4,203,888)
Cash flows from investing activities
Purchase of equipment		(52,410)
Net cash used in investing activities		(52,410)
Cash flows from financing activities
Payments of deferred financing costs	(100,000)
Proceeds from (payments of) revolving line of credit	3,000,000
Payments of Healthcare Royalty Partners debt	(23,709)	(80,328)
Proceeds from issuance of stock, net of issuance costs	(2,770)	695,598
Net cash provided by (used in) financing activities	2,873,521	615,270
Net increase (decrease) in cash and cash equivalents	(1,735,493)	(3,641,028)
Cash and cash equivalents at beginning of period	5,593,582	7,270,301
Cash and cash equivalents at end of period	$ 3,858,089	$ 3,629,273

XML 18 R6.htm IDEA: XBRL DOCUMENT

Description Of Business	6 Months Ended
Description Of Business	Jun. 30, 2016
Description Of Business [Abstract]
Description Of Business	1. Description of Business Stereotaxis designs, manufactures, and markets the Epoch® Solution, an advanced remote robotic navigation system for use in a hospital’s interventional surgical suite or “interventional lab”, that we believe revolutionizes the treatment of arrhythmias and coronary artery disease by enabling enhanced safety, efficiency, and efficacy for catheter-based or interventional procedures. The Epoch Solution is comprised of the Niobe® ES Magnetic Navigation System (“Niobe ES system”), Odyssey® Information Management Solution (“Odyssey Solution”), and the Vdrive® Robotic Navigation System (“Vdrive system”) and related devices. The Niobe ES system is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. This is achieved using externally applied magnetic fields that govern the motion of the working tip of the catheter or guidewire, resulting in improved navigation, efficient procedures, and reduced X-ray exposure. In addition to the Niobe ES system and its components, Stereotaxis has also developed the Odyssey Solution, which consolidates all lab information, enabling doctors to focus on the patient for optimal procedure efficiency. The platform also features a remote viewing and recording capability called the Odyssey Cinema™ system, an innovative system delivering synchronized content for optimized workflow, advanced care, and improved productivity. This tool includes an archiving capability that allows clinicians to store and replay entire procedures or segments of procedures. This information can be accessed from locations throughout the hospital’s local area network and over the global Odyssey Network, providing physicians with a tool for clinical collaboration, remote consultation, and training. Our Vdrive system provides navigation and stability for diagnostic and therapeutic devices designed to improve interventional procedures. The Vdrive system complements the Niobe ES system’s control of therapeutic catheters for fully remote procedures and enables single-operator workflow. It is sold as two options, the Vdrive system and the Vdrive Duo™ system. In addition to the Vdrive system and the Vdrive Duo system, we also manufacture and market various disposable components which can be manipulated by these systems. We promote the full Epoch Solution in a typical hospital implementation, subject to regulatory approvals or clearances. The full Epoch Solution implementation requires a hospital to agree to an upfront capital payment and recurring payments. The upfront capital payment typically includes equipment and installation charges. The recurring payments typically include disposable costs for each procedure, equipment service costs beyond the warranty period, and software licenses. In hospitals where the full Epoch Solution has not been implemented, equipment upgrade or expansion may be implemented upon purchase of the necessary components. As of June 30, 2016, the Company has an installed base of 129 Niobe ES systems. The core components of Stereotaxis’ systems have received regulatory clearance in the United States, European Union, Canada, China, Japan and various other countries. We have received regulatory clearance, licensing and/or CE Mark approvals necessary for us to market the Vdrive and Vdrive Duo systems with the V-CAS, V-Loop and V-Sono devices in the U.S., Canada and European Union. The V-CAS Deflect catheter advancement system has been CE Marked for sale in the European Union. We have received Food and Drug Administration (“FDA”) clearance and the CE Mark necessary for us to market our suite of Pegasus™ coronary peripheral guidewires in the United States and Europe. Since our inception, we have generated significant losses. As of June 30, 2016, we have incurred cumulative net losses of approximately $470.6 million. In 2016, the Company plans to continue developing the Niobe ES system with the goal of furthering clinical adoption and new system placements. We expect to incur additional losses in 2016 as we continue the development and commercialization of our products, conduct our research and development activities, advance new products into clinical development from our existing research programs and fund additional sales and marketing initiatives. During 2016, we will continue to monitor operating expenses and make additional investments in certain targeted areas. Our existing cash, cash equivalents, and borrowing facilities may not be sufficient to fund our operating expenses and capital equipment requirements through the next 12 months, which would require us to obtain additional financing. We may be required to raise capital or pursue other financing strategies to continue our operations. Until we can generate significant cash flow from our operations, we expect to continue to fund our operations with cash resources primarily generated from the proceeds of our past and future public offerings, private sales of our equity securities, and loans collateralized by working capital and equipment. We continue to explore financing alternatives, which may include the sale of equity securities or non-core assets, strategic collaboration agreements, debt financings, or distribution rights. We cannot accurately predict the timing and amount of our utilization of capital, which will depend on a number of factors outside of our control. We cannot assure that additional financing will be available on acceptable terms or that such financing will not be dilutive to our stockholders. If adequate funds are not available to us, we could be required to delay development or commercialization of new products, to license to third parties the rights to commercialize products or technologies that we would otherwise seek to commercialize ourselves, or to reduce the sales, marketing, customer support or other resources devoted to our products, any of which could have a material adverse effect on our business, financial condition, and operational results. In addition, we could be required to cease operations.

XML 19 R7.htm IDEA: XBRL DOCUMENT

Summary Of Significant Accounting Policies

6 Months Ended

Jun. 30, 2016

Summary Of Significant Accounting Policies [Abstract]

Summary Of Significant Accounting Policies

2. Summary of Significant Accounting Policies

Basis of Presentation

Financial Instruments

Revenue and Costs of Revenue

The Company accounts for revenue using Accounting Standards Codification Topic 605-25, Multiple-Element Arrangements (“ASC 605-25”).

Under our revenue recognition policy, a portion of revenue for Niobe systems, Vdrive systems and certain Odyssey systems is recognized upon delivery, provided that title has passed, there are no uncertainties regarding acceptance, persuasive evidence of an arrangement exists, the sales price is fixed and determinable, and collection of the related receivable is reasonably assured. Revenue is recognized for other types of Odyssey systems upon completion of installation, since there are no qualified third party installers. When installation is the responsibility of the customer, revenue from system sales is recognized upon shipment since these arrangements do not include an installation element or right of return privileges. The Company does not recognize revenue in situations in which inventory remains at a Stereotaxis warehouse or in situations in which title and risk of loss have not transferred to the customer. Amounts collected prior to satisfying the above revenue recognition criteria are reflected as deferred revenue. Revenue from services and license fees, whether sold individually or as a separate unit of accounting in a multiple-deliverable arrangement, is deferred and amortized over the service or license fee period, which is typically one year. Revenue from services is derived primarily from the sale of annual product maintenance plans. We recognize revenue from disposable device sales or accessories upon shipment and establish an appropriate reserve for returns. The return reserve, which is applicable only to disposable devices, is estimated based on historical experience which is periodically reviewed and updated as necessary. In the past, changes in estimate have had only a de minimis effect on revenue recognized in the period. We believe that the estimate is not likely to change significantly in the future.

Share-Based Compensation

Net Earnings (Loss) per Common Share (“EPS”)

Basic and diluted net earnings (loss) per common share are computed by dividing the net income (loss) for the period by the weighted average number of common shares outstanding during the period.

The following table sets forth the computation of basic and diluted EPS:


		Three months ended June 30,				Six months ended June 30,
Numerator:		2016		2015		2016		2015
Numerator for basic EPS	$	(2,333,116)	$	(1,538,687)	$	(4,607,417)	$	(4,674,268)
Numerator for diluted EPS	$	(2,333,116)	$	(1,538,687)	$	(4,607,417)	$	(4,674,268)
Denominator:
Denominator for basic EPS—weighted average shares		21,793,583		21,007,103		21,702,597		20,871,244
Denominator for diluted EPS—weighted average shares		21,793,583		21,007,103		21,702,597		20,871,244
Basic EPS	$	(0.11)	$	(0.07)	$	(0.21)	$	(0.22)
Diluted EPS	$	(0.11)	$	(0.07)	$	(0.21)	$	(0.22)

Recently Issued Accounting Pronouncements

In May 2014, the FASB issued ASU No. 2014-09, "Revenue from Contracts with Customers" which converges the FASB's and the International Accounting Standards Board's current standards on revenue recognition. The standard provides companies with a single model to use in accounting for revenue arising from contracts with customers and supersedes current revenue guidance. The standard is effective for annual and interim periods beginning after December 15, 2016. Early adoption is not permitted. The standard permits companies to either apply the adoption to all periods presented, or apply the requirements in the year of adoption through a cumulative adjustment. In April 2015, the FASB issued an exposure draft related to the deferral of the effective date, which would delay our effective date one year. Therefore, the standard would be effective for annual and interim periods beginning after December 15, 2017 (January 1, 2018 for the Company). We are currently evaluating the impact of adopting this accounting standard update on our financial statements and disclosures and have not concluded on an adoption method.

XML 20 R8.htm IDEA: XBRL DOCUMENT

Inventories

6 Months Ended

Jun. 30, 2016

Inventories [Abstract]

Inventories

3. Inventories

Inventories consist of the following:


	June 30, 2016	December 31, 2015

Raw materials	$ 2,476,263	$ 2,065,676
Work in process	876,105	24,758
Finished goods	2,014,872	2,433,819
Reserve for obsolescence	(32,553)	(19,971)
Total inventory	$ 5,334,687	$ 4,504,282

XML 21 R9.htm IDEA: XBRL DOCUMENT

Prepaid Expenses And Other Current Assets

6 Months Ended

Jun. 30, 2016

Prepaid Expenses And Other Current Assets [Abstract]

Prepaid Expenses And Other Current Assets

4. Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consist of the following:



	June 30, 2016	December 31, 2015

Prepaid expenses	$ 293,484	$ 454,822
Deferred financing costs	75,068	25,960
Deposits	245,650	136,583
Deferred cost of revenue	397	82,987
Total prepaid expenses and other assets	614,599	700,352
Less: Noncurrent prepaid expenses and other assets	(44,774)	(31,693)
Total current prepaid expenses and other assets	$ 569,825	$ 668,659

Certain prior year amounts have been reclassified to conform to the 2016 presentation.

XML 22 R10.htm IDEA: XBRL DOCUMENT

Property And Equipment

6 Months Ended

Jun. 30, 2016

Property And Equipment [Abstract]

Property And Equipment

5. Property and Equipment

Property and equipment consist of the following:


	June 30,	December 31,
	2016	2015

Equipment	$ 8,386,835	$ 8,496,636
Equipment held for lease	303,412	303,412
Leasehold improvements	2,320,368	2,320,368
	11,010,615	11,120,416
Less: Accumulated depreciation	(10,152,746)	(10,053,095)
Net property and equipment	$ 857,869	$ 1,067,321

XML 23 R11.htm IDEA: XBRL DOCUMENT

Intangible Assets	6 Months Ended
Intangible Assets	Jun. 30, 2016
Intangible Assets [Abstract]
Intangible Assets	6. Intangible Assets As of June 30, 2016, the Company had total intangible assets of $3,221,069. Accumulated amortization at June 30, 2016, was $2,684,840.

XML 24 R12.htm IDEA: XBRL DOCUMENT

Accrued Liabilities

6 Months Ended

Jun. 30, 2016

Accrued Liabilities [Abstract]

Accrued Liabilities

7. Accrued Liabilities

Accrued liabilities consist of the following:


	June 30,	December 31,
	2016	2015

Accrued salaries, bonus, and benefits	$ 2,652,318	$ 3,053,012
Accrued rent	1,159,038	1,361,379
Accrued licenses and maintenance fees	575,583	666,373
Accrued interest	494,067	494,703
Accrued warranties	258,450	316,835
Accrued taxes	313,379	324,226
Other	248,516	117,465
Total accrued liabilities	5,701,351	6,333,993
Less: Long term accrued liabilities	(270,296)	(275,603)
Total current accrued liabilities	$ 5,431,055	$ 6,058,390

XML 25 R13.htm IDEA: XBRL DOCUMENT

Deferred Revenue

6 Months Ended

Jun. 30, 2016

Deferred Revenue [Abstract]

Deferred Revenue

8. Deferred Revenue

Deferred revenue consists of the following:


	June 30,	December 31,
	2016	2015

Product shipped, revenue deferred	$ 338,831	$ 366,388
Customer deposits	1,050,000	2,505,000
Deferred service and license fees	6,668,089	6,583,745
Total deferred revenue	8,056,920	9,455,133
Less: Long-term deferred revenue	(620,945)	(2,009,198)
Total current deferred revenue	$ 7,435,975	$ 7,445,935

- Definition

The entire disclosure for deferred revenues at the end of the reporting period, and description and amounts of significant changes that occurred during the reporting period. Deferred revenue is a liability as of the balance sheet date related to a revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.

+ References + Details

XML 26 R14.htm IDEA: XBRL DOCUMENT

Long-Term Debt And Credit Facilities

6 Months Ended

Jun. 30, 2016

Long-Term Debt And Credit Facilities [Abstract]

Long-Term Debt And Credit Facilities

9. Long-Term Debt and Credit Facilities

Debt outstanding consists of the following:


	June 30, 2016		December 31, 2015
	Carrying	Estimated	Carrying	Estimated
	Amount	Fair Value	Amount	Fair Value

Revolving line of credit, due March 31, 2018	$ 3,000,000	$ 3,000,000	$ -	$ -
Healthcare Royalty Partners debt	18,114,408	18,405,468	18,080,159	18,429,177
Total debt	21,114,408	21,405,468	18,080,159	18,429,177
Less current maturities	(3,000,000)	(3,000,000)	—	—
Total long term debt	$ 18,114,408	$ 18,405,468	$ 18,080,159	$ 18,429,177

Certain prior year amounts have been reclassified to conform to the 2016 presentation.

Revolving Line of Credit

Healthcare Royalty Partners Debt

In November 2011, the Company entered into a loan agreement with Healthcare Royalty Partners. Under the agreement the Company borrowed from Healthcare Royalty Partners $15 million. The Company was permitted to borrow up to an additional $5 million in the aggregate based on the achievement by the Company of certain milestones related to Niobe ES system sales in 2012. On August 8, 2012, the Company borrowed an additional $2.5 million based upon achievement of a milestone related to Niobe ES system sales for the three months ended June 30, 2012. On January 31, 2013, the Company borrowed an additional $2.5 million based upon achievement of a milestone related to Niobe ES system sales for the twelve months ended December 31, 2012. The loan will be repaid through, and secured by, royalties payable to the Company under its Development, Alliance and Supply Agreement with Biosense Webster, Inc. (the “Biosense Agreement”). The Biosense Agreement relates to the development and distribution of magnetically enabled catheters used with Stereotaxis' Niobe ES system in cardiac ablation procedures. Under the terms of the agreement, Healthcare Royalty Partners will be entitled to receive 100% of all royalties due to the Company under the Biosense Agreement until the loan is repaid. The loan is a full recourse loan, matures on December 31, 2018, and bears interest at an annual rate of 16% payable quarterly with royalties received under the Biosense Agreement. If the payments received by the Company under the Biosense Agreement are insufficient to pay all amounts of interest due on the loan, then such deficiency will increase the outstanding principal amount on the loan. After the loan obligation is repaid, the royalties under the Biosense Agreement will again be paid to the Company. The loan is also secured by certain assets and intellectual property of the Company. The agreement also contains customary affirmative and negative covenants. The use of payments due to the Company under the Biosense Agreement was approved by our primary lender.

XML 27 R15.htm IDEA: XBRL DOCUMENT

Stockholders' Equity

6 Months Ended

Jun. 30, 2016

Stockholders' Equity [Abstract]

Stockholders' Equity

10. Stockholders’ Equity

Controlled Equity Offering

The Company entered into a Controlled Equity OfferingSM sales agreement (the “Sales Agreement”) in May 2014, as amended on March 26, 2015, with Cantor Fitzgerald & Co. (“Cantor”), as agent and/or principal, pursuant to which the Company could issue and sell, from time to time, shares of its common stock having an aggregate gross sales price of up to $18.0 million. The Company will pay Cantor a commission of 3.0% of the gross proceeds from any common stock sold through the Sales Agreement.

There were no proceeds from the Controlled Equity Offering during the three months ended June 30, 2016. As of June 30, 2016, $13.8 million of common stock remained available to be sold under this facility, subject to certain conditions as specified in the Sales Agreement. Due to the Company’s transfer to the OTCQX® Best Market on August 4, 2016, the Company’s ability to generate proceeds from the sale of stock under the Controlled Equity Offering in the future may be limited or prohibited.

Offerings of Common Stock

Stock Award Plans

A summary of the option and stock appreciation rights activity for the six month period ended June 30, 2016 is as follows:


	Number of Options/SARs	Range of Exercise Price	Weighted Average Exercise Price per Share

Outstanding, December 31, 2015	706,494	$1.45 - $116.40	$9.34
Granted	1,000	$1.55	$1.55
Exercised	-	-	-
Forfeited	(21,111)	$1.74 - $99.00	$30.82
Outstanding, June 30, 2016	686,383	$1.45 - $116.40	$8.66

A summary of the restricted stock unit activity for the six month period ended June 30, 2016 is as follows:


	Number of Restricted Stock Units	Weighted Average Grant Date Fair Value per Unit

Outstanding, December 31, 2015	752,008	$2.63
Granted	791,600	$0.84
Vested	(274,850)	$2.56
Forfeited	(56,262)	$1.49
Outstanding, June 30, 2016	1,212,496	$1.53

- Definition

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB Topic 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74567-122707

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(e))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB Topic 4.C)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(d))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Preferred Stock
-URI http://asc.fasb.org/extlink&oid=6521494

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644

+ Details

XML 28 R16.htm IDEA: XBRL DOCUMENT

Fair Value Measurements

6 Months Ended

Jun. 30, 2016

Fair Value Measurements [Abstract]

Fair Value Measurements

11. Fair Value Measurements

Level 1: Values are based on unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.

Level 2: Values are based on quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, or other model-based valuation techniques for which all significant assumptions are observable in the market.

Level 3: Values are generated from model-based techniques that use significant assumptions not observable in the market.


	Fair Value Measurement Using
	Total		Quoted Prices in Active Markets for Identical Instruments (Level 1)	Significant Other Observable Inputs (Level 2)	Significant Unobservable Inputs (Level 3)
Assets at June 30, 2016:
Cash equivalents	$	74,346	74,346	—	—
Total assets at fair value	$	74,346	74,346	—	—
Liabilities at June 30, 2016:
Warrants issued May 2012	$	209,156	—	—	209,156
Warrants issued August 2013	$	418,310	—	—	418,310
Total liabilities at fair value:	$	627,466	—	—	627,466
Assets at December 31, 2015:
Cash equivalents	$	524,083	524,083	—	—
Total assets at fair value	$	524,083	524,083	—	—
Liabilities at December 31, 2015:
Warrants issued May 2012	$	143,681	—	—	143,681
Warrants issued August 2013	$	650,449	—	—	650,449
Total liabilities at fair value:	$	794,130	—	—	794,130

Level 1

Level 2

The Company does not have any financial assets or liabilities classified as Level 2.

Level 3

The following table sets forth a summary of changes in the fair value of the Company’s Level 3 financial liabilities for the six month period ended June 30, 2016:


	Warrants issued May 2012	Warrants issued August 2013	Total Liabilities
Balance at beginning of period	$ 143,681	$ 650,449	$ 794,130
Issues	-	-	-
Settlements	-	-	-
Revaluation	65,475	(232,139)	(166,664)
Balance at end of period	$ 209,156	$ 418,310	$ 627,466

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

XML 29 R17.htm IDEA: XBRL DOCUMENT

Product Warranty Provisions

6 Months Ended

Jun. 30, 2016

Product Warranty Provisions [Abstract]

Product Warranty Provisions

12. Product Warranty Provisions

The Company’s standard policy is to warrant all Niobe, Odyssey, and Vdrive systems against defects in material or workmanship for one year following installation. The Company’s estimate of costs to service the warranty obligations is based on historical experience and current product performance trends. A regular review of warranty obligations is performed to determine the adequacy of the reserve and adjustments are made to the estimated warranty liability as appropriate.

Accrued warranty, which is included in other accrued liabilities, consists of the following:


	June 30, 2016		December 31, 2015
Warranty accrual, beginning of the fiscal period	$	316,835	$	364,548
Accrual adjustment for product warranty		48,064		171,384
Payments made		(106,449)		(219,097)
Warranty accrual, end of the fiscal period	$	258,450	$	316,835

XML 30 R18.htm IDEA: XBRL DOCUMENT

Commitments And Contingencies	6 Months Ended
Commitments And Contingencies	Jun. 30, 2016
Commitments And Contingencies [Abstract]
Commitments And Contingencies	13. Commitments and Contingencies The Company at times becomes a party to claims in the ordinary course of business. Management believes that the ultimate resolution of pending or threatened proceedings will not have a material effect on the financial position, results of operations or liquidity of the Company.

XML 31 R19.htm IDEA: XBRL DOCUMENT

Subsequent Events	6 Months Ended
Subsequent Events	Jun. 30, 2016
Subsequent Events [Abstract]
Subsequent Events	14. Subsequent Events On August 2, 2016, Stereotaxis, Inc. (the “Company”) received a determination letter from the Nasdaq Hearings Panel (the “Panel”) notifying the Company that its common stock would be delisted from The Nasdaq Capital Market (“Nasdaq”) and that suspension of trading in the shares would be effective at the open of business on August 4, 2016. The determination letter also indicated that Nasdaq would complete the delisting by filing a Form 25 Notification of Delisting with the Securities Exchange Commission, after applicable appeal periods have lapsed. The Panel made the determination to delist the Company’s common stock because the Company did not demonstrate compliance with the minimum $35 million market value of listed securities requirement for a period of ten consecutive trading days by August 1, 2016, as required by a decision previously issued by the Panel on May 2, 2016. The Company’s shares of common stock commenced trading on the OTCQX® Best Market on August 4, 2016 under the Company’s current ticker symbol of “STXS.” In August 2016, the Company entered into a sublease agreement to sublease approximately 27,000 square feet of office space through December 31, 2018.

XML 32 R20.htm IDEA: XBRL DOCUMENT

Summary Of Significant Accounting Policies (Policies)

6 Months Ended

Jun. 30, 2016

Summary Of Significant Accounting Policies [Abstract]

Basis Of Presentation

Basis of Presentation

Financial Instruments

Revenue And Costs Of Revenue

Revenue and Costs of Revenue

The Company accounts for revenue using Accounting Standards Codification Topic 605-25, Multiple-Element Arrangements (“ASC 605-25”).

Share-Based Compensation

Net Earnings (Loss) Per Common Share ("EPS")

Net Earnings (Loss) per Common Share (“EPS”)

Basic and diluted net earnings (loss) per common share are computed by dividing the net income (loss) for the period by the weighted average number of common shares outstanding during the period.

The following table sets forth the computation of basic and diluted EPS:


		Three months ended June 30,				Six months ended June 30,
Numerator:		2016		2015		2016		2015
Numerator for basic EPS	$	(2,333,116)	$	(1,538,687)	$	(4,607,417)	$	(4,674,268)
Numerator for diluted EPS	$	(2,333,116)	$	(1,538,687)	$	(4,607,417)	$	(4,674,268)
Denominator:
Denominator for basic EPS—weighted average shares		21,793,583		21,007,103		21,702,597		20,871,244
Denominator for diluted EPS—weighted average shares		21,793,583		21,007,103		21,702,597		20,871,244
Basic EPS	$	(0.11)	$	(0.07)	$	(0.21)	$	(0.22)
Diluted EPS	$	(0.11)	$	(0.07)	$	(0.21)	$	(0.22)

Recently Issued Accounting Pronouncements

XML 33 R21.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Tables)

6 Months Ended

Jun. 30, 2016

Summary Of Significant Accounting Policies [Abstract]

Computation Of Basic And Diluted EPS


		Three months ended June 30,				Six months ended June 30,
Numerator:		2016		2015		2016		2015
Numerator for basic EPS	$	(2,333,116)	$	(1,538,687)	$	(4,607,417)	$	(4,674,268)
Numerator for diluted EPS	$	(2,333,116)	$	(1,538,687)	$	(4,607,417)	$	(4,674,268)
Denominator:
Denominator for basic EPS—weighted average shares		21,793,583		21,007,103		21,702,597		20,871,244
Denominator for diluted EPS—weighted average shares		21,793,583		21,007,103		21,702,597		20,871,244
Basic EPS	$	(0.11)	$	(0.07)	$	(0.21)	$	(0.22)
Diluted EPS	$	(0.11)	$	(0.07)	$	(0.21)	$	(0.22)

XML 34 R22.htm IDEA: XBRL DOCUMENT

Inventories (Tables)

6 Months Ended

Jun. 30, 2016

Inventories [Abstract]

Schedule Of Inventories


	June 30, 2016	December 31, 2015

Raw materials	$ 2,476,263	$ 2,065,676
Work in process	876,105	24,758
Finished goods	2,014,872	2,433,819
Reserve for obsolescence	(32,553)	(19,971)
Total inventory	$ 5,334,687	$ 4,504,282

XML 35 R23.htm IDEA: XBRL DOCUMENT

Prepaid Expenses And Other Current Assets (Tables)

6 Months Ended

Jun. 30, 2016

Prepaid Expenses And Other Current Assets [Abstract]

Schedule Of Prepaid Expenses And Other Current Assets



	June 30, 2016	December 31, 2015

Prepaid expenses	$ 293,484	$ 454,822
Deferred financing costs	75,068	25,960
Deposits	245,650	136,583
Deferred cost of revenue	397	82,987
Total prepaid expenses and other assets	614,599	700,352
Less: Noncurrent prepaid expenses and other assets	(44,774)	(31,693)
Total current prepaid expenses and other assets	$ 569,825	$ 668,659

XML 36 R24.htm IDEA: XBRL DOCUMENT

Property And Equipment (Tables)

6 Months Ended

Jun. 30, 2016

Property And Equipment [Abstract]

Schedule Of Property And Equipment


	June 30,	December 31,
	2016	2015

Equipment	$ 8,386,835	$ 8,496,636
Equipment held for lease	303,412	303,412
Leasehold improvements	2,320,368	2,320,368
	11,010,615	11,120,416
Less: Accumulated depreciation	(10,152,746)	(10,053,095)
Net property and equipment	$ 857,869	$ 1,067,321

XML 37 R25.htm IDEA: XBRL DOCUMENT

Accrued Liabilities (Tables)

6 Months Ended

Jun. 30, 2016

Accrued Liabilities [Abstract]

Schedule Of Accrued Liabilities


	June 30,	December 31,
	2016	2015

Accrued salaries, bonus, and benefits	$ 2,652,318	$ 3,053,012
Accrued rent	1,159,038	1,361,379
Accrued licenses and maintenance fees	575,583	666,373
Accrued interest	494,067	494,703
Accrued warranties	258,450	316,835
Accrued taxes	313,379	324,226
Other	248,516	117,465
Total accrued liabilities	5,701,351	6,333,993
Less: Long term accrued liabilities	(270,296)	(275,603)
Total current accrued liabilities	$ 5,431,055	$ 6,058,390

XML 38 R26.htm IDEA: XBRL DOCUMENT

Deferred Revenue (Tables)

6 Months Ended

Jun. 30, 2016

Deferred Revenue [Abstract]

Schedule Of Deferred Revenue


	June 30,	December 31,
	2016	2015

Product shipped, revenue deferred	$ 338,831	$ 366,388
Customer deposits	1,050,000	2,505,000
Deferred service and license fees	6,668,089	6,583,745
Total deferred revenue	8,056,920	9,455,133
Less: Long-term deferred revenue	(620,945)	(2,009,198)
Total current deferred revenue	$ 7,435,975	$ 7,445,935

XML 39 R27.htm IDEA: XBRL DOCUMENT

Long-Term Debt And Credit Facilities (Tables)

6 Months Ended

Jun. 30, 2016

Long-Term Debt And Credit Facilities [Abstract]

Schedule Of Debt Outstanding


	June 30, 2016		December 31, 2015
	Carrying	Estimated	Carrying	Estimated
	Amount	Fair Value	Amount	Fair Value

Revolving line of credit, due March 31, 2018	$ 3,000,000	$ 3,000,000	$ -	$ -
Healthcare Royalty Partners debt	18,114,408	18,405,468	18,080,159	18,429,177
Total debt	21,114,408	21,405,468	18,080,159	18,429,177
Less current maturities	(3,000,000)	(3,000,000)	—	—
Total long term debt	$ 18,114,408	$ 18,405,468	$ 18,080,159	$ 18,429,177

XML 40 R28.htm IDEA: XBRL DOCUMENT

Stockholder's Equity (Tables)

6 Months Ended

Jun. 30, 2016

Stockholders' Equity [Abstract]

Summary Of Option And Stock Appreciation Rights Activity


	Number of Options/SARs	Range of Exercise Price	Weighted Average Exercise Price per Share

Outstanding, December 31, 2015	706,494	$1.45 - $116.40	$9.34
Granted	1,000	$1.55	$1.55
Exercised	-	-	-
Forfeited	(21,111)	$1.74 - $99.00	$30.82
Outstanding, June 30, 2016	686,383	$1.45 - $116.40	$8.66

Summary Of Restricted Stock Unit Activity


	Number of Restricted Stock Units	Weighted Average Grant Date Fair Value per Unit

Outstanding, December 31, 2015	752,008	$2.63
Granted	791,600	$0.84
Vested	(274,850)	$2.56
Forfeited	(56,262)	$1.49
Outstanding, June 30, 2016	1,212,496	$1.53

XML 41 R29.htm IDEA: XBRL DOCUMENT

Fair Value Measurements (Tables)

6 Months Ended

Jun. 30, 2016

Fair Value Measurements [Abstract]

Assets And Liabilities Measured At Fair Value On Recurring Basis By Level


	Fair Value Measurement Using
	Total		Quoted Prices in Active Markets for Identical Instruments (Level 1)	Significant Other Observable Inputs (Level 2)	Significant Unobservable Inputs (Level 3)
Assets at June 30, 2016:
Cash equivalents	$	74,346	74,346	—	—
Total assets at fair value	$	74,346	74,346	—	—
Liabilities at June 30, 2016:
Warrants issued May 2012	$	209,156	—	—	209,156
Warrants issued August 2013	$	418,310	—	—	418,310
Total liabilities at fair value:	$	627,466	—	—	627,466
Assets at December 31, 2015:
Cash equivalents	$	524,083	524,083	—	—
Total assets at fair value	$	524,083	524,083	—	—
Liabilities at December 31, 2015:
Warrants issued May 2012	$	143,681	—	—	143,681
Warrants issued August 2013	$	650,449	—	—	650,449
Total liabilities at fair value:	$	794,130	—	—	794,130

Summary Of Changes In Fair Value Of Level 3 Financial Liabilities


	Warrants issued May 2012	Warrants issued August 2013	Total Liabilities
Balance at beginning of period	$ 143,681	$ 650,449	$ 794,130
Issues	-	-	-
Settlements	-	-	-
Revaluation	65,475	(232,139)	(166,664)
Balance at end of period	$ 209,156	$ 418,310	$ 627,466

XML 42 R30.htm IDEA: XBRL DOCUMENT

Product Warranty Provisions (Tables)

6 Months Ended

Jun. 30, 2016

Product Warranty Provisions [Abstract]

Schedule Of Accrued Warranty


	June 30, 2016		December 31, 2015
Warranty accrual, beginning of the fiscal period	$	316,835	$	364,548
Accrual adjustment for product warranty		48,064		171,384
Payments made		(106,449)		(219,097)
Warranty accrual, end of the fiscal period	$	258,450	$	316,835

XML 43 R31.htm IDEA: XBRL DOCUMENT

Description Of Business (Details)	Jun. 30, 2016 USD ($) item	Dec. 31, 2015 USD ($)
Description Of Business [Abstract]
Installed base \| item	129
Cumulative net losses \| $	$ (470,566,095)	$ (465,958,678)

XML 44 R32.htm IDEA: XBRL DOCUMENT

Summary Of Significant Accounting Policies (Narrative) (Details) - USD ($)	6 Months Ended
	Jun. 30, 2016	Dec. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Deferred financing costs	$ 291,060	$ 349,018
Deferred financing costs related to line-of-credit arrangements	$ 75,068	$ 25,960
Stock Options And Stock Appreciation Rights [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation, requisite service period	4 years
Options and stock appreciation rights outstanding	686,383	706,494
Weighted average exercise price	$ 8.66	$ 9.34
Warrants [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock issuable upon exercise of outstanding warrants	2,040,365
Exercise price of warrants	$ 3.44
Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unvested restricted shares	1,212,496	752,008

XML 45 R33.htm IDEA: XBRL DOCUMENT

Summary Of Significant Accounting Policies (Computation Of Basic And Diluted EPS) (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Summary Of Significant Accounting Policies [Abstract]
Numerator for basic EPS	$ (2,333,116)	$ (1,538,687)	$ (4,607,417)	$ (4,674,268)
Numerator for diluted EPS	$ (2,333,116)	$ (1,538,687)	$ (4,607,417)	$ (4,674,268)
Denominator for basic EPS-weighted average shares	21,793,583	21,007,103	21,702,597	20,871,244
Denominator for diluted EPS-weighted average shares	21,793,583	21,007,103	21,702,597	20,871,244
Basic EPS	$ (0.11)	$ (0.07)	$ (0.21)	$ (0.22)
Diluted EPS	$ (0.11)	$ (0.07)	$ (0.21)	$ (0.22)

XML 46 R34.htm IDEA: XBRL DOCUMENT

Inventories (Details) - USD ($)	Jun. 30, 2016	Dec. 31, 2015
Inventories [Abstract]
Raw materials	$ 2,476,263	$ 2,065,676
Work in process	876,105	24,758
Finished goods	2,014,872	2,433,819
Reserve for obsolescence	(32,553)	(19,971)
Total inventory	$ 5,334,687	$ 4,504,282

XML 47 R35.htm IDEA: XBRL DOCUMENT

Prepaid Expenses And Other Current Assets (Details) - USD ($)	Jun. 30, 2016	Dec. 31, 2015
Prepaid Expenses And Other Current Assets [Abstract]
Prepaid expenses	$ 293,484	$ 454,822
Deferred financing costs	75,068	25,960
Deposits	245,650	136,583
Deferred cost of revenue	397	82,987
Total prepaid expenses and other assets	614,599	700,352
Less: Noncurrent prepaid expenses and other assets	(44,774)	(31,693)
Total current prepaid expenses and other assets	$ 569,825	$ 668,659

XML 48 R36.htm IDEA: XBRL DOCUMENT

Property And Equipment (Details) - USD ($)	Jun. 30, 2016	Dec. 31, 2015
Property, Plant and Equipment [Line Items]
Gross property and equipment	$ 11,010,615	$ 11,120,416
Less: Accumulated depreciation	(10,152,746)	(10,053,095)
Net property and equipment	857,869	1,067,321
Equipment [Member]
Property, Plant and Equipment [Line Items]
Gross property and equipment	8,386,835	8,496,636
Equipment Held For Lease [Member]
Property, Plant and Equipment [Line Items]
Gross property and equipment	303,412	303,412
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Gross property and equipment	$ 2,320,368	$ 2,320,368

XML 49 R37.htm IDEA: XBRL DOCUMENT

Intangible Assets (Details)	Jun. 30, 2016 USD ($)
Intangible Assets [Abstract]
Total intangible assets	$ 3,221,069
Accumulated amortization	$ 2,684,840

XML 50 R38.htm IDEA: XBRL DOCUMENT

Accrued Liabilities (Narrative) (Details)	3 Months Ended	6 Months Ended
Accrued Liabilities (Narrative) (Details)	Sep. 30, 2013 USD ($) ft²	Jun. 30, 2016 USD ($) ft²	Dec. 31, 2015 ft²
Office [Member]
Real Estate [Line Items]
Square feet of leased space		52,000	3,152
Sublease expiration date		Dec. 31, 2018
Demonstration And Assembly [Member]
Real Estate [Line Items]
Square feet of leased space		12,000
Unimproved [Member]
Real Estate [Line Items]
Square feet of leased space	13,000
Accrued lease termination costs \| $	$ 515,138
Accrued lease termination costs remaining \| $		$ 233,197

XML 51 R39.htm IDEA: XBRL DOCUMENT

Accrued Liabilities (Schedule Of Accrued Liabilities) (Details) - USD ($)	Jun. 30, 2016	Dec. 31, 2015	Dec. 31, 2014
Accrued Liabilities [Abstract]
Accrued salaries, bonus, and benefits	$ 2,652,318	$ 3,053,012
Accrued rent	1,159,038	1,361,379
Accrued licenses and maintenance fees	575,583	666,373
Accrued interest	494,067	494,703
Accrued warranties	258,450	316,835	$ 364,548
Accrued taxes	313,379	324,226
Other	248,516	117,465
Total accrued liabilities	5,701,351	6,333,993
Less: Long term accrued liabilities	(270,296)	(275,603)
Total current accrued liabilities	$ 5,431,055	$ 6,058,390

XML 52 R40.htm IDEA: XBRL DOCUMENT

Deferred Revenue (Details) - USD ($)	Jun. 30, 2016	Dec. 31, 2015
Deferred Revenue Arrangement [Line Items]
Total deferred revenue	$ 8,056,920	$ 9,455,133
Less: Long-term deferred revenue	(620,945)	(2,009,198)
Total current deferred revenue	7,435,975	7,445,935
Product Shipped, Revenue Deferred [Member]
Deferred Revenue Arrangement [Line Items]
Total deferred revenue	338,831	366,388
Customer Deposits [Member]
Deferred Revenue Arrangement [Line Items]
Total deferred revenue	1,050,000	2,505,000
Deferred Service And License Fees [Member]
Deferred Revenue Arrangement [Line Items]
Total deferred revenue	$ 6,668,089	$ 6,583,745

- Definition

The carrying amount of consideration received or receivable as of the balance sheet date on potential earnings that were not recognized as revenue in conformity with GAAP, and which are expected to be recognized as such within one year or the normal operating cycle, if longer, including sales, license fees, and royalties, but excluding interest income.

+ References + Details

- Definition

The noncurrent portion of deferred revenue amount as of balance sheet date. Deferred revenue is a liability related to a revenue producing activity for which revenue has not yet been recognized, and is not expected to be recognized in the next twelve months. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.

+ References + Details

XML 53 R41.htm IDEA: XBRL DOCUMENT

Long-Term Debt And Credit Facilities (Narrative) (Details)			1 Months Ended	6 Months Ended
	Jan. 31, 2013 USD ($)	Aug. 08, 2012 USD ($)	Nov. 30, 2011 USD ($)	Jun. 30, 2016 USD ($)	May 10, 2016 USD ($)	Dec. 31, 2015 USD ($)	Jun. 30, 2015 USD ($)	Dec. 31, 2014 USD ($)
Debt Instrument [Line Items]
Cash and cash equivalents				$ 3,858,089		$ 5,593,582	$ 3,629,273	$ 7,270,301
Term Loan [Member] \| Healthcare Royalty Partners Debt [Member]
Debt Instrument [Line Items]
Amount borrowed	$ 2,500,000	$ 2,500,000	$ 15,000,000
Additional amount which may be borrowed			$ 5,000,000
Percentage of royalties entitled to receive			100.00%
Maturity date				Dec. 31, 2018
Annual interest rate			16.00%
Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity				$ 10,000,000
Line of credit facility, maturity date				Mar. 31, 2018
Minimum tangible net worth requirement, period one					$ (24,000,000)
Minimum tangible net worth requirement, period two					$ (24,500,000)
Line of credit facility, amount outstanding				$ 3,000,000
Line of credit facility, current borrowing capacity				4,000,000
Line of credit facility, additional borrowings available				1,000,000
Total liquidity				4,900,000
Line of credit facility, repayments				$ 3,000,000
Minimum [Member] \| Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Liquidity ratio					1.50

XML 54 R42.htm IDEA: XBRL DOCUMENT

Long-Term Debt And Credit Facilities (Schedule Of Debt Outstanding) (Details) - USD ($)	6 Months Ended
	Jun. 30, 2016	Dec. 31, 2015
Debt Instrument [Line Items]
Less current maturities	$ (3,000,000)
Total long term debt	18,114,408	$ 18,080,159
Carrying Amount [Member]
Debt Instrument [Line Items]
Total debt	21,114,408	18,080,159
Less current maturities	(3,000,000)
Total long term debt	18,114,408	18,080,159
Estimated Fair Value [Member]
Debt Instrument [Line Items]
Total debt	21,405,468	18,429,177
Less current maturities	(3,000,000)
Total long term debt	$ 18,405,468	18,429,177
Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Line of credit facility, maturity date	Mar. 31, 2018
Revolving Credit Facility [Member] \| Carrying Amount [Member]
Debt Instrument [Line Items]
Total debt	$ 3,000,000
Revolving Credit Facility [Member] \| Estimated Fair Value [Member]
Debt Instrument [Line Items]
Total debt	3,000,000
Healthcare Royalty Partners Debt [Member] \| Term Loan [Member] \| Carrying Amount [Member]
Debt Instrument [Line Items]
Total debt	18,114,408	18,080,159
Healthcare Royalty Partners Debt [Member] \| Term Loan [Member] \| Estimated Fair Value [Member]
Debt Instrument [Line Items]
Total debt	$ 18,405,468	$ 18,429,177

XML 55 R43.htm IDEA: XBRL DOCUMENT

Stockholders' Equity (Narrative) (Details)				1 Months Ended	3 Months Ended	6 Months Ended
Stockholders' Equity (Narrative) (Details)	May 24, 2016 shares	Jun. 10, 2014 shares	Jun. 05, 2013 shares	May 31, 2014 USD ($)	Jun. 30, 2016 USD ($) shares	Jun. 30, 2016 USD ($) item shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Votes per share \| item						1
Dividends declared					$ 0	$ 0
Dividends paid						$ 0
Increase in number of shares authorized for issuance under the Plan \| shares	1,500,000	1,000,000	1,000,000
Stock award plans \| shares					1,508,565	1,508,565
Total compensation cost not yet recognized					$ 1,900,000	$ 1,900,000
Estimated forfeitures						$ 900,000
Weighted average amortization period of total compensation cost not yet recognized						4 years
Sales Agreement [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Aggregate gross sales price				$ 18,000,000
Commission percentage of gross proceeds				3.00%
Gross proceeds from common stock sold					0
Remaining common stock available					$ 13,800,000	$ 13,800,000
Warrants [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of common shares exercised upon conversion of warrants \| shares						267,256
Gross proceeds from stock warrants exercised						$ 293,982

XML 56 R44.htm IDEA: XBRL DOCUMENT

Stockholders' Equity (Summary Of Option And Stock Appreciation Rights Activity) (Details) - Stock Options And Stock Appreciation Rights [Member] - $ / shares	6 Months Ended	12 Months Ended
	Jun. 30, 2016	Dec. 31, 2015
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Number of Options/SARs, Outstanding, December 31, 2015	706,494
Number of Options/SARs, Granted	1,000
Number of Options/SARs, Exercised
Number of Options/SARs, Forfeited	(21,111)
Number of Options/SARs, Outstanding, June 30, 2016	686,383	706,494
Weighted Average Exercise Price per Share, Outstanding, December 31, 2015	$ 9.34
Weighted Average Exercise Price per Share, Granted	1.55
Weighted Average Exercise Price per Share, Exercised
Weighted Average Exercise Price per Share, Forfeited	30.82
Weighted Average Exercise Price per Share, Outstanding, June 30, 2016	8.66	$ 9.34
$1.45 - $116.40 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of Exercise Price, Lower Limit		1.45
Range of Exercise Price, Upper Limit		$ 116.40
$1.55 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of Exercise Price, Upper Limit	1.55
$1.74 - $99.00 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of Exercise Price, Lower Limit	1.74
Range of Exercise Price, Upper Limit	99.00
$1.45 - $116.40 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of Exercise Price, Lower Limit	1.45
Range of Exercise Price, Upper Limit	$ 116.40

XML 57 R45.htm IDEA: XBRL DOCUMENT

Stockholders' Equity (Summary Of Restricted Stock Unit Activity) (Details) - Restricted Stock Units [Member]	6 Months Ended
	Jun. 30, 2016 $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Restricted Stock Units, Outstanding, December 31, 2015 \| shares	752,008
Number of Restricted Stock Units, Granted \| shares	791,600
Number of Restricted Stock Units, Vested \| shares	(274,850)
Number of Restricted Stock Units, Forfeited \| shares	(56,262)
Number of Restricted Stock Units, Outstanding, June 30, 2016 \| shares	1,212,496
Weighted Average Grant Date Fair Value per Unit, Outstanding, December 31, 2015 \| $ / shares	$ 2.63
Weighted Average Grant Date Fair Value per Unit, Granted \| $ / shares	0.84
Weighted Average Grant Date Fair Value per Unit, Vested \| $ / shares	2.56
Weighted Average Grant Date Fair Value per Unit, Forfeited \| $ / shares	1.49
Weighted Average Grant Date Fair Value per Unit, Outstanding, June 30, 2016 \| $ / shares	$ 1.53

XML 58 R46.htm IDEA: XBRL DOCUMENT

Fair Value Measurements (Narrative) (Details) - USD ($)	6 Months Ended
Fair Value Measurements (Narrative) (Details) - USD ($)	Jun. 30, 2016	Dec. 31, 2015
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	$ 74,346	$ 524,083
Financial assets	74,346	524,083
Financial liabilities	627,466	794,130
Quoted Prices In Active Markets For Identical Instruments (Level 1) [Member] \| Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	74,346	524,083
Transfers into Level 1	0
Transfers out of Level 1	0
Financial assets	74,346	524,083
Significant Other Observable Inputs (Level 2) [Member] \| Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents
Financial assets
Financial liabilities
Significant Unobservable Inputs (Level 3) [Member] \| Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities	$ 627,466	$ 794,130
Significant Unobservable Inputs (Level 3) [Member] \| Recurring [Member] \| Warrants Issued May 2012 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant expiration date	May 01, 2018
Volatility rate	124.33%
Risk-free interest rate	0.58%
Closing stock price	$ 0.98
Significant Unobservable Inputs (Level 3) [Member] \| Recurring [Member] \| Warrants Issued August 2013 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant expiration date	Nov. 01, 2018
Volatility rate	113.17%
Risk-free interest rate	0.58%
Closing stock price	$ 0.98

XML 59 R47.htm IDEA: XBRL DOCUMENT

Fair Value Measurements (Assets And Liabilities Measured At Fair Value On Recurring Basis By Level) (Details) - USD ($)	Jun. 30, 2016	Dec. 31, 2015
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	$ 74,346	$ 524,083
Total assets at fair value	74,346	524,083
Warrants issued	627,466	794,130
Total liabilities at fair value	627,466	794,130
Warrants Issued May 2012 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants issued	209,156	143,681
Warrants Issued August 2013 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants issued	418,310	650,449
Quoted Prices In Active Markets For Identical Instruments (Level 1) [Member] \| Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	74,346	524,083
Total assets at fair value	74,346	524,083
Significant Other Observable Inputs (Level 2) [Member] \| Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents
Total assets at fair value
Total liabilities at fair value
Significant Other Observable Inputs (Level 2) [Member] \| Recurring [Member] \| Warrants Issued May 2012 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants issued
Significant Other Observable Inputs (Level 2) [Member] \| Recurring [Member] \| Warrants Issued August 2013 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants issued
Significant Unobservable Inputs (Level 3) [Member] \| Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities at fair value	627,466	794,130
Significant Unobservable Inputs (Level 3) [Member] \| Recurring [Member] \| Warrants Issued May 2012 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants issued	209,156	143,681
Significant Unobservable Inputs (Level 3) [Member] \| Recurring [Member] \| Warrants Issued August 2013 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants issued	$ 418,310	$ 650,449

XML 60 R48.htm IDEA: XBRL DOCUMENT

Fair Value Measurements (Summary Of Changes In Fair Value Of Level 3 Financial Liabilities) (Details)	6 Months Ended
	Jun. 30, 2016 USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Balance at beginning of period	$ 794,130
Issues
Settlements
Revaluation	(166,664)
Balance at end of period	627,466
Warrants Issued May 2012 [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Balance at beginning of period	143,681
Issues
Settlements
Revaluation	65,475
Balance at end of period	209,156
Warrants Issued August 2013 [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Balance at beginning of period	650,449
Issues
Settlements
Revaluation	(232,139)
Balance at end of period	$ 418,310

XML 61 R49.htm IDEA: XBRL DOCUMENT

Product Warranty Provisions (Details) - USD ($)	6 Months Ended	12 Months Ended
Product Warranty Provisions (Details) - USD ($)	Jun. 30, 2016	Dec. 31, 2015
Product Warranty Provisions [Abstract]
Standard product warranty coverage term	1 year
Warranty accrual, beginning of the fiscal period	$ 316,835	$ 364,548
Accrual adjustment for product warranty	48,064	171,384
Payments made	(106,449)	(219,097)
Warranty accrual, end of the fiscal period	$ 258,450	$ 316,835

XML 62 R50.htm IDEA: XBRL DOCUMENT

Subsequent Events (Details) - Office [Member] - ft²	6 Months Ended
Subsequent Events (Details) - Office [Member] - ft²	Jun. 30, 2016	Aug. 31, 2016	Dec. 31, 2015
Subsequent Event [Line Items]
Square feet of leased space	52,000		3,152
Sublease expiration date	Dec. 31, 2018
Subsequent Event [Member]
Subsequent Event [Line Items]
Square feet of leased space		27,000

EXCEL 63 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 67 FilingSummary.xml IDEA: XBRL DOCUMENT 3.5.0.2 html 89 216 1 false 30 0 false 6 false false R1.htm 00090 - Document - Document And Entity Information Sheet http://www.stereotaxis.com/role/DocumentDocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 00100 - Statement - Balance Sheets Sheet http://www.stereotaxis.com/role/StatementBalanceSheets Balance Sheets Statements 2 false false R3.htm 00105 - Statement - Balance Sheets (Parenthetical) Sheet http://www.stereotaxis.com/role/StatementBalanceSheetsParenthetical Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00200 - Statement - Statements Of Operations Sheet http://www.stereotaxis.com/role/StatementStatementsOfOperations Statements Of Operations Statements 4 false false R5.htm 00400 - Statement - Statements Of Cash Flows Sheet http://www.stereotaxis.com/role/StatementStatementsOfCashFlows Statements Of Cash Flows Statements 5 false false R6.htm 10101 - Disclosure - Description Of Business Sheet http://www.stereotaxis.com/role/DisclosureDescriptionOfBusiness Description Of Business Notes 6 false false R7.htm 10201 - Disclosure - Summary Of Significant Accounting Policies Sheet http://www.stereotaxis.com/role/DisclosureSummaryOfSignificantAccountingPolicies Summary Of Significant Accounting Policies Notes 7 false false R8.htm 10301 - Disclosure - Inventories Sheet http://www.stereotaxis.com/role/DisclosureInventories Inventories Notes 8 false false R9.htm 10401 - Disclosure - Prepaid Expenses And Other Current Assets Sheet http://www.stereotaxis.com/role/DisclosurePrepaidExpensesAndOtherCurrentAssets Prepaid Expenses And Other Current Assets Notes 9 false false R10.htm 10501 - Disclosure - Property And Equipment Sheet http://www.stereotaxis.com/role/DisclosurePropertyAndEquipment Property And Equipment Notes 10 false false R11.htm 10601 - Disclosure - Intangible Assets Sheet http://www.stereotaxis.com/role/DisclosureIntangibleAssets Intangible Assets Notes 11 false false R12.htm 10701 - Disclosure - Accrued Liabilities Sheet http://www.stereotaxis.com/role/DisclosureAccruedLiabilities Accrued Liabilities Notes 12 false false R13.htm 10801 - Disclosure - Deferred Revenue Sheet http://www.stereotaxis.com/role/DisclosureDeferredRevenue Deferred Revenue Notes 13 false false R14.htm 10901 - Disclosure - Long-Term Debt And Credit Facilities Sheet http://www.stereotaxis.com/role/DisclosureLongTermDebtAndCreditFacilities Long-Term Debt And Credit Facilities Notes 14 false false R15.htm 11001 - Disclosure - Stockholders' Equity Sheet http://www.stereotaxis.com/role/DisclosureStockholdersEquity Stockholders' Equity Notes 15 false false R16.htm 11101 - Disclosure - Fair Value Measurements Sheet http://www.stereotaxis.com/role/DisclosureFairValueMeasurements Fair Value Measurements Notes 16 false false R17.htm 11201 - Disclosure - Product Warranty Provisions Sheet http://www.stereotaxis.com/role/DisclosureProductWarrantyProvisions Product Warranty Provisions Notes 17 false false R18.htm 11301 - Disclosure - Commitments And Contingencies Sheet http://www.stereotaxis.com/role/DisclosureCommitmentsAndContingencies Commitments And Contingencies Notes 18 false false R19.htm 11401 - Disclosure - Subsequent Events Sheet http://www.stereotaxis.com/role/DisclosureSubsequentEvents Subsequent Events Notes 19 false false R20.htm 20202 - Disclosure - Summary Of Significant Accounting Policies (Policies) Sheet http://www.stereotaxis.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies Summary Of Significant Accounting Policies (Policies) Policies http://www.stereotaxis.com/role/DisclosureSummaryOfSignificantAccountingPolicies 20 false false R21.htm 30203 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.stereotaxis.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables 21 false false R22.htm 30303 - Disclosure - Inventories (Tables) Sheet http://www.stereotaxis.com/role/DisclosureInventoriesTables Inventories (Tables) Tables http://www.stereotaxis.com/role/DisclosureInventories 22 false false R23.htm 30403 - Disclosure - Prepaid Expenses And Other Current Assets (Tables) Sheet http://www.stereotaxis.com/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsTables Prepaid Expenses And Other Current Assets (Tables) Tables http://www.stereotaxis.com/role/DisclosurePrepaidExpensesAndOtherCurrentAssets 23 false false R24.htm 30503 - Disclosure - Property And Equipment (Tables) Sheet http://www.stereotaxis.com/role/DisclosurePropertyAndEquipmentTables Property And Equipment (Tables) Tables http://www.stereotaxis.com/role/DisclosurePropertyAndEquipment 24 false false R25.htm 30703 - Disclosure - Accrued Liabilities (Tables) Sheet http://www.stereotaxis.com/role/DisclosureAccruedLiabilitiesTables Accrued Liabilities (Tables) Tables http://www.stereotaxis.com/role/DisclosureAccruedLiabilities 25 false false R26.htm 30803 - Disclosure - Deferred Revenue (Tables) Sheet http://www.stereotaxis.com/role/DisclosureDeferredRevenueTables Deferred Revenue (Tables) Tables http://www.stereotaxis.com/role/DisclosureDeferredRevenue 26 false false R27.htm 30903 - Disclosure - Long-Term Debt And Credit Facilities (Tables) Sheet http://www.stereotaxis.com/role/DisclosureLongTermDebtAndCreditFacilitiesTables Long-Term Debt And Credit Facilities (Tables) Tables http://www.stereotaxis.com/role/DisclosureLongTermDebtAndCreditFacilities 27 false false R28.htm 31003 - Disclosure - Stockholder's Equity (Tables) Sheet http://www.stereotaxis.com/role/DisclosureStockholderSEquityTables Stockholder's Equity (Tables) Tables 28 false false R29.htm 31103 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.stereotaxis.com/role/DisclosureFairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.stereotaxis.com/role/DisclosureFairValueMeasurements 29 false false R30.htm 31203 - Disclosure - Product Warranty Provisions (Tables) Sheet http://www.stereotaxis.com/role/DisclosureProductWarrantyProvisionsTables Product Warranty Provisions (Tables) Tables http://www.stereotaxis.com/role/DisclosureProductWarrantyProvisions 30 false false R31.htm 40101 - Disclosure - Description Of Business (Details) Sheet http://www.stereotaxis.com/role/DisclosureDescriptionOfBusinessDetails Description Of Business (Details) Details http://www.stereotaxis.com/role/DisclosureDescriptionOfBusiness 31 false false R32.htm 40201 - Disclosure - Summary Of Significant Accounting Policies (Narrative) (Details) Sheet http://www.stereotaxis.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNarrativeDetails Summary Of Significant Accounting Policies (Narrative) (Details) Details http://www.stereotaxis.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies 32 false false R33.htm 40202 - Disclosure - Summary Of Significant Accounting Policies (Computation Of Basic And Diluted EPS) (Details) Sheet http://www.stereotaxis.com/role/DisclosureSummaryOfSignificantAccountingPoliciesComputationOfBasicAndDilutedEpsDetails Summary Of Significant Accounting Policies (Computation Of Basic And Diluted EPS) (Details) Details http://www.stereotaxis.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies 33 false false R34.htm 40301 - Disclosure - Inventories (Details) Sheet http://www.stereotaxis.com/role/DisclosureInventoriesDetails Inventories (Details) Details http://www.stereotaxis.com/role/DisclosureInventoriesTables 34 false false R35.htm 40401 - Disclosure - Prepaid Expenses And Other Current Assets (Details) Sheet http://www.stereotaxis.com/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsDetails Prepaid Expenses And Other Current Assets (Details) Details http://www.stereotaxis.com/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsTables 35 false false R36.htm 40501 - Disclosure - Property And Equipment (Details) Sheet http://www.stereotaxis.com/role/DisclosurePropertyAndEquipmentDetails Property And Equipment (Details) Details http://www.stereotaxis.com/role/DisclosurePropertyAndEquipmentTables 36 false false R37.htm 40601 - Disclosure - Intangible Assets (Details) Sheet http://www.stereotaxis.com/role/DisclosureIntangibleAssetsDetails Intangible Assets (Details) Details http://www.stereotaxis.com/role/DisclosureIntangibleAssets 37 false false R38.htm 40701 - Disclosure - Accrued Liabilities (Narrative) (Details) Sheet http://www.stereotaxis.com/role/DisclosureAccruedLiabilitiesNarrativeDetails Accrued Liabilities (Narrative) (Details) Details http://www.stereotaxis.com/role/DisclosureAccruedLiabilitiesTables 38 false false R39.htm 40702 - Disclosure - Accrued Liabilities (Schedule Of Accrued Liabilities) (Details) Sheet http://www.stereotaxis.com/role/DisclosureAccruedLiabilitiesScheduleOfAccruedLiabilitiesDetails Accrued Liabilities (Schedule Of Accrued Liabilities) (Details) Details http://www.stereotaxis.com/role/DisclosureAccruedLiabilitiesTables 39 false false R40.htm 40801 - Disclosure - Deferred Revenue (Details) Sheet http://www.stereotaxis.com/role/DisclosureDeferredRevenueDetails Deferred Revenue (Details) Details http://www.stereotaxis.com/role/DisclosureDeferredRevenueTables 40 false false R41.htm 40901 - Disclosure - Long-Term Debt And Credit Facilities (Narrative) (Details) Sheet http://www.stereotaxis.com/role/DisclosureLongTermDebtAndCreditFacilitiesNarrativeDetails Long-Term Debt And Credit Facilities (Narrative) (Details) Details http://www.stereotaxis.com/role/DisclosureLongTermDebtAndCreditFacilitiesTables 41 false false R42.htm 40902 - Disclosure - Long-Term Debt And Credit Facilities (Schedule Of Debt Outstanding) (Details) Sheet http://www.stereotaxis.com/role/DisclosureLongTermDebtAndCreditFacilitiesScheduleOfDebtOutstandingDetails Long-Term Debt And Credit Facilities (Schedule Of Debt Outstanding) (Details) Details http://www.stereotaxis.com/role/DisclosureLongTermDebtAndCreditFacilitiesTables 42 false false R43.htm 41001 - Disclosure - Stockholders' Equity (Narrative) (Details) Sheet http://www.stereotaxis.com/role/DisclosureStockholdersEquityNarrativeDetails Stockholders' Equity (Narrative) (Details) Details http://www.stereotaxis.com/role/DisclosureStockholdersEquity 43 false false R44.htm 41002 - Disclosure - Stockholders' Equity (Summary Of Option And Stock Appreciation Rights Activity) (Details) Sheet http://www.stereotaxis.com/role/DisclosureStockholdersEquitySummaryOfOptionAndStockAppreciationRightsActivityDetails Stockholders' Equity (Summary Of Option And Stock Appreciation Rights Activity) (Details) Details http://www.stereotaxis.com/role/DisclosureStockholdersEquity 44 false false R45.htm 41003 - Disclosure - Stockholders' Equity (Summary Of Restricted Stock Unit Activity) (Details) Sheet http://www.stereotaxis.com/role/DisclosureStockholdersEquitySummaryOfRestrictedStockUnitActivityDetails Stockholders' Equity (Summary Of Restricted Stock Unit Activity) (Details) Details http://www.stereotaxis.com/role/DisclosureStockholdersEquity 45 false false R46.htm 41101 - Disclosure - Fair Value Measurements (Narrative) (Details) Sheet http://www.stereotaxis.com/role/DisclosureFairValueMeasurementsNarrativeDetails Fair Value Measurements (Narrative) (Details) Details http://www.stereotaxis.com/role/DisclosureFairValueMeasurementsTables 46 false false R47.htm 41102 - Disclosure - Fair Value Measurements (Assets And Liabilities Measured At Fair Value On Recurring Basis By Level) (Details) Sheet http://www.stereotaxis.com/role/DisclosureFairValueMeasurementsAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisByLevelDetails Fair Value Measurements (Assets And Liabilities Measured At Fair Value On Recurring Basis By Level) (Details) Details http://www.stereotaxis.com/role/DisclosureFairValueMeasurementsTables 47 false false R48.htm 41103 - Disclosure - Fair Value Measurements (Summary Of Changes In Fair Value Of Level 3 Financial Liabilities) (Details) Sheet http://www.stereotaxis.com/role/DisclosureFairValueMeasurementsSummaryOfChangesInFairValueOfLevel3FinancialLiabilitiesDetails Fair Value Measurements (Summary Of Changes In Fair Value Of Level 3 Financial Liabilities) (Details) Details http://www.stereotaxis.com/role/DisclosureFairValueMeasurementsTables 48 false false R49.htm 41201 - Disclosure - Product Warranty Provisions (Details) Sheet http://www.stereotaxis.com/role/DisclosureProductWarrantyProvisionsDetails Product Warranty Provisions (Details) Details http://www.stereotaxis.com/role/DisclosureProductWarrantyProvisionsTables 49 false false R50.htm 41401 - Disclosure - Subsequent Events (Details) Sheet http://www.stereotaxis.com/role/DisclosureSubsequentEventsDetails Subsequent Events (Details) Details http://www.stereotaxis.com/role/DisclosureSubsequentEvents 50 false false All Reports Book All Reports stxs-20160630.xml stxs-20160630.xsd stxs-20160630_cal.xml stxs-20160630_def.xml stxs-20160630_lab.xml stxs-20160630_pre.xml true true ZIP 69 0001193125-16-677968-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-16-677968-xbrl.zip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

Large accelerated filer

Accelerated filer

Non-accelerated filer

¨ (Do not check if a smaller reporting company)

Smaller reporting company